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The involvement of human papilloma virus (HPV) in the aetiology 
and progression of cervical intraepithelial neoplasia (CIN) is still 
unresolved. This study was designed to assess the immunological 
responses to HPV types in patients presenting with varying degrees of 
CIN and in control groups, using in vitro measures of cellular and 
humoral responses. 
Lymphocyte proliferation assays (LPA) were performed using 
peripheral blood mononuclear cells (PBM) and various papillomavirus (PV) 
antigens. Twenty -five per cent (23/92) of patients with CIN responded 
to antigens derived from purified BPV, HPV -1 or HPV -2 with or without 
detergent disruption. The responses correlated with a past history of 
skin warts rather than cervical abnormalities, and the percentage of 
responders was similar to that in laboratory personnel (30 %) and lower 
than that in a group with recalcitrant common warts (50 %). Antigens 
specific to HPV -16 and HPV -18, in the form of bacterially expressed 
fusion proteins derived by the transcription and translation of the E6 
and E4 open reading frames (ORF), occasionally produced specific 
positive responses, provided contaminating E.coli B galactosidase 
sequences had been removed during purification. Responses were low 
and suggested that the numbers of memory T cells specific to PV 
antigens were low and at the lower limit of detection of LPA. An 
indirect ELISA was developed to detect circulating IgG to PV antigens 
in colposcopy patients. Fifty per cent of patients had antibodies to 
disrupted HPV -1, HPV -2 or both, suggesting that a predominantly 
type- specific response was being detected. No correlation of immune 
responses with a degree of dysplasia or the presence of koilocytes in 
cervical biopsies was noted, but a high incidence of forgotten or 
inapparent past infection with cutaneous HPV types was found. 
In situ hybridisation (ISH) methods using non -radioactively labelled, 
cloned probes and synthetic oligonucleotide probes were developed for 
use on paraffin sections. Synthetic probes allowed a quicker, less 
destructive hybridisation protocol, with the sensitivity of detection being 
(y) 
improved by an anti -biotin -immunogold conjugated immunoglobulins -silver 
enhancement (IGSS) detection system. Double staining of PV antigen 
and nucleic acid on the same section was achieved. Synthetic 
oligonucleotides offer an exciting new tool for diagnostic virology, 
worthy of exploitation in many systems. 
Implantation of human foreskin infected with HPV -11 was shown to 
provide an animal model, albeit technically difficult, in which HPV could 
be produced, but a more practical technique of productive HPV infection 
in vitro is still required if the biology and pathogenesis of HPV 
infections is to be clarified further. 
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INTRODUCTION 
1. General Introduction 
Papillomaviruses form one genus of the Papovaviridae family of 
small icosahedral viruses containing double- stranded circularly closed 
DNA. Papillomaviruses (PV; from papilla meaning nipple and orna 
meaning tumour) are widely distributed in nature and occur in numerous 
animal species including rabbits, hamsters, sheep, goats, deer, cattle, 
horses, dogs, monkeys and even birds (Pfister, 1984). Man is no exception 
and human papillomavirus (HPV) has long been recognised as the 
causative agent of skin warts (Strauss et al., 1 950). As such it was 
considered to be the first known human tumour virus (Rowson & Mahy, 
1967). The structural properties of the virus were well worked out in 
the early 1960's because large quantities of virus could be obtained from 
clinical lesions such as plantar warts, but, in defying all attempts to 
culture it in vitro, HPV effectively by- passed that era of virology when 
the biology and pathology of viral infectivity and replication was worked 
out for those viruses which grew readily in cell culture. The literature 
of the 60's and early 70's is full of unsuccessful attempts to learn more 
of the infectious nature of this virus (see Cubie, 1972a). It required, 
however, the leap into biology at the molecular level rather than virology 
at the particle level for progress to be achieved and interest in HPV to 
be renewed. 
The last ten years have seen a fruitful collaboration between 
molecular biologists, virologists, clinicians and veterinarians, and the 
picture of HPV involvement in tumour progression which has unfolded is 
fascinating and still far from complete. The work presented here offers a 
further fragment in the enigmatic jigsaw of HPV pathogenesis. 
- 2 - . 
2. General Characteristics of Papillomaviruses 
2.1. Virus Structure 
The Papillomaviruses (PVs) are non -enveloped, icosahedral 
particles of 50 -55 nm in diameter (Crawford and Crawford, 1963) with 
the capsid composed of 72 capsomeres, and for human 
papillomaviruses these are arranged in a righthanded lattice (Klug 
and Finch, 1965). The subunits have a hollow, cylindrical structure 
(Noyes, 1964) and are connected at their base by bridge -like structures 
(Yabe et al., 1979) as shown in Figure 1. Double stranded DNA is 
contained within the capsid and "full particles" can be readily separated 
by equilibrium gradient centrifugation in caesium chloride from "empty 
particles" devoid of DNA (Breedis et al., 1962). 
Virion protein makes up about 88% of the particle mass 
(Crawford, 1969) with up to ten polypeptides having been detected in 
different PVs on polyacrylamide gel electrophoresis (PAGE) after sodium 
dodecyl sulphate (SDS) disruption (Favre et al., 1975a). The capsomere 
subunit in each PV type was represented by the major polypeptide of 
MW 54,000 daltons and in different studies there appeared to be up to 
six irregularly detected polypeptides (Favre et al., 1977; Pfister et al., 
1977; Lancaster and Olson, 1978). These were considered to be 
breakdown products of the major polypeptide, produced by the use of 
trypsin during purification (Pfister et al., 1977). In addition, four low 
molecular weight polypeptides closely associated with DNA and 
comparable to cellular histones were resolved (Lancaster and Olson, 
1982). Using further purification procedures, Meinke and Meinke (1981) 
confirmed the major capsid protein to have a MW of 53,500 daltons, to 
be very acidic and negatively charged as with structural subunits of 
other viruses. These workers also noted two slightly smaller 
polypeptides, the histone -like peptides and in addition, two large 
polypeptides in low concentration but with MWs greater than 70,000 
daltons. The inability to obtain viral material free of contaminating 
4a 
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Fig 1 Structure of HPV Particles 
A. Negatively stained particles showing hexagonal (a) and pentagonal 
(b) contours. 
B. Tentative model showing twofold (a), threefold (b) and fivefold (c) 
axes of symmetry. 
(From Yabe Y, Sadakane H and Isono H (1979): Virology 96, 547 -552). 
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protein made these early results difficult to interpret, and it is only 
very recently, by the use of molecularly cloned and expressed viral 
fragments that more light has been shed on the protein content of PVs 
(vide infra). 
The DNA of all PVs is double stranded, circular and 
supercoiled (Crawford, 1 969) and has a MW of 5 x 106, corresponding to 
approximately 8000 base pairs (bp) (Kleinschmidt et al., 1965). 
Experiments on polyoma using mild chemical reducing agents to induce 
progressive scission in the chain (Vinograd et al., 1965) suggested the 
unusual twisted circular form for papovavirus DNA and, in electron 
micrographs of HPV, supercoiled (Component I) and open rings 
(Component II) are easily seen (Follett and Crawford, 1967). There are 
20 turns in the supercoiled form, estimated by the use of ethidium 
bromide as an intercalating agent (Crawford and Waring, 1967). 
The DNA of the cottontail rabbit papilloma virus (CRPV), 
described by Shope in 1933, was the first tumour virus DNA to be 
analysed in detail, and was found to have an adenine plus thymine 
(A +T) to guanine plus cytosine (G +C) ratio of 1.08 (Watson and 
Littlefield, 1960). Buoyant density measurements of HPV -DNA showed 
a slightly lower G +C content (Crawford and Crawford, 1963). 
Nevertheless, using the current technology of the time with nearest 
neighbour sequence analysis, Subak -Sharpe and his colleagues (1966) 
concluded that HPV and CRPV were similar to each other and to their 
host DNAs in the patterns of doublets obtained. 
2.2 Papillomavirus Plurality and Relatedness 
2.21 Early Studies 
The infectious nature of skin warts and their transmissibility 
within sterile cell free filtrates of lesions was well recognised in the 
later 19th and early 20th centuries (Ciuffo, 1907 and see Cubie, 1972a). 
Not long after, the apparent identity between the filterable agent of 
- 4 - 
genital warts and common warts was shown by transmission experiments 
(Waelsch, 1918) and for more than 50 years thereafter, despite the 
diversity of clinical lesions induced, it was thought that the same agent 
was involved. Differences in clinical morphology were thought to be 
related to anatomical site, the age of the lesion and to host -related 
factors (Rowson and Mahy, 1967). This belief was maintained by early 
studies searching for antigenic variation: reactions of identity in 
Ouchterlony gel diffusion tests with human antisera were obtained using 
antigens from simple plantar warts, mosaic plantar warts and common 
hand warts (Ogilvie, 1970 -). On the other hand, Almeida and her 
colleagues in 1969 suggested that antigenic differences did exist between 
skin wart virus and the virus causing genital warts with a one way 
serological cross between them : antisera to skin warts reacted with 
both skin and genital wart viruses while antisera to genital warts 
reacted only with genital warts. Epidemiological data suggesting that 
venereal transmission was the main route of infection with genital warts 
(Oriel, 1971a) added weight to the view that two HPV types existed and 
the absence of sequences homologous to skin wart DNA in genital 
warts in the first molecular hybridisation experiments (zur Flausen et 
aí.,1974; Delap et al., 1976) supported this. 
Early on it had also appeared that there was no antigenic 
cross -reaction between papilloma virions of different species in 
immunodiffusion studies (Le Bouvier et al., 1966); Favre et al., 1974). 
However, common antigenic determinants could be detected in plantar 
wart sections by using serum from rabbits bearing CRPV- induced 
carcinomas in which virus replication was incomplete (Orth et al., 1978). 
The effect could be neutralised by preincubation with alkali disrupted 
HPV virions but not with intact particles. These results suggested the 
existence of a common internal antigen and this was confirmed by 
Jenson et al., (1980) using antiserum to SDS- disrupted BPV. 
- 5 
2.22 Molecular Advances 
Following the discovery of the specific nature of the double 
stranded breaks produced by restriction endonucleases (Smith and Wilcox, 
1970), together with the ability to separate and resolve the resulting 
fragments by electrophoresis, rapid advances were made in the study of 
the structure of the genomes of PVs. The first physical map of 
HPV -DNA was produced by Favre et al. (1975b) using DNA from plantar 
warts. In addition to the three breaks produced by HindII and HindIII 
endonucleases, they found two Eco RI cleavage sites in their 
preparation. However, the observation of different but very weak 
electrophoretic bands at the detection limit of their system, suggested 
to these authors the presence of sequence rearrangements, or, as 
became increasingly and rapidly apparent, HPV "variants ". In 1974, zur 
Hausen and colleagues had shown that cRNA to component I DNA from 
plantar warts did not hybridise with all common wart samples tested, 
and in 1976, Gissmann and zur Hausen found two different cleavage 
patterns in three individual preparations of plantar warts. By 1977, 
the same workers had described four different cleavage patterns from 
26 separate preparations of plantar and common warts, and called them 
HPV -1, 2, 3, and 4 (Gissmann et al., 1977). Orth's group in Paris 
(Orth et al., 1977) similarly described three types, one of which 
corresponded to the most frequently found pattern in Gissmann's study, 
and which was associated with plantar warts rich in virus particles. 
These preparations were also designated HPV -1, 2 and 3. At the same 
time, two classes of bovine papilloma virus (BPV -1 and BPV -2) were 
described by Lancaster & Olson (1978), and it became clear that a 
classification system for PVs was required. Following an international 
meeting in Alabama in 1978, a scheme was established (Coggin & zur 
Hausen, 1979) whereby papillomaviruses would be designated PV and the 
species conveyed by the first two letters of the specific name, with the 
exception of human and bovine PVs which were designated by convention 
as HPV and BPV. New preparations could be considered independent 
- 6 
types when there was less than 50% homology between them as shown 
by DNA -DNA hybridisation and sub -types where the homology was 
incomplete but > 50%. Where possible, type- specific differences were 
to be confirmed by significant titre changes in reciprocal assays of 
standard serological procedures. 
A major problem, however, in these early studies on the DNA 
isolated from individual lesions, was the minute amount of nucleic acid 
available for such tests. The use of molecular cloning of PV genomes 
into bacterial plasmid, (Heilman et al., 1980 ; De Villiers et al., 1981), 
however, enabled large quantities of homogeneous genetic material to 
be produced and further increased the intensity of the search for 
additional HPV types. By 1987, 50 types of HPV had been 
differentiated (Pfister, 1987a) and in the last year a further 7 have 
been accepted as new types (von Knebel Doeberitz et al., 1988). 
The identification of an unknown papilloma virus is currently based on 
molecular cloning of its DNA followed by blot hybridisation to all known 
types (Gissmann, 1984). These types are organised in groups according 
to the extent of their homologies and these are shown in Table 1, with 
the common types depicted in bold. Only a few types have been 
totally sequenced, in particular, HPV -1 a (Danos et al., 1982); HPV -6b 
(Schwarz et al., 1983); HPV -16 (Seedorf et al. 1985 and corrected by 
Baker et al., 1987); 1-1PV -11 (Dartman et al., 1986); HPV -18 (Cole & 
Danos., 1987) and HPV -5 (Zachow et al., 1987). Because of its 
heterogeneity, HPV -2 remains unsequenced. The judicious use of single 
restriction endonucleases allows differentiation of many HPV types and 
this is shown in Figure 2 for the enzyme Pst 1. 
While many more types have been recognised in the human 
system, there are now known to be at least six types of BPV of which 
BPV-1, BPV -2 and BPV -4 have been sequenced (Chen et al., 1982; 
Groff, Mitra and Lancaster, 1986; Patel 1987, 
respectively). So far only a single type of CRPV has been recognised 
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HPV lA HPV 2A HPV 3A HPV 4 HPV SA HPV 6B HPV 7 HPV 8 HPV 10 HPV 11 HPV 16 HPV 18 
Fig 2. Pst -1 restriction site maps of common HPV: 
(adapted from von Knebel Doeberitz C, Bunge R, Buchert J 
and de Villiers E -M, 1988). 
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2.3 Genetic Organisation in Papillomaviruses 
Analysis of the nucleotide sequence homology between 
different PV under conditions of reduced stringency enabled Law and 
co- workers (1979) to show as much as 70% homology in certain regions 
between HPV -1, BPV -1, BPV -2 and CRPV. The regions of conserved 
homology appeared specific for the Papilloma genus since no stable 
hybrids could be detected between the DNA of HPV -1 and either 
polyoma, SV40 or BK virus. Because the homologous regions were not 
contiguous, it was thought that one of the conserved sequences must 
encode a portion of a capsid protein to explain the common 
genus- specific internal antigen. 
Following complete sequencing of HPV -1 a and BPV -1 it 
became evident that the genomes of both were organised in a similar 
fashion, each containing a single coding DNA strand on which open 
reading frames (ORFs) in all three frames were similarly distributed. 
The other strand appeared to be blocked by many stop codons in each 
of the reading frames (Danos et al., 1982; Chen et al., 1982). Danos 
and his colleagues defined two regions of the HPV -la genome : a 
putative early region containing two large ORFs designated El and E2 
and several split ones, and a late region also with two large ORFs, L 1 
and L2, considered to encode the structural polypeptides (Danos et al., 
1982). In 1980 an American group had shown that both BPV DNA from 
virons, and cloned BPV -1 or BPV -2 DNA could transform mouse cells 
(Lowy et al., 1980). A cloned fragment representing 69% of the 
genome was all that was required and five distinct transcripts mapping 
on this fragment were found within transformed cells. The 31% 
fragment was not expressed in the transformed cells but only in 
productively infected cells. This fragment, like the L region of 
HPV -1 a, was shown to contain two large ORFs separated by a single 
translational stop codon and to encode the major capsid protein (Chen 
et al., 1982). By working together, the French and American workers 
showed most elegantly how similar was the overall organisation between 
- 8 
HPV -1 a and BPV -1. By aligning the regions of greatest homology (in 
L 1, El /E2 and the beginning of L2), and starting the nucleotide 
numbering from the Hpa -I site in both, eight ORFs coding for peptides 
of more than 90 amino acids were designated in the early region and 
numbered El to E8 on the basis of their size, homology and location, 
while two ORFs encoding structural proteins, designated L1 and L2 and 
transcribed only in productively infected cells were found in the late 
region (Danos et al., 1983). The L1 of both viruses showed extensive 
homology, with divergence occurring simply by an accumulation of point 
mutations. The L2 regions were much more variable and it was 
suggested that the peptide coded by this region might play a role in 
host restriction. 
Little homology was detected in the region of the genomes 
where E2, E3 and E4 overlapped. Polypeptides encoded by E6 and E7 
would have sparse amino acid homology but would be rich in 
Cys -X -X -Cys moieties suggesting that the tertiary structure would be 
maintained despite divergence in the primary amino acid sequence. E5 
and E8 were found to be quite different on each viral genome. 
Finally, a non -coding region (NCR) between the end of L 1 and start of 
E6 also showed several conserved sequences, suggesting regulatory 
signals for viral gene expression and DNA replication. Recently it has 
been shown that the NCR contains not only promoter and enhance'; 
elements, but also a glucocorticosteroid -reactive element (GRE) which 
can be activated by dexamethasone with resulting increase in 
transcription (Gloss et al., 1987). 
This important comparative analysis led the way for further 
studies on the genomic organisation of different papillomaviruses, and 
despite considerable sequence heterology, similar organisation was shown 
in the first ten papillomaviruses whose complete DNA sequences were 
determined (Giri and Danos, 1986). A composite figure of several 
established profiles is presented in Figure 3. Nevertheless, it must be 










































































































































































































































































































biologically similar properties to different Papillomaviruses. Indeed, 
minor sequence divergence in one region may cause major biological 
differences while apparently more major nucleotide changes may be 
irrelevant in terms of pathogenic properties (Pfister, 1987( 1). 
2.31 Gene Function 
BPV was shown many years ago to be capable of transforming 
bovine and mouse fibroblasts in culture (Black et al., 1963; Thomas et 
al., 1964) and more recently this has been confirmed using type specific 
BPV -1 and BPV -2 virions of fibropapilloma origin (Dvoretsky et al., 
1980), extracted BPV -1 and BPV -2 DNA (Law et al., 1981; Moar 
et al., 1981), molecularly cloned BPV -1 and BPV -2 DNA (Lowy et al., 
1980) and BPV -4 DNA from a truly epitheliotropic virus (Campo and 
Spandidos, 1983). Much of the information on gene function in PV has 
been obtained from the study of mouse cell lines morphologically 
transformed by BPV -1, within which the genome replicates autonomously 
in the nucleus as a multicopy plasmid (Schiller, 1987). In such cells, 
only the E genes are transcribed and then only at very low levels. 
Indeed, between 0.1 -0.2% of the mRNA species in a BPV transformed 
cell is of viral origin and some mRNA species represent only a very 
small fraction of the total (Yang et al., 1985). As a result, several 
predicted mRNA species remain undiscovered, but gradually a picture of 
gene function and interaction is emerging. 
In the BPV -1 plasmid replication system, replication and 
transformation are intricately tied. A functional El is required for 
replication of the plasmid since El mutants become integrated (Broker 
and Botchan, 1986) and El itself consists of two genes, one of which is 
required directly for replication while the other modulates that 
replication (Schiller, 1987). The BPV E2 ORF transactivates early gene 
expression via an enhancer in the long control region (LCR). This 
mechanism of gene regulation is conserved between PVs since BPV E2 
can transactivate the expression of HPV genomes with the E2 product 
- 10 - 
binding directly to the conserved enhancer sequence ACCG -CGGT 
(Phelps and Howley, 1987). Very recent extension of these findings has 
shown that different E2 proteins transactivate transcription by a 
common mechanism (Giri and Yanif, 1988). Not only did the E2 of 
HPV -18 or BPV -1 transactivate the LCR of CRPV, but the E2 of CRPV 
acted similarly on the LCR of BPV -1, HPV -1 and HPV -18. 
The E6 gene is capable of independently transforming C127 
mouse cells (Schiller et 041130. It can also act synergistically with E5, 
another independent transforming gene, which is so similar in those PVs 
which induce fibropapillomas that it may play a major role in the 
proliferation of dermal elements (Schiller, 1987). E7 does not have 
intrinsic transforming ability, but in the BPV -1 system it can act with 
E6 to play a role in the maintenance of high plasmid copy number 
(Lusky and Botchan, 1985). 
It is becoming apparent, however, that BPV gene functions 
cannot be extrapolated entirely to the HPV system. In HPV -16 and 
HPV -18, for example, transforming activity has been principally assigned 
to E7 (Smotkin and Wettstein, 1987; Kanda et al., 1988), and E5 is 
often deleted during integration of HPV -16/18 into the host genome 
(Schwarz et al., 1985). The E6 -E7 region is consistently transcribed in 
cervical tumour cell lines with three transcripts, E6, E7 and E6* formed 
by the removal of 182 nucleotides from within E6 (Schwarz and 
Schneider- Gadicke, 1986). Sequence comparison suggests the spliced 
transcript could only be found in HPV types 16, 18, 31 and 33 and not 
in HPV -1, or HPV -6/11 which lack the appropriate donor -acceptor splice 
sites (Schwarz et al., 1987). Thus the E6* transcript may provide an 
important difference between high and low oncogenicity in HPV types. * 
Details of the currently established functions of BPV genes are 
presented in Table 2, together with known functions of HPV and CRPV 
genes. 
Additional gene functions for particular sequences have been 

































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































product from the conserved sequences of BPV -1 , HPV -1 and HPV - 
6 was remarkably similar to that of polyoma and SV40 large T antigen. 
Similarly the E4 of HPV -8 showed homology with EBV -EBNA 2, 
necessary for the immortalisation of B lymphocytes by EBV. A similar 
function could explain the frequent malignant conversions associated 
with HPV -8 (Fuchs et al., 1986). Recently the E7 gene was shown to 
have a similar function to Adeno El a in transactivating the Adeno E2 
gene (Phelps et al., 1988). Since the El a gene product can complex 
with retinoblastoma gene product to disrupt its tumour suppressor 
effects (Whyte et al., 1988), it could be that HPV E7 ORF has a 
similarly disruptive effect on normal cellular control functions. 
This mechanism of gene regulation is conserved between PVs 
since BPV E2 can transactivate the expression of HPV genomes, with 
the E2 product binding directly to the conserved enhancer sequence, 
ACCG -CGGT (Phelps and Howley, 1987). Very recent extension of 
these findings has shown that different E2 proteins transactivate 
transcription by a common mechanism (Giri and Yanif, 1988). Not only 
did the E2 of HPV -18 or BPV -1 transactivate the LCR of CRPV, but 
the E2 of CRPV acted similarly on the LCR of BPV -1, HPV -1 and 
HPV -18. 
2.32 Gene Products 
The 31% non -transforming genomic fragment containing only 
two large ORFs is considered to encode the structural proteins found in 
productively infected cells. By indirect evidence from arrimo acid 
analysis, the major capsid protein of BPV -1 particles was assigned to 
the L 1 ORF (Meinke and Meinke, 1981) and this was confirmed by 
finding that sera raised against disrupted BPV -1 particles would react 
with synthetic L1 but not L2 (Pilacinski et al., 1984). Since BPV -1 
virion antigens also react with antibodies to L2, it was considered that 
L2 also encoded a viral structural polypeptide (Pilacinski et al., 1984). 
Extensive studies by Western blotting with antisera produced 
- 12 - 
against individually expressed ORFs of HPV -1 a have shown that the 
major virion polypeptide of MW 57,000 (and equivalent to VP1 of Favre 
et al., 1975 and protein 2 of Gissmann et al., 1977) was the primary 
product of L1 (Doorbar and Gallimore, 1987). Very low levels of 
proteins of MW 50,000 and 43,000 (VP2 and 3 or proteins 3 and 4 of 
the earlier studies) were shown to be breakdown products only 
occasionally detected, with their frequent detection in early studies 
being due to the use of trypsin in virus purification. A polypeptide of 
MW 78,000 (and equivalent to the 76,000 polypeptide noted by Orth et 
al., (1977) or the 86,000 protein reported by Gissman et al., (1977)) was 
considered to be the product of L2, with a 65,000 moiety as its 
occasional breakdown product (Doorbar and Gallimore, 1987). 
At the amino acid level, the L 1 product is rich in cysteine 
(Chen et al., 1982). This protein is highly conserved between different 
PVs ( Danos et al., 1982; Schwarz et al., 1983; Giri et al., 1985; 
Seedorf et al., 1985; Fuchs et al., 1986) and the resultant covalently 
linked subunits give a molecule which is resistant to SDS disruption. 
The L2 product, on the other hand, lacks cysteine and dissociates 
readily in SDS. As a result, while antisera to both L 1 and L2 produce 
similar staining patterns in sections of warts, only the antiL1 serum will 
cross -react with other PVs. The use of SDS -disrupted BPV particles to 
produce a group -specific antiserum is therefore readily explained by the 
lack of dissociation of conserved L 1 and the dissociation of 
non -conserved, type- specific L2. 
It has long been known that the purification of virions from 
infected tissue may yield heavy full (buoyant density 1.36 g /ml) and 
light full (1.34 g /ml) as well as empty (1.29 g /ml) particles (Pass and 
Maizel, 1973) and it has recently been suggested by Mose- Larsen et al. 
(1987) that in BPV -1 at least, the heavy full particles contain a 
glycosylated form of L I. The increase in molecular 
mass is associated with charge modifications of L 1 thought to be 
necessary to reduce the conformational stress between adjacent subunits 
- 13 - 
on the 5- and 6- fold axes of symmetry. Doorbar and Gallimore 
(1987) suggested an alternative reason for heavy full particles might be 
the presence of larger amounts of the heavier L2 in such particles. 
Yet another explanation for heavier particles may come from 
the presence in highly purified HPV -1 virions of E4 proteins. Although 
described as an early gene, E4 products have many of the 
characteristics of late proteins and are found in abundance in HPV -1 
induced lesions, representing as much as 20% of total wart protein 
content (Doorbar et al., 1986). These products are associated with 
cytoplasmic and nuclear inclusions ( Croissant et al., 1985) and 
electrophoretic analysis shows doublets of 16 and 17,000 MW and of 10 
and 11,000 MW (Doorbar et al., 1986). The 17,000 MW moiety is 
synthesised deep in wart tissue and as it decreases it is replaced by the 
16,000 product. In the middle layers, antigenically related species of 
various sizes are found, probably as a result of post translational 
modification, and in the superficial layers, the 10 and 11,000 species 
predominate (Breitburd et al., 1987). The existence of E4 proteins as 
doublets, their persistence in the upper layers and their accumulation in 
granules is reminiscent of filaggrin, a component of keratohyalin 
granules (Breitburd et al., 1987) and indeed, E4 products do bind to 
filaggrin by electrostatic attraction (Doorbar et al., 1988). 
Although the function of E4 proteins is unknown, their 
production in parabasal layers of productively infected cells suggests a 
role in virion maturation (Doorbar et al., 1986) while its great 
abundance in HPV -1 lesions and not in others may reflect an influence 
on the amount of virus produced (Breitburd et al., 1987). Recently 
Doorbar and his colleagues (1988, personal communication) have 
postulated that the binding of E4 and filaggrin prevents the formation 
of a cross -linked keratin matrix in superficial cells, possibly allowing 
virus to escape more readily from fragile cells. 
The search for specific gene products of PVs has gained 
momentum as the transforming potential of both BPV and HPV has been 
- 14 - 
exploited. The ready availability of transformed cervical cell lines 
containing HPV such as HeLa (HPV -18), CaSki (HPV -16; Patillo, 1977; 
Yee et al., 1985) and SiHa (HPV -16; Friedl et al., 1970; Yee et al., 
1985) has enabled specific mRNAs and their translated products to be 
identified]. Thus, the E2 of CRPV has been detected equally in both 
benign and malignant tumours (1 Jetts.tciq et al., 1987) as a highly 
phosphorylated protein of MW 42000, while the E5 gene product of 
BPV -1 is a very hydrophobic protein of 44 amino acids associated with 
cell membranes (Schlegel et al., 1986). E5 is the smallest viral 
transforming protein yet characterised. The E6 protein of BPV -1 can 
be detected in both the nuclear and membrane fractions (Androphy et 
al., 1985). It has a MW of 15,500 and its regularly spaced 
Cys -x -x -Cys sequences reveal possible zinc ion binding. 
Transcription of El was shown by Pater and Pater (1985) but 
the major transcripts in cervical carcinoma cell lines and in biopsies of 
cervical carcinomas are from the E6 /E7 region (Smotkin and Wettstein, 
1987; Shirasawa et al., 1987) and protein products of E6 and E7 have 
been found in both (Seedorf et al., 1987; Smotkin and Wettstein, 1987; 
Banks et al., 1987) although they are not always detected (Lehn et al., 
1985; Pater and Pater, 1988). Indeed, a very recent report suggests 
that continued expression of E7 is essential for the maintenance of the 
transformed phenotype (Crook et al., 1989). Recent work suggests that 
the 20,000 E7 protein is a cytoplasmic phosphoprotein with similar zinc 
binding sequences as E6, abundantly produced but with a half -life of 
about 1 hour (Smotkin and Wettstein, 1987), while the 16,500 E6 
polypeptide may be expressed only at very low levels (Banks et al., 
1987). 
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3. Pathogenesis of Papillomaviruses 
3.1 General Biological Properties of PVs 
Infection of cutaneous or mucosal epithelium with 
papillomaviruses induces squamous tumours in a wide variety of animals. 
Such tumours usually show limited growth and often regress 
spontaneously (Massing and Epstein, 1963). Productive infection occurs 
only in fully differentiated squamous cells and electron microscopical 
analysis of cutaneous warts reveals virions in increasing numbers from 
the stratum granulosum through the stratum spinosum and eventually to 
crystalline arrays within the nuclei of degenerating keratinocytes (see 
Cubie, 1972a). 
It is generally believed that the virus infects basal cells of 
the epidermis following minor abrasions of the skin as has been shown 
for CRPV (Nasseri and Wettstein, 1984a) and establishment of infection 
may depend on the activation of cell division during healing. The 
expression of early viral genes to promote proliferation and delay 
activation of superficial keratinocytes leads to the characteristic 
hyperplasia of warts. The control of late gene expression, however, is 
tightly linked to the state of differentiation of the squamous cells. 
Thus, while in situ DNA or RNA hybridisation may reveal the presence 
of papilloma genomes and transcripts in the parabasal layers, structural 
proteins and particles are only found in the permissive terminally 
differentiated cells of the upper layers. 
3.2 Recent Attempts to Produce Models of PV Infection in the 
Laboratory 
3.21 Cell Culture Studies 
Despite the lack of success of early cell culture experiments 
with HPV (see Cubie 1972a; Cubie, 1974), attempts continued to be 
made to detect HPV activity in cultured cells. Butel (1972) obtained 
- 16 - 
transient stimulation of cellular DNA synthesis 24 hours after infecting 
foetal rabbit kidney cells with plantar wart virus, and in a similar 
experiment, Lancaster and Meinke (1975) obtained transient DNA 
synthesis in human lung fibroblasts after infection with HPV. Their 
cultures continued to contain a stable amount of HPV -DNA, equivalent to 
about 0.2 viral genomes /cell, throughout 40 cellular doublings. The cells 
were not transformed however and had the same life span as uninfected 
controls. In 1975 Eisinger and colleagues successfully infected a human 
epithelioid cell line with HPV from hand warts under condition of pH 
stress. The cells appeared to produce virus particles over many 
passages. This is the only record of a productive HPV infection 
in vitro, but the cell line died out and the experiment could not be 
repeated. (Eisinger, personal communication). 
Once it was realised that PV viral replication and virion 
assembly was only found in cells which were keratinising, interest 
switched to the culture of keratinocytes for HPV propagation. Direct 
expiant culture of the keratinocytes from epidermal warts (Niimura 
et al., 1975) laryngeal warts (Steinberg et al., 1982) and anogenital warts 
(Rose et al., 1987) has been described, but no evidence of vegetative 
growth was obtained. La Porta and Taichman (1982) successfully 
infected human foreskin keratinocytes grown on irradiated NIH 3T3 
feeder layers with HPV from plantar warts to produce a cell -line in 
which HPV -DNA persisted at 50 -200 copies /cell and replicated as a 
stable episome for up to 8 passages, but with no evidence of virus 
replication or cell transformation. Viral DNA replication occurred only 
in the proliferating cells and not in cells undergoing differentiation. 
Perhaps the use of epidermal growth factor, and cholera toxin to 
encourage proliferation prevented progression to vegetative production in 
the differentiated cells, or perhaps because HPV -1 does not normally 
infect genital epithelium, replication was blocked (Taichman et al., 1984). 
While no model for vegetative replication of HPV has yet 
evolved, the transformation of rodent cells with HPV of various types is 
- 17 - 
now well documented. Successful tranformation with focus formation 
of C127 cells by HPV -1 and HPV -5 DNA was reported by Watts et al., 
(1984). However, the HPV -1 clones grew poorly in soft agar and 
produced no tumours in nude mice, whereas HPV -5 clones showed both 
anchorage independence and tumorigenicity. DNA remained as multiple 
persistent episomal copies. These results with HPV -1 DNA have not 
been reproduced by others, although some success with HPV -8 cloned 
fragments from the E6 region was recently reported when the 
transfotmaion was driven by a retroviral LTR. (Iftner et al., 1988). 
Cloned HPV -1, 2, 3, 4 and 9 were successfully transfected with the HSV 
thymidine kinase (tk +) gene into mouse L cells lacking tk. Integration 
of the HPV -DNA into the host genome occurred in all cases (Brackmann 
et al., 1983). Similarly, co- transfection of HPV -1 DNA with origin - 
minus SV40 into rat fibroblasts or human keratinocytes led to integration 
of the HPV -1 (Burnett and Gallimore, 1983i1985),It should be noted, 
however, that co- transfection with dominant markers may make the 
recognition of transformed cells easier, but it may also per se 
encourage integration of those HPV types considered to be less 
oncogenic. 
HPV -16 DNA or specific fragments containing the E6 /E7 ORFs 
have been shown to transform mouse 3T3 cells (Yasumoto et al., 1986), 
rat 371 cells (Kanda et al., 1988), and primary rat cells in conjunction 
with activated ras gene and a retroviral LTR (Matlashewski et al., 1987) 
or activated ras in the presence of dexamethasone (Pater et al., 1988). 
HPV 16/18 DNA can also transform human foreskin fibroblasts and human 
epithelial cells (Pirisi et al., 1987; Kaur and McDougall, 1988; 
Matlashewski et al., 1988) and the transforming activity has been 
localised to the E6 /E7 region of the HPV -16 genome (Storey et al., 1988; 
Woodworth et al., 1989; Bedell et al., 1989). Di Paolo et al., (1987) 
noted that cells transformed by HPV -16 underwent drastic chromosomal 
alterations including deletion of chromosome 12 in the region of the 
Ki -ras -2 gene. Progressive integration of HPV sequences during 
- 18 - 
transformation was noted. Although transformed, the transfected human 
cells were not tumorigenic in nude mice, while the mouse cells were; 
this suggests that HPV -16 has oncogenic potential but that a unique 
interaction between viral DNA and the host cell is necessary to establish 
tumorigenicity with specific integration being required for progression to 
the fully malignant state. Recently Poiaescu et al. (1987) reported a 
cell, line in which multiple copies of HPV -18 were integrated at a single 
heritable fragile site on chromosone 12 and noted that in Hejj cells, 
HPV -18 is integrated at four sites, three of which are at or in close 
proximity to fragile sites. 
Transfection of human cells with HPV provides a useful in vitro 
model to study the molecular biology and oncogenic potential of specific 
HPV types in a human background. Refinements to the techniques will 
bring a greater awareness of specific host -virus interactions. 
3.22 Animal Models 
Attempts to produce an animal model of vegetative replication 
of HPV have until recently been unsuccessful. In 1971, Kreider et al. 
failed to induce papillomas in human skin transferred to the 
immunologically privileged hamster cheek pouch after infection with wart 
extracts and in 1973, Pass et al. similarly failed to produce papillomas 
when infected human skin was grafted onto mice treated with 
anti -lymphocytic serum. Although Cubie (1976) induced small nodules 
containing a few intranuclear virus -like particles on human skin 
exposed to a purified extract of simple plantar warts and grafted onto 
athymic "nude" mice, no true papillomas developed over a 10 -week 
observation period. Kreider and his colleagues (1979), on the other 
hand, were able to obtain neoplastic transformation of normal rabbit skin 
grafted to nude mice with CRPV. Kreider continued to exploit the 
nude mouse system and eventually in 1985 reported the successful growth 
of condylomata acuminata containing HPV -11 when fragments of normal 
cervical tissue were suspended in an extract of genital warts and then 
- 19 - 
implanted under the renal capsule of the nude mouse (Kreider et al., 
198.5). Extension of this work suggested that the most vigorous 
proliferative response to HPV -11 was engendered by the use of 
split- thickness human foreskin rather than cervical epithelium 
(Kreider et al., 1986). Virus from the experimental condylomata was 
successfully used to infect fresh foreskins and it was possible to produce 
sufficient HPV -11 from experimental grafts to purify the virions on 
cesium chloride gradients (Kreider et al., 1987). Because the 
condylomata develop as cysts with all the keratin layers contained in 
the core of the cyst rather than being desquamated as in natural lesions, 
a rich source of virions is retained. Approximately 50% of 
experimental infections resulted in cyst formation. This unique system 
proves that transformation of human tissues by papillomaviruses under 
controlled experimental conditions is possible. 
Other small rodents might also provide suitable animal models 
for the study of PV. In the 1970s, a papillomavirus was found in 
epithelial proliferations, particularly keratoncanthomas, of Mastomys 
natalensis (MnPV; Muller and Gissmann, 1978). Some colonies of 
Mastomys harbour endogenous MnPV and this is associated with a high 
rate of stomach carcinoma. It is thought that food additives might act 
as co- factors in tumour induction (Amtmann et al., 1984). A closely 
related virus has recently been described in naturally occurring papillomas 
and viral DNA was found in several different types of skin lesions in the 
European harvest mouse, Micromys minutus (Sundberg et al., 1987). 
Because viral DNA was also found in 21/34 histologically normal skin 
biopsies it was suggested that this virus would remain endogenous and be 
transmitted vertically in much the same way as MnPV (Sundberg et al., 
1987). Endogenous PV genomes are also thought to be responsible for 
the papillomas readily induced in hairless mice with low doses of UV 
light. Progression from papilloma to carcinoma -in -situ and to squamous 
cell carcinoma has been observed, and sequences related to MnPV were 
detected in 36% of tumours (Gallagher et al., 1984; Tilbrook et aí.,1989). 
- 20 - 
3.3 Morphological and Histological Characteristics of HPV Lesions 
3.31 Cutaneous Sites 
It is well recognised now that certain types of HPV are 
associated with particular morphological characteristics, but the 
association is not absolute (Jablonska et al., 1985b). Broadly speaking, 
skin warts can be divided into three groups :- 
(i) Common warts which are usually exophytic, multiple, irregular 
nodules often on the hands, or superificial spreading mosaic - 
type warts on the feet. (Figure 4a and b). They are usually 
caused by HPV -2 (Laurent et al., 1982) although the smaller 
endophytic lesions may also be caused by HPV -4 (Jablonska et 
al., 1985) and the hyperproliferative lesions common in butchers 
by HPV -7 (Orth et al., 1983). HPV -7 has recently been 
reported to be common in fishmongers too (Rudlinger et al., 
1989) with the chronic maceration of the skin of the hands of 
both groups due to moisture and cold, possibly contributing to 
infection. A similar situation appears to exist in poultry 
workers (Guillet, 1987) although the virus type found in these 
workers has yet to be identified. 
Histologically, common warts show prominent papillomatosis 
acanthosis, hypergranulosis and hyperkeratosis. Within granular 
cells of HPV -2 lesions there is often a marked clearing of the 
cytoplasm, with numIe:rous keratohyalin granules and HPV - 
4 have more pronounced crescentic nuclei (Jablonska et al., 
1985). 
(ii) Myrmecia (Figure 4.c) or deep, painful endophytic warts 
surrounded by a horny ring, commonly but not always found on 
the plantar surface of the foot and always induced by HPV - 
1. They have a peak incidence in children aged 12 -15 (Pfister 
and zur Hausen, 1978). 
In the electron microscope, HPV -1 lesions contain densely 
-20a 
Fig 4. Typical cutaneous lesions due to HPV 
(a) Common hand wart (b) Mosaic plantar wart 
(c) Myrmecia or simple plantar wart (d) Plane wart 
(e) Condylomata acuminata 
(originals kindly provided by Dr. M.H. Bunney). 
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packed virus particles often in crystalline array and it is from 
such lesions that much of the early virus preparations were 
made (Cubie, 1972a). Histologically, they have an almost 
totally disorganised granular layer due to their endophytic 
growth. Clear cytoplasm with eosinophilic inclusions are 
prominent in the stratum granulosum, the eosinophilic 
inclusions being associated with the two low molecular weight 
polypeptides (of 16,000 and 17,000) unique to HPV -1 lesions 
(Breitburd et al., 1987). Parakeratotic cells in the upper 
layers contain nuclear basophilic inclusions, and it is these that 
contain the virions. 
(iii) Plane warts which are slightly raised, flat topped small lesions 
often on the face, occurring as multiple crops. (Figure 4d). 
They are usually caused by HPV -3 or HPV -3 related types such 
as HPV -10 (Orth and Favre, 1985). Papillomatosis in these 
lesions is slight, but perinuclear vacuolisation of cells of the 
upper layers is again evident. In the EM, this is shown to be 
due to the accumulation of keratin filaments at the cell 
periphery, giving a net -like structure in which pyknotic nuclei 
are centrally suspended. No free keratohyalin granules are 
observed (Croissant et al., 1985). 
Plane warts exhibit a characteristic phenomenon of spontaneous 
regression of the whole crop, with all lesions becoming 
involuted within 2 -6 weeks. (Tagami et al., 1977), in total 
contrast to the absence of lymphocyte cell infiltration in 
common and plantar warts (vide infra). 
A variety of cutaneous warts develops in people suffering from 
epidermodysplasia verruciformis (EV) which is thought to be linked to a 
rare recessive abnormal allele of an autosomal gene (Orth, 1986a). 
Selective and partial defects of cell mediated immunity (Jablonska, 1986) 
in these patients are associated with the development of disseminated 
skin warts which persist throughout life. Many of the lesions contain 
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HPV -like particles (Ruiter and van Muttern, 1966), resemble flat warts 
and are localised on the extremities and face. They may be induced 
by HPV -3 or HPV -10 as in the general population or by a whole series 
of HPV types only found in EV patients (Kremsdorf et al., 1983; 1984). 
Other lesions resemble the reddish plaques of pityriasis versicolor rather 
than warts (Jablonska & Orth, 1985a). These lesions are induced by 
HPV 5, 8 and 9 and exhibit a common histological picture. The 
beautiful studies of Croissant (Croissant et al., 1985) show that viral 
DNA -containing cells found in groups or columns have a uniformly pale 
cytoplasm, while more superficial cells look clear due to the loss of 
tonofilaments. Prominent tiny drops of keratinohyalinlike material can 
be observed and virions are packed round the margin of the nuclei of 
the upper granular layers close to condensed chromatin. 
About one -third of EV patients develop multiple skin carcinomas, 
approximately 25 years after the development of benign lesions, with 
malignant conversion occurring at light exposed sites ( Jablonska et al., 
1972). The carcinomas harbour no HPV -like particles (Ruiter and van 
Mullem, 1970) but only HPV -5 and some HPV -5 related DNA sequences 
(e.g., HPV -8, 14, 17, 20) (Ostrow et al., 1982; Pfister et al., 19834.; 
Kremsdorf et al., 1984; Lutzner et al., 1984; Pfister, 1987b), whereas 
benign lesions in the same patients can contain many different types, 
suggesting a role for HPV -5 in the development of neoplasia in EV 
patients (vide infra). Conversely, HPV -3 lesions do not become 
malignant (Orth et al., 1979). 
Skin cancers in EV patients are discussed more fully in Section 
3.54 and the immune defects in such patients in Section 4.4. 
3.32 Muco-cutaneous sites 
Genital warts or condylomata acuminata occur in men on the 
penis and anus and in women on the vagina, vulva and perineum as 
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small verrucous papules or as raised multiple lesions resembling common 
warts, or even as hyperplastic pedunculated cauliflower -like masses 
(Oriel, 1971b; Figure 4(a)) Human papilloma virions can occasionally be 
found in small numbers in such lesions (Dunn and Ogilvie, 1968) and 
more than 90% of German cases have been shown to be caused by 
HPV -6 and the related HPV -11 (Gissmann et al., 1982.:). Malignant 
conversion of condylomata acuminata is well documented with Boxer and 
Skinner noting 65 cases in the literature, 8 of which had metastatic 
involvement (Boxer and Skinner, 1977). 
Histologically, condylomata show epithelial thickening due to 
extreme acanthosis and papillomatosis but without the hyperkeratosis of 
external cutaneous warts. Cells of the stratum spinosum become 
several times larger than normal with distinct perinuclear vacuolisation 
(Grussendorf- Conen, 1985). A chronic inflammatory infiltrate is usually 
observed. 
Warts of the throat or laryngeal papillomas are the most 
common benign neoplasm of the larynx in children (Steinberg and 
Abramson, 1985) although they also occur with similar aetiology in 
adults. Laryngeal papillomas in children can easily block the small 
airway, making surgical intervention essential and life- saving, but 
recurrences are frequent and children can require surgery every four 
weeks or so (Steinberg et al., 1983) with spread from the surgical 
trauma a well recognised complication (Duff, 1971). The papillomas 
have a thickened spinous layer with increased nucleoli, and there is a 
delay in maturation of the upper layers with a lack of keratohyalin and 
a loss of superficial flattening (Steinberg and Abramson, 1985). It had 
long been suggested that laryngeal papillomas were another 
manifestation of wart virus infection, but proof was lacking until 
recently. 
HPV common antigen was found by Lack and his colleagues 
(1980) in a few superficial cells in about half of the tissues examined 
and by careful reprocessing of tissue showing antigen positivity, 
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papilloma -like particles with nuclear localisation were found. In 
addition, HPV DNA subtypes related to HPV -6 were shown to be present 
by Southern blot analysis (Mounts et al., 1982). About 50% of 
laryngeal papillomas examined by Gissmann's group in Germany 
contained the closely related HPV -11 (Gissmann et al., 1982, 1983) and 
more recently all ten cases examined in Leeds were positive for HPV -6 
or HPV -11 (Terry et al., 1987). Not only have HPV DNA sequences 
been found in the laryngeal papillomas themselves but also in normal 
tissue adjacent to papillomas and in normal tissue from previous 
papilloma patients in remission, suggesting that the HPV DNA can 
persist with no clinical sign of disease (Steinberg et al., 1983). 
There is some epidemiological evidence to link laryngeal 
papillomas with genital condylomata, with the suggestion that genital 
wart virus is acquired from the mother during birth, leading to the 
development of laryngeal papillomas after a variable latent period. In 
the series presented by Quick et al., (1978), 60% of children with 
laryngeal papillomas had a maternal history of condylomata acuminata. 
Conversely, only 2/23 children in the study from Steinberg and 
Abramson (1985) had a positive maternal history and, furthermore, two 
children who developed laryngeal papillomas in the first few weeks of 
life, were born by Caesarean section. 
Maternal transmission to the infant has likewise been assumed in 
early cases of condylomata acuminata in childhood (Patel and Groff, 
1972), but Roman and Fife (1986) could not correlate the finding of 
3/70 HPV positive lesions in newborn foreskin with maternal 
abnormalities. The possibility of latent infection will be discussed 
below. 
Other lesions of the oral cavity, particularly focal epithelial 
hyperplasia of Heck (FEH) found in Eskimos and American Indians 
(Práetorius- Clausen, 1972) have also been shown to be associated with 
HPV. HPV -13 has been found in FEH (Pfister et al., 1983) and HPV -2 
in common warts of the oral mucosa (Lutzner, et al., 1982). 
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Papillomatous lesions frequently carry HPV -11 related types (Naghashfar 
et al., 1985; Zoning et al., 1985) while HPV is variably found in other 
oral lesions and tumours (vide infra, Section 3.55). 
The interesting co- existence of EBV and HPV in cells from 
lesions of oral hairy leukoplakia in AIDS patients was described 
(Greenspan et al., 1984) but has not been confirmed by others. 
Mucosal epithelium of the oral cavity and larynx, like the 
epithelial surfaces round the genital area, differ from external skin in 
the degree of keratinisation which is present. Yet HPV replicates only 
in terminally differentiated cells and it is understandable that papilloma 
virus antigens, and even more so, typical papilloma particles, are found 
only rarely and scantily in these lesions. Nevertheless, the search for 
HPV DNA sequences has revealed the association between papilloma 
viruses and laryngeal and genital papillomas, thus confirming a 
long- standing clinical belief. 
3.33 Dysplastic Lesions of the Genital Tract 
Morphological changes similar to those seen in HPV infections 
were first observed in smears and sections of the uterine cervix by 
Meisels and Fortin (1 976) and Purola and Savia (1977), often in 
association with cervical intraepithelial neoplasia (CIN). Tiny flat 
warts, usually in the tranformation zone where cell division is more 
rapid were revealed following application of acetic acid and 
magnification with a colposcope (Reid et al., 1980). These lesions have 
been variously named non -condylomatous wart virus infection (NCWVI - 
Reid et al., 1980), flat condylomata or condylomata plana (Meisels et 
al., 1977) and they are almost indistinguishable colposcopically from mild 
cervical dysplasia or CIN. Histological examination of punch biopsies 
from such lesions show a slightly thickened epithelium and the presence 
in the superficial layers of "koilocytes" i.e., ballooned cells with 
distorted, pyknotic nuclei and a large perinuclear space (Koss and 
Durfee, 1956). A subset of CIN lesions where the changes are more 
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severe with koilocytes covering the whole thickness with disordered 
stratification and bizarre hyperchromatic nuclei were called atypical 
condylomata (Meisels et al., 1981) or type 2 CIN lesions (Pilotti et al., 
1981). 
It was the similarity of koilocytes to the vacuolated enlarged 
cells of the granular layers of many types of wart which prompted a 
search for HPV in cervical lesions and the presence of koilocytes is now 
considered pathognomonic of HPV infection. Such a presence provided 
histological evidence of HPV infection in more than 90% of cases of 
CIN in Australian women (Reid et al., 1982). Confirmation of a viral 
aetiology again came from the finding of papillomavirus -like particles in 
N i 4 044 L I /trey ) 
the nuclei of koilocytes (Laverty? i9/9) 1979; Pilotti et al., 1981) and 
indeed Laverty found particles easier to detect in NCWVI than in 
condylomatous lesions. Further confirmation came from the detection 
of papilloma antigen in similar superficial cells using antiserum against 
the group antigen (Woodruff et al., 1980; Morin et al., 1981) and the 
demonstration of HPV DNA sequences most frequently of types HPV 6, 
11 and 16 (Gissmann et al., 1983; McCance et al., 1983) in the deeper 
layers. It was suggested that HPV was capable of establishing a 
permissive, productive infection only in differentiated superficial cells 
and a non -permissive infection in the deep layers which might then 
undergo transformation to dysplasia. (Fletcher and Norval, 1983). 
Because of the difficulties in distinguishing NCWVI from CIN, 
searches have been carried out in many countries for the presence of 
HPV DNA sequences in CIN of all grades of severity, including 
carcinoma in situ (now classified as CIN III) and invasive carcinoma. 
It soon became obvious that HPV -16 (Durst et al., 1983) and to a lesser 
extent, HPV -18 (Boshart et al., 1984) were preferentially associated with 
severe dysplasias and cancer. A selection of prevalence surveys in 
various populations where it has been possible to compare the CIN 
gradings from biopsies, smears or cervical swabs and match them with 
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considerable variation in the percentages obtained by each group of 
workers, there is an obvious increase in the percentage of HPV 16/18 
positive cases as the severity of the lesion increases. These findings all 
add weight to the speculation that infection with HPV -16/18 might 
increase the risk of development of a malignant tumour (vide infra). 
However, they do not represent full epidemiological investigations : 
some do not include controls or do not describe the controls adequately 
to prevent selection biases (Munoz et al., 1988); some use biopsies and 
others cytological specimens which cannot readily be compared because 
of sampling variation, yet no study has been made which compares the 
results from biopsies and cytological specimens from the same patients. 
Furthermore, different methods of DNA detection with widely differing 
sensitivities have been used and analysis of other risk factors in 
comparisons between groups have not been made. Finally, the 
increased finding of HPV sequences in apparently normal cervices in 
recent studies, after laser ablation (Wickenden et al., 1985), in the 
normal epithelium at a distance from observable lesions (Ferenczy et 
al., 1985) and in control populations (Cox et al., 1986; Macnab et al., 
1986; Meanwell et al., 1987; Reeves et al., 1987; Schneider et al., 1987) 
suggests that latent HPV infection requires other risk factors for 
progression. 
A histological pointer of increased risk was noted by Crum et 
al. (1984) in a study of "flat condyloma" in which lesions were divided 
according to the presence or absence of abnormal mitotic figures 
(AMF). 70% of lesions with AMF were found to harbour HPV -16 while 
77% without AMF did not. Thus the suggestion was made that lesions 
containing both AMF and HPV -16 were the most likely to progress. 
The association between these factors was recently confirmed (Ionesco 
et al., 1987). In this study, 7 out of 13 HPV -16 positive flat 
condyloma and 20 out of 30 HPV -16 positive CIN lesions all also showed 
AMF and /or basal and parabasal cell nuclear atypia. The presence of 
AMF suggests aneuploidy, a recognised characteristic of malignancy. 
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Jakobsen (1983) and Reid et al. (1984) showed that increasing aneuploidy 
occurred with increasing severity of CIN but using flow cytometry, 
Hughes et al. (1987) found similar proportions of aneuploid cells not only 
in all grades of CIN, but also in lesions which had histological evidence 
of papillomavirus infection in the absence of CIN. HPV typing of 
these lesions, however, was not done, and it might be valuable to 
consider AMF, aneuploidy and HPV type in the same lesions. 
Intraepithelial neoplasia of the external genitalia, or Bowenoid 
papulosis, showing as small flat often inconspicuous papules on the penis 
or as multiple confluent, elevated and often pigmented lesions of the 
vulva and perineum in women (Obalek et al., 1985) are similarly 
associated with HPV -16. Bowen's disease itself is regarded as 
carcinoma in situ and is found in older men. HPV -16 was found in 
8/10 German cases (Ikenberg et al., 1983) and 12/14 Polish cases 
(Obalek et al., 1985). Papillomavirus -like particles were observed in 
individual cases of Bowenoid papulosis (Obalek et al., 19 $5) 
and a few cases have been HPV antigen positive (Braun et al., 
1983; Gross et al., 1985a). Histologically, hyperplasia with numerous 
AMF and large dyskeratotic cells is seen, and, like the HPV -16 
containing CIN lesions, koilocytes are absent. Bowen's disease and 
cervical neoplasia are often found to co -exist (Hilliard et al., 1979). 
Given the various terminologies currently in use, Gross et al. 
(1985b) called for a new nomenclature for papillomavirus infection in 
the anogenital region, dividing the lesions into three distinct clinical 
groups: condylomata acuminata, flat cervical warts and pigmented 
papules. They stressed the lack of correlation between koilocytic type, 
clinical type or virus type, with the exception that HPV -16 was 
frequently found in non -koilocytic lesions with severe epithelial atypia 
including AMF and an absence of structural antigen. The limitations 
and uses of different methods of classification are shown in Table 5, 
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3.4 The Male Factor in HPV Transmission 
Extensive epidemiological studies over the last 150 years since 
Rigoni -Stern (1842) noted the lack of development of cervical carcinoma 
in nuns have clearly shown that age at first intercourse and 
multiple sexual partners are risk factors associated with the 
development of cancer of the cervix (Rotkin, 1973; Singer et al., 1976) 
and of CIN (Harris et al., 1980). As a result, Singer and his 
colleagues suggested that a closer look should be taken at the male 
partner to identify "high risk males" (Singer et al., 1976). They 
proposed at the time that different levels of histones in the sperm head 
or of polyamines in seminal plasma might exert deleterious effects on 
the stem cells of the transformation zone of the cervix. Several 
infectious agents have been incriminated in the transmission of the 
vo,ikc etl, 
disease, but without conclusive evidence (Alexander, 1973;h In 
particular, herpes simplex virus (HSV) type 2 seemed a likely agent, but 
the evidence was mainly serological (Rawls,, 1973) and inconclusive, since 
varying percentages of patients in different areas developed cervical 
cancer in the absence of HSV antibodies. 
Zur Hausen (1976, 1977) suggested that the localisation of 
genital warts, their venereal transmission and malignant transition 
provided overwhelming evidence to support the involvement of HPV in 
genital dysplasias and the concept of the "high risk male" as the vector 
of HPV infection with the woman as the host in whom cancer developed 
gathered momentum. This was confirmed by Campion et al. (1985) who 
found that one third of women who had been the sole sexual consort for 
at least one year of men with condylomata acuminata not only had 
similar genital lesions but also have cervical abnormalities. Similar 
HPV types were found in each pair of sexual partners. Although HPV 
types 6 and 11 are commonly found in penile condylomata acuminata 
and can readily be transmitted from these productively infected lesions, 
six of the nine men who were consorts of women with CIN also have 
HPV -16 in their lesions. Perhaps these men, in addition to their 
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obvious genital warts, had inconspicuous lesions of Bowenoid papulosis 
which were sampled at the same time. Certainly, Gross and his 
colleagues (1985c) suggest that it is these inconspicuous lesions in young 
males which act as the natural reservoir for HPV -16 and in which the 
virus can replicate, preferentially destroying infected cells and thus 
preventing progression to neoplasia, and at the same time providing a 
source of virus to infect the sexual partner (Gissmann & Schwarz, 
1986). Support for this hypothesis came from the finding of HPV -16 
Garcinorna in S ;rl 
DNA in a penile Bowenoid papule and a concurrent,(CIS)in the sexual 
partner. (Hauser et al., 1985). 
3.5 Malignant Transformation in Papillomaviruses 
Several animal PVs are capable of inducing carcinomas, but in 
each system studied some component in addition to the PV itself 
appears to be required. In the earliest studied system, CRPV- induced 
papillomas rapidly progressed to carcinomas in the presence of chemical 
carcinogens such as tar (Rous and Friedewald, 1944). Bladder tumours 
in cattle are associated with BPV -2 and alimentary tract carcinomas 
with BPV -4, but in both of these systems, the ingestion of bracken fern 
contributes to the progression to malignancy (Lancaster & Olson, 1982). 
Carcinomas also develop round the eyes of cattle (Ford et al., 1982) and 
the faces and ears of sheep (Vanselow et al., 1982) in tropical and 
sub -tropical Australia where precursor lesions containing PV progress in 
association with chronic exposure to sunlight. In man too, the 
carcinogenic and immunosuppressive effects of uv -light cause progression 
of HPV -5 induced papillomas in patients with EV. Children whose 
laryngeal papillomas were treated by X -ray often developed laryngeal 
carcinomas in later life, and genital lesions induced by different HPVs 
progress to frank carcinomas in the presence of various mutagenic 
stimuli. All of these additional components share mutagenic and in 
some cases immunosuppressive properties which may act in conjunction 
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with an underlying PV infection to cause tumorigenic progression. In 
this section, the bovine papilloma system is described in detail as a 
model for HPV- induced genital tumour development and the CRPV 
papilloma- carcinoma complex as a model for HPV- induced cutaneous 
carcinogensis in EV patients. 
3.51 The bovine papilloma model 
Six distinct BPV types have been isolated and characterised and 
these can be divided into two sub -groups. Subgroup A (BPV -1, 2 and 
5) induce cutaneous fibropapillomas while sub -group B (BPV 3, 4 and 6) 
infect only squamous epithelial cells (Jarrett et al., 1984). The 
different types are readily distinguished by the their restriction 
endonuclease cleavage patterns and their degree of DNA sequence 
homology. BPV -1 and BPV -2 have a wide tissue range in cattle and 
also show the broadest experimental host range exhibited by any PV 
(Lancaster and Olson, 1982). For example, fibrosarcomas can be 
induced in horses and in hamsters. These can metastasise to internal 
organs, expecially the lungs, and BPV can be found in large quantities 
(100 -700 copies per cell) within them (Lancaster et al., 1976; Lancaster 
et al., 1977). 
The tumours produced in vivo by BPV -1 and BPV -2 do not have 
obvious human counterparts, but they are of interest because the 
infection is non -permissive in the dermis and only at much later stages 
of infection do particles accumulate in the upper epidermal layers with 
lymphocyte infiltration finally leading to regression (Jarrett, 1985). 
BPV -1 has shown no potential for malignant progression in vivo despite 
transformation in vitro, but BPV -2 on the other hand can produce 
tumours of the urinary bladder when inoculated experimentally. An 
infective agent resembling bovine wart virus was noted in 6/16 
suspensions prepared from spontaneous bladder tumours (Olson et al., 
1965) but the major aetiological factor in the development of bladder 
tumours was the ingestion of bracken fern (Olson et al., 1969). Even 
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at this time, the carcinogenic and immunosuppressive effects of bracken 
were known and Olson suggested a co-operative action between bracken 
fern and virus in the development of neoplasia. 
The viruses of the true epithelial papillomas in cattle, the 
sub -group B viruses, are different not only from sub -group A viruses 
but also from HPVs and CRPV. Their genomes are considerably 
smaller (MW 4.4 x 106 rather than .5 x 106) and have a sequence length 
of 7200 bp, with neither BPV -4 nor BPV -6 possessing the gene for the 
interspecies PV antigen (Campo and Coggins, 1982). BPV -4 is the best 
studied member of the group as a result of its association with upper 
alimentary tract papillomas and the development of alimentary 
carcinomas again following the in estion of bracken fern. 
Examination of large numbers of cattle, mainly from farms in 
Argyll infested with bracken (Jarrett et al., 1978) showed that 96% of 
those with carcinomas had multiple papillomas at adjacent sites, 
containing BPV -4 (Campo et al., 1980). Older papillomas contained 
less virus and were less successful in inducing papilloma formation in 
calves and indeed, experimental papillomas more than 9 months old were 
both virus and viral DNA free (Jarrett, 1987). It appeared that 
although required for the induction of papillomas, the presence of BPV -4 
DNA was not necessary for progression to, nor maintenance of, the 
transformed state. (Campo et al., 1985). 
Intradermal inoculation of BPV -4 into hamsters led to the 
growth of malignant sarcomas (Moar et al., 1986), and molecularly 
cloned BPV -4 DNA transformed NIH 3T3 cells and, less efficiently, 
C127 mouse fibroblasts (Campo and Spandidos, 1983). In both these 
systems, the BPV -4 DNA persisted as multiple copies of non -integrated 
monomers. In most cell lines established with linear DNA, the genome 
was no longer present and in the few which did contain viral DNA, this 
was in an integrated, rearranged state (Smith and Campo, 1988). 
Similarly, explanted cell lines originating from alimentary papillomas or 
carcinomas produced fully transformed epithelial cells, but neither they 
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nor the nude mouse tumours derived from them contained any viral DNA 
(Campo and Jarrett, 1987). It seems likely that BPV-4 acts by a "hit 
and run" mechanism. It executes an early event which results in 
cellular proliferation, thus increasing the target size for subsequent 
neoplastic events, perhaps with amplification of epidermal growth factor 
receptors (Smith et al., 1987) or with the activation of cellular 
oncogenes (Amtmann et al., 1987). In addition, the trauma caused by 
eating hard sharp bracken further increases the local epithelial mitotic 
rate and the chemicals within the fern could act as promoters long 
after the virus has vanished (Campo and Jarrett, 1987). If this model 
is correct, there is only an indirect involvement of BPV-4 in the 
process of alimentary canal carcinogenesis. 
The interaction between BPV-4, bracken and immunosuppression 
is being investigated by Campo and Jarrett in a complex experiment 
whereby calves born of papillomatosis- free mothers were obtained at 
birth and reared in isolation (Campo and Jarrett, 1986). Calves 
inoculated with BPV -4 alone developed alimentary papillomas which 
eventually regressed. Animals given a regular bracken diet in addition 
to BPV -4 developed multiple papillomas which have persisted for years 
and at least one has progressed to malignancy, with no detectable BPV - 
4 DNA in the tumour. Several animals which received bracken feed 
only developed cutaneous warts caused by BPV -1 and BPV -2 at the sites 
of repeated venepuncture. While it is just possible that BPV -1 or 
BPV -2 carried on the footpads of flies would allow transmission of virus 
from the wild, by analogy to the suggested transmission of CRPV by 
insects (Dalmat, 1958), it seems more likely that these viruses were 
persisting in a latent form, becoming activated by skin damage and 
immunosuppression (Campo and Jarrett, 1987). 
Circulating lymphocytes have been suggested as a possible site 
of latency and indeed BPV -2 DNA was found in lymphocytes of four 
animals given bracken, BPV -1 DNA in two animals given virus and both 
BPV -1 and BPV -2 DNA in some field cases, but not in a number of 
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gnotobiotic and newborn calves (Jarrett, 1987). Discussion following 
the CIBA Foundation Symposium on Papillomaviruses (CIBA Foundation 
Synposium 120, p133, 1986) volunteered the information that HPV -6 DNA 
had been found in the lymphocytes of a patient with laryngeal 
papillomas (Steinberg) and in one patient with EV (L. Gissmann on 
behalf of A.J. Faras) but not in a further five EV patients (G.Orth on 
behalf of S. Obalek) while HPV -5 had been found in the sperm of both 
an adult male with EV and his unaffected young son (M.S. Campo). 
Further work on these aspects is required. 
Thus, two models of naturally occurring malignancies are 
associated with BPV :- 
1. Bladder carcinomas in which BPV -2 is present in a multicopy 
episomal state, either as an opportunistic pathogen or exerting 
its full oncogenic potential in a specialised environment. 
2. Alimentary carcinomas, in which BPV -4 appears to play an 
initiating role, but is no longer required thereafter. 
In both systems the involvement of an environmental 
carcinogenic and immunosuppressive agent is central to malignant 
progression. All of these elements have counterparts in the human 
situation. 
3.52 Genital cancers and HPV 
At the same time as HPV DNA was detected in dysplastic 
lesions, viral components were also sought in malignant tumours. 
Neither PV particles nor viral antigen were observed in genital 
carcinomas thought to have developed from papillomas (Gissmann, 1984; 
Syrjanen, 1984) but PV DNA could be readily detected in blots or on 
sections using swabs, scrapes or biopsies in up to 90% of malignant 
cervical disease (Singer and McCance, 1985) with HPV -16 in about 50% 
of cases, HPV -18 in about 20% and others (HPV -10, 11, 31, 33 and 35 
and other unidentified types) in a small proportion of biopsies (Gissmann 
and Schwarz, 1986). 
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The massive prospective study in Finland begun in 1981 and 
involving more than 500 women in six -monthly follow -ups, (Syrjanen, 
1983a; Syrjanen et al., 1985b) has shown that progression was most 
frequent (33.3 %) and regression most infrequent (5.6 %) in HPV -16 
lesions (Syrjanen et al., 1987cß). On the other hand, a number of HPV -6 
and HPV -11 containing lesions also progressed during the follow -up. 
Furthermore HPV -6 has been found in one of a sample of 29 cervical 
carcinomas examined by Gissmann and colleagues (1983) as well as in 
locally invasive Buschke- Lowenstein tumours (Gissmann et al., 1982) and 
it would be premature to dismiss as insignificant the oncogenic potential 
of the HPV types most commonly associated with condylomata 
acuminata. 
Recently an increasing number of cases of infection with 
multiple HPV types has been reported. McCance et al. (1985b) 
described five women with multifocal genital intraepithelial neoplasia in 
each of whom HPV -6 and HPV -16 was found; Winkler et al. (1986) 
described both HPV6 and HPV -16 in 65% of 43 patients with similar 
lesions; Del Mistro et al. (1987) identified two types of HPV in 13 of 
15 males with uretheral condylomata acuminata and it could be that 
HPV types act synergistically - possibly with types 6 and 11 increasing 
cellular proliferation such that an increased incidence of AMF is induced 
by HPV -16. 
One of the most worrying aspects clinically of cervical 
carcinoma development today is the rapidity with which some lesions 
progress. Paterson et al. (1984) found 56 women out of 312 with 
cervical cancer had had negative smears in the three years preceding 
cancer development. When the smears were reviewed, about half were 
regraded as abnormal, but in the others, a short pre- invasive phase 
seems likely. This rapid progression was more common in younger 
women. Syrjanen et al. (1985a) reported a well documented case of a 
lesion containing HPV 16/18 progressing to invasive cancer in less than 
three years and a further 5.5% of 343 women who progressed to CIS 
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within eighteen months. There is increasing evidence that HPV -16 and 
HPV -18 can be found in the cervix of cytologically normal women. In 
situ hybridisation of the cells from cervical swabs has shown these types 
in 5% of the first 300 examined (Wagner et al., 1984). Furthermore in 
Britain, McCance et al. (1985a) and Murdoch et al. (1988) have shown 
HPV -16 to be present in age- matched controls with colposcopically and 
histologically normal cervices as well as in normal tissue from sites 
adjacent to the HPV -16 containing lesions, a situation similar to the 
persistence of HPV 6/11 in DNA in normal tissue from sites adjacent to 
laryngeal papillomas (Steinberg et al., 1983). Indeed, a recent 
publication using the sensitive polymerase chain reaction (PER) has 
shown HPV -16 and /or HPV -11 sequences to be present in 70% and 84% 
respectively of two groups of women with cytologically normal cervices 
(Young et al., 1989; Tidy et al., 1989). 
HPV -6 DNA has also been detected in 10% of cervical scrapings 
from cytologically normal women attending a sexually transmitted 
disease clinic (Wickenden et al., 1985), viral antigen in 2 out of 25 
histologically normal cervical epithelium (Walker et al., 1983) and even 
virus particles in 14/22 cervical biopsies with no evidence of HPV 
infection (Syrjanen et al., 1985b). Thus HPV can replicate without 
producing clinical symptoms and could be transmitted by asymptomatic 
carriers. 
The suggestion that HPV of some types at least is capable of 
remaining in a latent state is further supported by the much higher 
frequency of HPV -16 and HPV -18 positive smears in pregnant women, 
perhaps due to reactivation under different immunological and hormonal 
influences (Gissmann and Schwarz, 1986). The occurrence and 
regression of flat lesions of Bowenoid papulosis of the anogenital skin is 
similarly associated with pregnancy and delivery (Pfister, 1987b). 
It has already been pointed out that in the male, HPV -16 can 
replicate to a limited extent and produce small amounts of infectious 
virus (Gissmann and Schwarz, 1986). It could be that in cervical cells, 
- 37 - 
replication is inhibited by tissue specificity, with persistence occurring 
more readily than in the male, allowing time for a variety of co- factors 
to exert synergistic effects. In this sense, the HPV -16- 
papilloma- carcinoma progression may be compared to the BPV -2 model 
where virus is produced in specific cutaneous lesions, but when it 
reaches the bladder epithelium, perhaps from the paragenital lesions 
with which BPV -2 can also be associated (Jarrett, 1985), it can persist 
and undergo limited transcription but nothing more. The difference 
between the two systems, however, lies in the episomal persistence of 
the BPV -2 genomes in bladder carcinomas compared with the integrated 
pattern almost invariably seen with HPV -16 in cervical carcinomas 
(Boshart et al., 1984; Durst et al., 1985, Shirasawa et al., 1986, 
Murdoch et al., 1988). 
Two distinct patterns of integration of HPV -16 have been 
observed either in head -to -tail arrangements or as a single copy, but 
integration occurs at a remarkably specific point on the viral genome 
usually between El and E2, such that only E6, E7 and part of El can 
be transcribed from the viral early promoter (Gissman and Schwarz, 
1986). Occasionally integration occurs slightly downstream within E2 
or even L2 (McCance 1986) and Shirasawa et al., (1987) recently 
reported a cell line in which the complete HPV -16 genome was 
integrated. Transcription, predominantly of E6 and E7, in cervical 
carcinomas and cell lines derived from them, has already been described 
(Section 2.32). While the function of these gene products continues to 
be investigated in transformed cell lines, their exact role in -vivo is 
unknown, and indeed transcription of early genes is not always found in 
biopsy specimens of cervical carcinomas (Lehn et al., 1985; Orth, 1986b; 
Pater and Pater, 1988). This could be due to inactivation of 
transcription or to a very low copy number of HPV -16 DNA per cell 
(Orth, 1986b). Perhaps in these few tumours a situation exists more 
akin to that of BPV -4 induced tumours in which PV -DNA is no longer 
detectable in the alimentary canal carcinomas. One might speculate 
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that human cervical carcinomas being removed as expediently as possible 
for the patient's welfare have rarely reached this final stage of 
oncogenic potential. 
Nevertheless, HPV specific mRNAs are found in over 80% of 
cervical tumours (Orth, quoted by McCance, 1986) and indeed it has 
been suggested that there may be unregulated persistent E6 /E7 
transcription due to the disruption on integration of E2, with its 
trans -activating and counter -acting repressor functions (Gripe et al., 
1987). These workers suggested that keratinoytes contained a cellular 
factor which acted on the short enhancer element 5' to E6 and E7 and 
which would normally be suppressed by a functional E2. 
The integration of HPV -16 and HPV -18 at random sites on the 
cellular genome would suggest that the site of integration is not 
important (McCance, 1986). However some particular cellular insertion 
sites may alter the expression of cellular genes. Thus in an analysis 
of four cervical carcinoma cell lines and one primary cervical cancer, 
Durst et al., (1987) found integration near and activation of c -myc in 
HeLa and C -4I cells while in the other two lines no close linkage to 
cellular oncogenes was found. The HPV -16 sequences localised to two 
areas which contained the proto- oncogenes c -src -1 and c- ras -1. 
Similarly, Shirasawa et al. (1987) in 3 of 5 Japanese derived cervical 
carcinoma cell lines detected c -myc and c- Ha -ras expression at about 
nine times the level found in normal cells. Certainly transfection 
studies with HPV -16 DNA in vitro have shown that co- operation 
between the viral DNA and EJ -ras can occur to establish transformation 
(Matlashewski et al., 1987). In a study of invasive cervical cancers, 
Riou et al. (1985) found a 3 -30 fold amplification of c -myc and /or 
c- Ha -ras in 21/37 advanced tumours. The absence of oncogene 
amplification in the earlier stage tumours suggested that a role for myc 
and ras was confined to the late stages. 
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3.53 The rabbit papilloma- carcinoma complex 
The oldest model of viral cutaneous carcinogenesis is that of the 
Shope papilloma- carcinoma complex. The cotton tail rabbits of 
mid -West America appear to be "horned" (Figure 6) due to papillomatous 
growths which may persist, regress or undergo malignant transformation 
in about 25% of cases. In 1933 Shope and Hurst discovered that the 
filterable agent from these papillomas could induce papillomas in 
domestic rabbits, but could not then be transmitted from domestic 
rabbits, which showed a much higher incidence of progression to 
carcinoma. Yet, the gross and histological appearances of the tumours 
were identical and even at this time Shope noted that perhaps they 
represented the two extremes of a neoplastic process. Viral antigen 
was abundant in superficial cells of the cottontail papillomas, but not in 
domestic rabbit papillomas (Noyes and Mellors, 1957). Nevertheless, Ito 
and Evans (1961) showed that DNA extracted from domestic rabbit 
papillomas was still infectious and tumorigenic and could be detected in 
granular cell nuclei (Orth et al., 1971) by in situ RNA -DNA 
hybridisation. 
More recently, Stevens and Wettstein (1979) showed that the 
DNA isolated from papillomas, primary carcinomas and even metastatic 
carcinomas all contained equivalent amounts of viral DNA (10 -100 
copies per diploid cell equivalent of DNA). The DNA appeared almost 
entirely episomal but variable in amount and length (Wettstein and 
Stevens, 1982). Integration into the host genome was rare, occurring 
in only a few primary tumours, but also in the Vx2 and Vx7 
transplantable tumours (Sugawara et al., 1983) which had been induced 
by CRPV 50 years earlier and maintained in vivo by serial passage. 
That the CRPV genome participates in the malignant process 
was shown by early work comprehensively reviewed by Kreider and 
Bartlett (1981), but the relationship between persistence of the viral 
DNA and progression is far from clear. Wettstein and Stevens (1981) 
showed that a small amount of viral RNA was transcribed in a 
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Fig 6. "Hornéd cottontail rabbits infected naturally with CRPV 
(drawn by Alison F. Cubie after sketches of Ernest Thompson 
Seton reproduced in Kreider and Bartlett, 1981). 
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proportion of both virus -producing tumours and benign and malignant 
non -virus -producing tumours. Two major RNA species mapping to E6 /E7 
and E2 were found in both benign and malignant tumours (Nasseri and 
Wettstein, 1984a; Phelps et al., 1985; Danos et al., 1986). 
Virus -producing tumours also have major RNA species which originate in 
El of the early region and include most of the L 1 and L2 ORFs (Phelps 
et al., 1985). Clearly, therefore, there is a transcriptional difference 
between productively and non -productively infected tumours but not 
between benign, malignant and metastatic lesions despite the viral DNA 
being exclusively extrachromosomal and non -rearranged (Phelps et al., 
1985). Interestingly, the maintained Vx2 and Vx7 tumours also produce 
RNA transcripts mapping to E6 /E7 and E2 although they are fully 
integrated in head -to -tail tandem repeats (Nasseri and Wettstein, 1984b), 
suggesting that such expression is necessary for the maintenance of the 
malignant phenotype. 
While spontaneous regression of CRPV- induced rabbit papillomas 
is clearly mediated by a cell- mediated immune response, the involvement 
of immunosuppression in tumour progression is less clearly defined (see 
Kreider & Bartlett, 1981). For example, steroid treatment inhibited 
regression of lesions but did not enhance tumour development, 
(McMichael, 1967) while infection in utero not only inhibited regression 
but increased the rate of transformation (Fischer and Syverton, 1951). 
In rabbits in which papillomas persisted a serum factor which blocked 
lymphocyte cytotoxicity was demonstrated (Hellstrom et al., 1969), while 
the enhanced immune stimulus generated by anaerobic corynebacteria in 
the normal flora of rabbit skin encouraged regression in the natural host 
(Seto et al., 1980). 
Thus in the CRPV papilloma- carcinoma complex there is an 
inter play of host factors including genetic background, environmental 
factors including restricted distribution and the effects of co- carcinogens, 
coupled with the immune response to virus challenge. CRPV is 
therefore an exciting and important model for similar human neoplasms. 
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Unfortunately, research with CRPV has been hampered by the limited 
supply of virus from infected wild cottontail rabbits and by the lack of 
availability of syngeneic rabbits for studies at the cellular level. With 
the supply of CRPV being assured through the successful cloning of the 
genome (Wettstein and Stevens, 1981) and the development of syngeneic 
rabbits, it should be feasible to define the immunobiology of progression 
and spontaneous regression more thoroughly (Kreider and Bartlett, 1985). 
3.54 Skin cancers in epidermodysplasia verruciformis 
The comparison between the Shope papilloma- carcinoma 
progression and that seen in EV patients with pityriasis -like warts is 
striking. The genetic background of the patient, leading to an inherited 
predisposition to warts, plays a role in the initiation of the neoplastic 
process, just as the genetic background of rabbits influences the eventual 
outcome of infection. Although spontaneous regression is a very rare 
event in EV, it has been observed in a few patients infected with HPV -3 
(Jablonska et al., 1982a). Progression is much more common and is 
associated with a depressed cell mediated immunity, detected by reduced 
cutaneous responsiveness to DNCB and of lymphocytes to non -specific 
mitogens (Jablonska et al., 1982b) just as depressed cellular immunity 
could influence the rabbit papilloma progression as described above. 
Similarly, as CRPV infection of rabbits in utero or in the neonatal period 
decreases the regression rate, perhaps too in EV, infection at an 
immunologically immature stage, as in utero, is responsible for the 
life -long persistence of EV infections. (Jablonska et al., 1983). The 
influence of extrinsic factors in both cases is also obvious - the 
co- carcinogenic effects of tar and methylcholanthrene in the Shope 
system and the localisation of carcinoma development in HPV- induced 
lesions to sun exposed areas in EV patients. Ultraviolet irradiation is 
well recognised to induce transient immunosuppression and to increase 
viral skin infections (Norval et al., 1986). The carcinogenic effect of 
X -rays applied to premalignant lesions in EV patients has also been noted, 
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with resulting deeply invasive carcinomas (Jablonska et al., 1983). 
These comparisons between the rabbit and EV models of viral oncogenesis 
are shown in Figure 7. 
There are of course some differences in the two systems. For 
example, CRPV- induced lesions occur characteristically at sites of 
trauma, whereas EV lesions, although most abundant at exposed and 
traumatised sites, are disseminated all over the body. CRPV infections 
are totally confined to hair -bearing epidermis and it has been suggested 
that the susceptible cell may be the migrating wound epithelium derived 
from the hair follicle sheath cell (Kreider and Bartlett, 1985). Given 
the distribution of lesions, this is unlikely to be true for EV. 
Carcinomas developing from rabbit papillomas are usually invasive with 
metastases in the regional lymph nodes common and pulmonary 
of $(.41, tibbib 
metastases occurring in 25%A(Kreider and Bartlett, 1981), whereas EV 
carcinomas are more frequently only locally destructive although 
occasional metastases have been reported (Ostrow et al., 1982). 
At the molecular level, plenty of virus particles can be found in 
both cottontail papillomas (Stone et al., 1959) and in EV lesions including 
those that have progressed as far as CIS (Ruiter and van Mullem, 1970), 
but none are detectable in domestic rabbit papillomas, CRPV- induced 
carcinomas or EV carcinomas (Orth et al., 1980). The papillomavirus 
genome, however, is present in all virally- induced tumours in both 
systems. The rabbit papillomas are all produced by a single virus type 
and CRPV would appear to have a well conserved genome (Yanit; 1986) 
whereas EV lesions are induced by a large number of HPV types. On 
the other hand, carcinomatous lesions harbour only HPV -5 and closely 
related types (Ostrow et al., 1982; Pfister et al., 1983; Lutzner et al., 
1984; Yutsudo et al., 1985) leading to the suggestion that HPV -5 related 
types are themselves endowed with malignant potential in the presence of 
other influences. Certainly malignant conversion does not depend on 
immune status, since EV patients harbouring only HPV -3 and no cancers 
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Neither the HPV -5 genome, which, by in situ hybridisation was 
found abundantly but only in a few cells (Orth et al., 1980), nor the 
CRPV genome as described above, appears to be integrated. Rather they 
remain in the multicopy episomal state with transcription being restricted 
to the early region of the genome. In the CRPV model, expression of 
E6 and E7 is required for both wart and tumour development, and Orth 
(1986a) has shown E6 and E7 transcripts to be present in EV carcinomas 
also. 
The long delay required for the transformation of warts in both 
rabbits and EV patients coupled with the reduced delay and increased 
frequency of malignancy in the presence of carcinogenic agents (tar and 
UV respectively), suggests that several mutations or DNA 
re- arrangements within the host cell sequence may be required, perhaps 
leading to co- operation between viral genes and cellular oncogenes 
(Schneider -Maunoury et al., 1987). However, no co- operation of CRPV 
or of CRPV plus the DNA modifier DMBA (dimethylbenzanthruìe) with 
Ha -ras, Ki -ras or human c -myc oncogenes could be found except for a 
three -fold amplification of Ha -ras in the Vx7 transplantable carcinoma 
where all viral sequences are integrated. A slight impairment of 
UV- induced DNA repair synthesis has been observed in some EV patients 
(Proniewska et al., 1980) and this may enhance the carcinogenic effect of 
UV itself. However,the lack of integration and lack of oncogene 
activation suggest a different mechanism for oncogenic progression. 
3.55 Other potentially associated cancers 
More than 20 years ago, the late Dr. R.H.A. Swain of this 
Department had a conviction that HPV would be involved in bladder 
papillomas and their malignant progression (Cubie, personal recollection; 
Ogilvie, 1970a.). There is as yet no firm evidence for such a process 
although Del Mistro et al. (1987) having reported HPV -6/11 in uretheral 
condylomata, also found HPV -6/11 in 3 cases of bladder condylomata. 
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In 1983, Spradbrow and his colleagues in Queensland who were 
aware of the association of BPV with carcinomas on sun -exposed 
unprotected skin of sheep and cattle (Vanselow, 1982; Ford et al., 1982), 
examined four human hyperkeratotic skin cancers attributed to chronic 
exposure to sunlight and found PV particles in one. More recently, 
Gassenmaier et al., (1986) in Germany found evidence of HPV in 14/32 
cases of solitary keratoacanthoma, most being associated with HPV -25, 
and Jablonska et al., (1987) reported a new HPV, HPV -36 (related to 
HPV -5) in a case of actinic keratosis in an immuno- competent individual. 
Other skin lesions will no doubt continue to be examined in both normal 
individuals and in the immunocompromised in the search for further HPV 
involvement. 
Although the best known site of HPV infection in the respiratory 
tract is the larynx, other lesions have been probed for the presence of 
HPV. Thus while six patients with verrucous carcinoma of the larynx 
all showed HPV -16 related sequences (Brandsma et al., 1986) only one of 
42 biopsies of laryngeal carcinomas harboured HPV (HPV -30; Kahn et al., 
1986) and similarly only one of 24 biopsies of carcinoma of the lung of 
various histological types contained HPV, again HPV -16 (Stremlau et al., 
1985. However, a metastatic squamous cell carcinoma of the lung in an 
adult who had had juvenile laryngeal papillomatosis without radiation 
therapy or a history of smoking, contained HPV -11 in high copy number 
(Byrne et al., 1987). Fungiform papillomas of the nose appear to 
harbour HPV -11 whereas in inverted nasal papillomatosis only 2/13 had 
detectable HPV sequences (Brandsma et al., 1987). 
The oral cavity has also proved a popular site for investigation. 
In general the papillomatous lesions appear to harbour HPV, usually of 
HPV -11 related types (Naghashfar et al., 1985; Loning et al., 1985) but 
so also did leukoplakias (Loning et al., 1985) and, surprisingly, 7/8 lesions 
of lichen planus harboured HPV -16 related types (Maitland et al., 1987). 
This HPV -16 variant was also found in 5/12 normal oral tissues and 
appeared to have the same restriction endonuclease pattern as the HPV- 
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16 variant found by de Villiers et al. (1985) in a specimen of a tongue 
carcinoma. 
These results probably represent only the tip of the iceberg of 
the search for HPV sequences in malignant tissues, but they include two 
interesting findings. Firstly Stremlau's patient who developed a lung 
carcinoma which contained HPV -16 had had a cervical cancer removed 9 
years earlier and it has been known for some time that the incidence of 
lung cancer in the first five years after treatment for cervical cancer 
is unusually high (Mould do Barrett, 1976). While the anaplastic nature 
of the lung carcinoma could not confirm that this was a metastasis, the 
presence of HPV -16 sequences in pelvic and para- aortic lymph nodes of 
patients with cervical cancer has been found (Lancaster et al., 19863 F J,s ß.,1yß8 
+n& 1ií9) 
Secondly, the patient reported by Byrne et al., (1987) in whom a 
metastatic lung carcinoma could be related to laryngeal papillomas also 
developed a liver metastasis in which extrachromosomal HPV -11 was 
found, but with a large 2.2Kó tandem repeat in the LCR of the viral 
genome. Duplication of transcriptional control and enhancer elements 
could contribute to carcinogenic progression and it is interesting to note 
that similar repeats within the LCR have been noted in the cloned 
HPV -6 DNA from a Buschke- Lowenstein tumour (Boshart and zur Hausen, 
1986) and from an unusually aggressive verrucous carcinoma of the vulva 
(Rando et al., 1986a, b). Watanabe et al. (1984) reported that a BK 
virus mutant with duplications in the control region for early 
transcription could transform rat or hamster cells more efficiently than 
wild type BK giving it a replicative advantage as found with the HPV -6 
and HPV -11 variants described above. This interpretation should be 
viewed cautiously, however, in the light of recent work by Kasher and 
Roman (1988) in which they studied 7 HPV -6b clones, which, after 
propagation in E.colit presented 3 distinct sequence patterns due to 
insertion and deletions occurring at the same site within the purine- 
thymidine rich region of the LCR and considered that this was a "hot 
spot" for recombination in E.coli. 
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4. Immune Responses to Human Papillomaviruses 
Studies with animal PVs have shown that both humoral (HI) and 
cell mediated immune (CMI) responses develop in papilloma infections 
(Lee and Olson, 1969) and that regression is due in many cases to a CMI 
response (Kreider, 1963; Lee and Olson, 1968). Bovine papillomas 
continue to grow in the presence of circulating antibodies and then 
regress simultaneously following lymphocyte infiltration. Over the 
years, many investigators have attempted to clarify the roles of different 
parts of the immune response in HPV infections. 
4.1 Humoral Responses 
The first experiments to investigate the frequency with which 
spontaneous regression occurred in wart virus infections looked at 
antibody development. Antibody could be demonstrated by various 
techniques in 45 -70% of patients with warts particularly around the time 
of regression, and was frequently of the IgM class and therefore unlikely 
to offer protection from subsequent attacks (see Cubie, 1972a). 
Indeed, Matthews and Shirodaria (1973), using immunofluorescence on wart 
sections, found HPV- specific IgM antibodies in 100% of patients with 
regressing warts, but only in half of those whose warts were not 
regressing. The presence of CF antibodies appeared to Pyrhonen and 
Johansson (1975) to be associated with rapid cure. Seventy -five per 
cent of their patients with CF antibodies had lost their warts within 2 
months, and it was suggested that the antibodies could be responsible for 
rejection. However, they also noted that rapid regression occurred in 
some people in the absence of detectable antibodies and concluded that 
L. Tit uSt be responsible here. 
Several workers have used indirect immunofluorescence to look 
for antibodies to HPV using sections of skin warts as antigen source. 
Genner (1971) was the first to describe this method but the reactions 
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obtained were weak. The technique was also used by Matthews and 
Shirodaria (1973), Pass and Maizel (1973), Shirodaria and Matthews (1975) 
and by Viac et al. (1977b). In all of these studies the incidence of 
antibody development was higher in those whose warts were regressing. 
When patients were examined according to the clinical type of 
wart present, approximately 50% of those with plantar warts (generally 
myrmecia) and 25% of those with hand and other types of wart were 
found to have antibody by gel diffusion amplified by countercurrent 
electrophoresis (Cubie, 1972b). Antibody was slow to develop during an 
infection, could persist for at least 13 years, and did not appear to 
prevent re- infection. Yet some people with repeated attacks never 
developed detectable antibody and conversely several people who thought 
they had never had warts did develop antibody, suggesting sub -clinical 
infection (Cubie, 1972b). The frequent occurrence of sub -clinical or 
latent infection was confirmed by Pyrhonen (1978) who found 52% (33/64) 
of a group of medical students without any history of warts had HPV 
antibodies by immunodiffusion. He also noted many patients with a 
weak antibody response and no regression of their lesions during the 
period of follow -up. 
These studies were, of course, carried out using pools of 
semi -purified virus particles, before the plurality of HPVs was fully 
recognised and the specificity of each antibody response or of the HPV 
type causing infection was not known. However, HPVs isolated from 
different epithelial lesions were shown to be antigenically distinct when 
no cross -reactions were obtained with animal antisera raised against 
different HPVs isolated from skin warts (Gissman et al., 1977; Orth et 
al., 1977; Pass et al., 1977), and so a certain amount of re- evaluation 
of serological data was carried out using newer serological techniques 
such as radio -immunoassay (RIA) and enzyme -linked immunosorbent assay 
(ELISA). Pfister and zur Hausen (1978) describe an RIA using an HPV -1 
antigen (or more accurately an HPV 1 -3 antigen since the typing was 
based on protein analysis of pooled plantar lesions) and iodinated anti- 
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HPV -1 rabbit antiserum. In a nonselected population, maximal 
prevalence of antibodies to HPV -1 (50 %) was found in the age group 
11-20 years, this being the age group in which HPV -1 induced warts are 
most frequently seen. With increasing age, the percentage of HPV -1 
antibody positive sera decreased. However, in looking at specific 
populations with warts and other lesions, 45 -55% of adults with plantar 
and common warts had antibody to HPV -1, as had 53% of 47 patients 
with condylomata acuminata, approximately 40% of patients with various 
carcinomas and 26% of patients with Hodgkin's disease. Pyrhonen 
et al. (1980) used an ELISA test, but again with pooled papilloma 
homogenates containing several HPV types as antigen, and found IgG 
antibodies in 44% and IgM in 71% of people with various types but 
mostly common warts. 
Because it just is not possible to produce sufficient virion 
material from individually typed lesions (other than perhaps for HPV -1 
where particle production is high), only very small numbers of sera have 
been examined using totally type specific reagents. Jablonska et al. 
(1982b) showed only 3 out of 21 patients with flat warts to have 
anti -HPV -3 antibodies and 3 out of 12 with common warts to have 
anti -HPV -2 antibodies. Similarly, Kienzler et al. (1983) report 
anti -HPV -1 antibodies in 39% of people with myrmecia. In patients 
with EV, 72.8% had specific antibodies to HPV -1, 2 or 3 using 
immunodiffusion, whereas 80% of healthy family members of EV patients 
did not, arguing against a protective role for antibodies (Jablonska et al., 
1980). In a study of patients with recalcitrant common warts treated 
with bleomycin (Bunney et al., 1984) HPV -2 antibodies were found by 
immunofluorescence on sections of common warts in sera from 8/22 
(36 %) patients before treatment and in 12/15 (80 %) after 6 weeks of 
treatment with or without HPV -1 antibodies in addition (Bunney and 
Cubie, unpublished data). 
In a very recent large survey in Belfast, using an indirect 
immunofluorescent test to detect specific IgM antibodies, Steele and 
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colleagues (1988) found 23.4% to have HPV -1 antibodies and 44.5% to 
have HPV -2 antibodies in a population of 376 patients with cutaneous 
warts. None of 50 randomly selected patients had anti -HPV -4 IgM. 
The realisation that PVs shared a common antigen, detectable on 
SDS- disruption of purified particles (Jenson et al., 1980) gave a different 
approach in providing antigen for serological testing. Using a disrupted 
BPV -2 antigen, Baird (1983) described an ELISA in which he reported 
that patients with anogenital warts, CIN, or invasive carcinoma of the 
cervix, all had higher antibody levels than control groups of children or 
adults. Positive results in 95 %, 60% and 93% of cases respectively 
were obtained when measured simply by comparison of absorbance 
readings. However, the absorbancies in all patients were very low 
(< 0.3) and although some positive responses were noted in a recent study 
in similar patients, using a similar ELISA system, the very high 
proportion of positives noted by Baird was not observed (Beiss et al., 
1987). 
Very recently, attempts have been made to examine the 
serological response in patients with genital warts and cervical dysplasias 
using antigens prepared by the expression of fragments of HPV -DNA 
molecularly cloned in bacteria or by synthetic production of polypeptides 
determined from the DNA sequences of specific ORFs. By Western 
blotting with HPV -6b L1 fusion protein as antigen, Li et al. (19874) found 
specific antibodies in 18/30 patients attending a colposcopy clinic. In 
more extensive studies, Denison et al. (1988) also using Western and 
dot -blotting and fusion proteins to ORFs of HPV -6b and HPV -16, 
reported that the predominant activity of patients with condylomata 
acuminata was to the major capsid protein encoded by HPV -6b L1, 
although occasional responses to L2, E4 and E2 were also detected. In 
their hands, sera which reacted with HPV -6b L1 did not react with 
HPV -16 L1 despite the considerable conservation of this ORF among PVs. 
Care must be taken, however, in assessing the specificty of L 1 
fusion proteins for serological studies. Li et al. (1987.) noted, for 
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example, that experimentally produced rabbit antiserum to their 
particular HPV 6b L1 could recognise L1 proteins in both HPV -1 and 
HPV -6/11 sections. Furthermore, the use of monoclonal antibodies to 
BPV -L1 has shown the existence of both type- specific and group specific 
epitopes within L1 (Nakai et al., 1986). Possibly the group- specific 
epitopes may be dependent on conformation, while Western blots which 
detect mainly linear epitopes would reveal only type- specific reactt3ns 
(Jenison et al., 1988). Certainly, work from Strike et al. (1986) showed 
the group -specific region of L1 to contain beta turns, with a highly 
hydrophilic region and several well conserved stretches with low polarity, 
but they too used Western blots in their analysis. 
Very recently an HPV -16 L1 fusion protein expressed in vaccinia 
virus was described (Browne et al., 1988). Antibodies to it and to a 
synthetic peptide to the C- terminal 14 amino acids of HPV -16 L1 both 
reacted well with the HPV -16 L1 target in Western blots, whereas group 
specific polyclonal serum and antiserum to HPV -6b L 1 fusion protein 
failed to react. Furthermore, a monoclonal antibody to the HPV -16 LI 
fusion protein has been produced which is capable of detecting antigen in 
cervical lesions containing HPV -16 or HPV -33 but not HPV -6 or 
HPV -11. Although one does not expect late antigens to be produced 
frequently in HPV -associated cervical neoplasia, it might be worth while 
examining sera from patients with koilocytic lesions and from normal 
controls for antibodies to HPV -16 L1. 
For some serological investigations, the L2 ORF may provide a 
more satisfactory source of specific antigens since this ORF is not 
conserved among PVs apart from a short sequence near the N- terminus 
(Komly et al., 1986). Both Komly and co- workers and Firzlaff et al. 
(1988) have shown the specificty of antisera to a truncated fusion protein 
of L2 from which the N- terminus is absent. Alternatively, a 13 amino 
acid synthetic peptide to the C- terminus of LI of HPV -6b has been 
shown to be type specific (Li et al., 19874), like the HPV -16 L1 synthetic 
peptide described above (Browne et al., 1988). 
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4.2 Cellular Immunity 
4.21 In vitro studies. 
The recognition of specific antigens by immune lymphocytes can 
be measured in vitro by three different reaction principles (Kirchner, 
1986): the production of biologically active molecules (lymphokines) on 
specific antigenic recognition by lymphocytes, the proliferation of specific 
clones of lymphocytes and the cytotoxicity of lymphocytes. 
4.211 HPV- specific reactions 
HPV- specific reactions can be detected using tests under the 
first two of these principles. The leucocyte migration inhibition test 
(LMI) is based on the production and effect of lymphokines and was first 
used by Morison (1975a) in a study of 118 patients with warts, utilising a 
semi -purified pooled wart extract as antigen. Most of the patients 
developed a positive response at or near the time of resolution of their 
lesions but the response only lasted about 3 months. However, of 9 
patients who showed a positive response at the time of first examination, 
8 were clear of their warts within 2 months, suggesting that a positive 
response was an integral part of successful resolution. 
The presence of an LMI factor was similarly shown in 4/7 
patients who had had warts for less than one year (Lee and Eisinger, 
1976). A single case of LMI in response to a specific HPV -3 antigen 
was reported by Jablonska et al. (1982a), in a patient with EV in whom 
all lesions slowly regressed after two pregnancies. A positive LMI 
response was detected from 6 -18 months after the second delivery. 
Lymphoproliferative (LP) responses have been used more 
frequently as an in vitro measure of CMI. Again using a semi -purified 
virion antigen, Ivanyi and Morison (1976) found "mild" stimulation in 
patients with active warts was followed by increased stimulation after 
resolution. Similarly, 5 of the 7 patients who had warts of short 
duration in Lee and Eisinger's study (1976) gave positive responses after 
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6 days of culture although the extent of proliferation was low. 
Nevertheless, all these results from both LMI and LP studies support the 
concept that a cell- directed immune response plays a role in regression 
of human warts. 
However, Lee and Eisinger (1976) also detected positive 
responses in a group of people who thought they had never had warts, 
again giving credence to the idea of latent infection, and a further group 
whose warts had lasted a long time showed relatively little response. 
Because the response to non -specific mitogens such as 
phytohaemagglutinin (PHA) is normal in this group of patients, it was 
suggested by these workers that there might be a group of people 
genetically unresponsive to virus, thus enabling persistence to occur or 
tolerance to the virus to be induced, perhaps by immunological blocking 
of lymphocytotoxic cells as suggested in persistent rabbit papillomas 
(Hellstrom et al., 1969). A soluble factor of this type was apparently 
found in the wart tissues of a patient with warts of 20 years duration - 
the addition of a saline extract of one of the patient's warts abolished a 
positive LMI response to HPV antigen (Freed and Eyres, 1979). 
4.212 Non -specific reactions 
It was recognised many years ago that immunosuppressed 
patients such as renal allograft recipients (RAR) and patients with 
deficiencies of CMI secondary to Hodgkin's lymphoma and chronic 
lymphocytic leukaemia were more prone to papilloma infections which 
could become disseminated and non -regressing (Spencer and Andersen, 
1970; Morison, 1975b). Several investigators have therefore looked at 
non -specific CMI responses and peripheral blood lymphocytes for evidence 
of deficiencies in wart -bearing patients. 
Morison (1975c) suggested that wart patients were less responsive 
than controls to PHA and purified protein derivative (PPD) in LMI tests 
and the deficiency was related to the duration of the wart infection. 
Using a sheep red cell rosette assay to measure T -cell levels in 
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peripheral blood, Chretien et al. (1978) noted decreased levels in 72 
healthy people with current warts and 21 who had had warts in the past 
compared with controls with no past history of warts. 
Using specific T -cell markers recently, Lodi and colleagues 
(1987) noted a decrease in peripheral blood CD4+ cells in patients with 
both common and genital warts, and a resultant drop in CD4 + /CD8+ 
ratio. A similar change in ratio in patients with flat warts was due 
rather to an increase in CD8+ while patients with plantar warts showed 
no difference from controls. These results reflect the earlier in vitro 
results obtained by Obalek and his colleagues in Warsaw (1980). 
PHA -induced LP was not significantly altered in patients with HPV -1 
induced plantar warts, but it was reduced in those with HPV -2 and 
HPV -3 lesions. Jablonska et al. (1980) considered indeed that defects in 
CMI facilitated infection with HPV -2 and HPV -3. Similarly in 16 
women with recalcitrant genital warts, Seski et al. (1978) found a 
reduction in the LP response to PHA, pokeweed mitogen (PWM) and 
concanavalin A (Con A), while Avgerinou et al., (1986) reported a 
reduction in LMI response to tuberculin and DNCB in 30 patients with 
recurrent genital warts. On the other hand, in small groups of women 
with genital warts or cervical dysplasia, neither Jablonska et al., (1982b) 
nor Neill (1984) working in this laboratory, found significant alterations in 
LP responses to non -specific mitogens. 
Most patients with EV show a significant reduction in the LP 
response to PHA (Prawer et al., 1977) and a decrease in circulating T 
cells (Jablonska et al., 1980). The deficiencies, however, were similar 
to those observed in patients with long standing and widespread plane 
warts, and they were also similar in EV patients whether the infecting 
type was HPV -3 or the potentially more oncogenic HPV -5 suggesting that 
the virus itself rather than the extent of T cell defect is a decisive 
factor in malignant transformation (Jablonska et al., 1982b). 
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4.213 Cytotoxic cell responses 
Killing of virally- infected cells may be mediated directly by 
natural killer (NK) cells or by antibody dependent cytotoxic cells (ADCC) 
via antibody bound to target cells. These two functions may even be 
provided by the same effector cell acting through different receptors 
(Roitt et al., 1985). One or two attempts to look at this aspect of 
immunity in vitro have been reported. Neil and Norval (1984) in a 
study of 105 patients with CIN of varying degrees found no difference in 
NK activity against Chang liver cells or against the K562 myeloid cell 
line in any of the patient groups nor in K cell activity in an ADCC 
assay on Chang cells. Likewise, normal NK activity against K562 cells 
has been shown in patients with EV (Androphy et al., 1984) although 
Kaminski et al., (1985) reported heightened NK activity in 4 of 6 EV 
patients who had multiple skin cancers. On the whole, decreased NK 
activity is associated with a high incidence of malignancy (Hanna, 1985) 
and so this result in EV patients is somewhat surprising. However, it is 
postulated that the increased activity may prevent uncontrolled growth of 
the malignant skin tumours and explain why metastases are so rare in EV 
patients (Kaminski et al., 1985). Extending the assay to further groups 
of patients including some with Bowenoid papulosis and some with 
HPV -16 associated anogenital carcinomas, Malejczyk et al., (1987) found 
NK activity against K562 cells to be similar in these patients and in 
controls. 
Until recently it has been impossible to produce HPV- infected 
cells in vitro to act as specific target cells in cytotoxic assays. 
However, the establishment of a continuous keratinocyte cell line from 
an HPV -16 associated vulvar Bowenoid papule (SKV -1 cells) enabled 
Malejczyk et al., (1987) to look for specific reactions. They found that 
both the patients with Bowenoid papulosis and those with anogenital 
carcinoma had markedly depressed NK activity compared with controls. 
Since different clones of NK cells have been shown to have different 
target specificities (Herberman and Ortaldo, 1981), it is possible that a 
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single subset of effector cells mediates the specific decrease in NK 
activity against HPV -16 containing target cells. The degree of 
suppression appeared to be related to the degree of malignancy and it is 
postulated that the inability to eliminate cells infected with potentially 
oncogenic HPVs might be an important factor in the development of HPV - 
induced neoplasm. Furthermore, the defective NK activity shown in 
patients with various malignancies including leukaemias might explain the 
persistence and progression of HPV- induced lesions in these patients. 
Recently, further extensions to this work have been accomplished 
(Jablonska, 1988; personal communication). EV patients with lesions 
induced by EV specific HPV types had normal activity against K562 and 
SKV -1 cells, but three had reduced activity to keratinocytic target cells 
derived from a premalignant lesion of an EV patient. EV patients with 
HPV -3 induced lesions showed reduced activity to all target cells tested, 
in line with their deficient CMI when measured by other parameters. 
Similarly, only patients with HPV -16 lesions and not those with HPV -6 
associated lesions had reduced NK activity towards the HPV -16 
containing cell line (Malejczyk et al., 1989). In addition, sera from 
most of the Bowen's papulosis and carcinoma patients could exert an 
inhibitory effect on the cytotoxicity of normal NK cells against SKV -1 
targets. This further supports the theory already described ( Hellstrom 
et al., 1969; Lee and Eisinger, 1976; Freed and Eyres, 1979) that a 
serum factor capable of blocking lymphocytotoxic cells accounts at least 
in part for the persistence and /or progression of papilloma infection. 
A different type of _ cell mediated tumour cell destruction has 
been observed in vitro by Tagami et al. (1985) in spontaneously regressing 
plane warts. Primary explant cultures of inflamed warts were shown to 
contain not only wart -derived keratinocytes but in 9 out of 10 cases, 
massive numbers of lymphocytes which migrated out of the explants, 
attacked the keratinocytes and induced degenerative changes. 
Outgrowths from explants of non -inflamed warts showed keratinocytic 
monolayers within 10 days as with normal skin, and no 
- 56 - 
degenerative changes. Although subtype monoclonals were not available 
at the beginning of the study, cells in a few explants were typed and it 
was found that suppressor /cytotoxic T cells outnumbered helper cells. 
4.22 In vivo Studies 
Cell mediated immunity can also be investigated in vivo by 
looking at the delayed hypersensitivity (DH) skin reactivity to 
intradermal inoculation of both non -specific and specific viral antigens. 
Thus, in 1974, Brodersen et al. reported that the tuberculin reaction in 
a group of previously BCG vaccinated children with common warts was 
significantly reduced compared with a group of controls, in general 
agreement with Morison's (1975c) in vitro data of reduced LP to mitogens 
in wart patients. Ibis lent support to the generally held view at the 
time that CMI was impaired in patients with warts. Thivolet et al. 
(1977) reported the use of formaldehyde- inactivated purified HPV as 
stimulating antigen for intradermal testing and found 75% of patients 
with a past history of warts reacted positively. In extending these 
results, the same workers showed that DH reactions were most frequent 
par:, Ys ,,;aV. 
in,warts of 6 -24 months duration, developed around the time of 
regression and lasted longer than detectable circulating antibodies (Viac 
et al., 1977a). Responses were lowest in a group of patients with flat 
warts and although only 7 patients were studied, this too mirrors the 
results of in vitro studies in similar patients (Obalek et al., 1980). In 
a group of genital wart patients, however, positive responses were 
obtained as often as in those with plantar warts (Viac et al., 1978). 
Repeated intradermal testing with the same antigen was carried 
out on a group of patients with multiple warts (Viac et al., 1977b). 
After three such testings, the patients could be divided into those whose 
warts had resolved following the acquisition of specific CMI and of 
circulating IgG antibodies (10 patients) and those who showed only weak 
or non -existent specific immune responses and in whom warts persisted 
(12 patients). Thus the outcome of similar HPV infections in different 
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individuals is influenced by their different immune responses to the 
virus. 
4.3 Local Immune Reactions 
4.31 Nature of antigens produced 
As wart virus infections probably occur wholly within the 
epidermal element of the skin, access to the systemic immune system is 
limited and it is appropriate to look for evidence of local immune 
reactions to the infection. 
Using cryostat sections of different skin wart biopsies, 
intranuclear viral antigen staining is readily observable by fluorescence 
with hyperimmune rabbit antisera against viruses from similar lesions 
(Genner, 1971; Pass and Maizel, 1973). Type- specific guinea pig 
antisera have also been used to detect nuclear viral antigens in HPV -1, 
2, 3 and 5 induced lesions using the more sensitive anti -complementary 
immunofluorescence test (Chorzelski et al., 1983). However, in 
addition to the viral antigens, Pass et al. (1971) demonstrated cellular 
antigens of human wart tissue which were present in normal tissue and 
markedly increased in warts and some epidermal tumours. Using 
antisera against wart tissue homogenates Pass and Marcus (1973) showed 
that there were two such nonviral antigens, one nuclear and one on the 
cell surface. Shirodaria and Matthews (1975) similarly noted that the 
sera of some patients contained, in addition to antiviral antibodies, an 
antibody of the IgM class directed against the wart cell itself and 
present more frequently than the antiviral antibodies. 
4.32 Immunocytochemical analysis 
4.321 Initial studies 
The most obvious form of local immune reaction to wart 
infection is seen histologically in the massive lymphocyte infiltration 
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which precedes resolution of a crop of plane warts (Tagami et al., 1974; 
Tagami et al., 1977; Berman and Winkelmann, 1977). The 
mononuclear cell- associated injury to the epidermis is similar to that 
seen in DH reactions and is observed in the patients as an acute 
inflammatory reaction. The sudden eruption of large numbers of tiny 
new warts often signals the onset of involution (Berman and Berman, 
1978), perhaps because cellular destruction releases infectious particles 
capable of initiating new infections just prior to the resolution of them 
all, or because heightened immunological activity results in the 
expression of previous subclinical infections. Cellular infiltration can 
also be observed histologically in common warts at the time of 
regression, but the effects are not so dramatic, oedema and 
inflammation are less obvious and resolution occurs over a longer period 
(Berman and Winkelmann, 1980). 
In studying regressing plane warts at the ultrastructural level 
Oguchi et al. (1981a) noted both lymphocytes and activated macrophages 
in the infiltrate, the former with pseudopodia often extending into 
epidermal cells and the latter interacting with degenerating epithelial 
cells, fusing with or invading them. In addition epidermal Langerhans 
cells showed enhanced activity with increased cell granules (Oguchi et 
al., 1981b). Specific histochemical stains such as acid 
naphthylacetate esterase (ANAE) were also used to differentiate some of 
the cells in the infiltrate, enabling Tagami et al. (1985) to show that 
lymphocytes, mainly T cells, predominated over macrophages in 
regressing plane warts and were capable of attacking keratinocytes to 
bring about degenerative changes. 
Staining with ANAE was also used by Syrjanen (1983b) to look 
at sections of cervical dysplasias. He found increasing numbers of 
T lymphocytes associated with advancing atypia both in HPV lesions 
and in lesions lacking koilocytes, and a decrease in the number of B 
cells as the severity of the lesions increased. No significant 
differences in T cells, B cells and macrophages were observed amongst 
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lesions which regressed, remained stationary or progressed (Syrjanen et 
al., 1984). However, the patterns obtained with this stain are difficult 
to interpret and the method has been totally superceded by the use of 
sensitive and specific monoclonal antibodies for subset analysis. With 
such powerful tools valuable information has been obtained, and it is 
relevant at this point to describe current understanding of the different 
elements involved in immune reactions in the skin. 
4.322 The skin immune system 
The skin immune system comprises many elements, of which the 
principal ones are the Langerhans cell (LC), a bone -marrow derived 
dendritic cell of the monocyte- macrophage series with 
antigen -presenting properties (Stingl et al., 1978), keratinocytes and 
epidermotropic T lymphocyte subpopulations. Other immunologically 
relevant cells in the skin include mast cells, macrophages, granulocytes, 
indeterminate cells, veiled cells and the endothelial cells of capillaries 
and afferent lymphatics (Bos and Kapsenberg, 1986). 
Langerhans cells are the epidermal equivalent of macrophages 
and as such are central to the skin immune system. They are capable 
of phagocytosis and of migration from skin to lymph nodes and they 
play an important role in the induction of many types of T cell 
response including the induction of proliferative and cytotoxic T cell 
responses (Katz et al., 1985). also play a major role in DH 
reactions (Toews et al., 1980) in preventing the induction of 
unresponsiveness to antigen presented cutaneously. This was shown in 
mice whose first exposure to DNFB occurred through skin depleted of 
LC, and which, on subsequent challenge onto normal skin, were unable 
to become specifically sensitised. The mice had become profoundly 
unresponsive. Thus LC in the skin act as an immune surveillance 
system, and their absence will lead to tolerance and in the case of 
viruses, persistence. 
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Langerhans cells can be identified immunocytochemically by 
their ATPase activity (Wolff and Winkelmann, 1967), by their expression 
of major histocompatibility (MHC) Class II antigen (Streilein and 
Bergstrasser, 1980), their Fc -IgG and C3b receptors (Stingl et al., 1977) 
common thymocyte antigen (T6; Murphy and Harrist, 1982) and the 
presence of S100 protein (Cocchia et al., 1981). ATPase activity and 
the presence of S100 protein can be estimated on formalin -fixed 
paraffin embedded sections, but the other markers are detected on 
frozen sections with the appropriate monoclonal antibodies. The MHC 
Class II antigens are encoded by the HLAD region on chromosome 6 and 
gene products with specificities DP, DQ and DR have been found within 
this complex (Roitt, et al., 1985). HLA -DR is the most abundantly 
expressed surface marker on LC, and activation of the cell results in its 
increased expression (Berman et al., 1985). 
An increase in Langerhans cells in benign skin lesions was 
observed by Gatter et al. (1984b) and a reduction in number with 
changes to a stunted morphology in malignant lesions. The majority of 
cells surrounding the tumours were of the helper /inducer subset (Th /i). 
At the time it was noted that two cases of verruca vulgaris were an 
exception to this rule in behaving more like malignant tumours. 
In normal skin, HLA -DR expression is restricted to LC, but 
there is now considerable evidence to show that keratinocytes can be 
induced to express this antigen in a variety of skin disorders (Aiba and 
Tagami, 1984; Aubock et al., 1986), particularly those in which there is 
evidence of lymphocyte infiltration and keratinocyte damage (Lampert, 
1984) and including contact dermatitis (Gawkrodger et al., 1987). It is 
interesting that HLA -DR expression can be induced in neonatal and 
normal skin by 3- interferon (8 -IFN; Berman et al., 1985) and that weak 
antigen expression is occasionally noted in normal skin (Gawkrodger et 
al., 1987). 
The interplay of cells and soluble factors is far from resolved, 
but it appears that activated LC either locally or after migration 
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to nearby lymph nodes produce IL -1 which attracts T cells from the 
peripheral circulation and stimulates their proliferation. They in turn 
infiltrate the dermis and epidermis, producing á -IFN which leads to the 
synthesis and expression of HLA -DR on keratinocytes in the immediate 
vicinity of these T cells. The keratinocytes in response produce 
epidermal thymocyte activating factor (ETAF) which may further 
stimulate T cells (Sauder, 1985). Keratinocytes expressing HLA -DR do 
not appear to have an inductive role since they are apparently never 
seen in the absence of, or preceding, a dermal infiltrate (Aubock et al., 
1986). On the other hand, the stratum corneum can act as a reservoir 
for preformed ETAF, perhaps enabling it to initiate the earliest events 
associated with the inflammatory response (Daynes et al., 1985). 
Finally, it has been postulated that keratinocytes expressing HLA -DR 
may acquire the ability to present processed antigen in association with 
DR, and then be recognised as nonautologous by cytotoxic T cells 
(Morhenn et al., 1985). 
4.323 Subset analysis 
Iwatsuki and his colleagues in Japan (Iwatsuki et al., 1986) 
looked further at regressing plane warts and found that LC were present 
in both the cells of the dermis and the epidermis, sometimes in 
apposition to T cells. Of the T cell infiltrate, Th /i outnumbered 
suppressor /cytotoxic T cells (Ts /c). Only about 40% of the infiltrate 
at the early stages of regression consisted of macrophages and there 
were a small number of NK cells in 3 out of 4 late inflammatory 
lesions. Although satellite cell necrosis as a marker of direct cell 
killing and observable as a damaged keratinocyte surrounded by 
lymphocytes was observed occasionally, the relative lack of Ts /c cells 
su böc.s+°4' to these workers that the immune reaction involved was more - " 
complex than direct cytotoxicity and probably involved soluble factors 
such as interleukins and interferon (Iwatsuki et al., 1986). 
Gatter et al. (1984b) reported a predominance of Th /i in two 
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cases of cutaneous warts, but in a large study of 75 nonregressing 
warts, Chardonnet et al. (1986) found that no T cell subset 
predominated in cutaneous or mucosal warts induced by HPV -1 or 
HPV -2, although CD8+ cells were more frequent in lesions with 
detectable viral antigen. The epidermis was depleted of LC, again 
particularly in lesions with antigen, but larger numbers of LC were 
found in the dermis suggesting migration following activation. Overall, 
65% of biopsies had an abnormal distribution of LC and 29% had no 
epidermal LC. 
Subset analysis has been more extensively studied in cervical 
dysplasias with and without evidence of HPV infection than in other 
cutaneous wart lesions. Morris et al. (1983) made use of some of the 
first available monoclonals for such analysis and found that in patients 
with wart virus infection (without evidence of CIN) there was an overall 
depletion of T cells, and those that were present were predominantly 
Ts /c. B cells were few in number and LCs were reduced, with those 
remaining confined to the basal layers having lost their interdigitating 
processes. By contrast, 3 patients with CIN showed a heavy 
infiltration of Ts /c cells and an increase in LC with spindle shaped 
morphology but still lacking cytoplasmic processes. The results 
suggested that the ability of wart virus to persist in cervical epithelium 
was a direct consequence of its ability to deplete the tissue of LC and 
T lymphocytes (Morris et al., 1983). Syrjanen's contemporary study 
(Syrjanen et al., 1984) showed a slight but not statistically significant 
decrease in the ratio of Th /i to Ts /c in progressing lesions and 
recorded, but did not comment on, a large drop in the .percentage of LC 
in progressing lesions. 
In contrast to the results from Morris's group, the recent 
studies of Tay et al. (1987a and b) have shown the ratio of CD4 + to 
CD8+ to decrease not only in HPV infections but also in CIN, due to a 
depletion of CD4+ rather than an increase in CD8+ (Tay et al., 1987b). 
Activated lymphocytes (Tac +) were not observed and there were no 
significant changes in total T cells or their proportions in the epidermis. 
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This lack of stimulation or of subepithelial disturbance of T cells could 
be the result of LC depletion in both HPV and CIN (Tay et al., 1987a) 
and, together with the selective depletion of CD4+ in the epidermis, 
suggests a local intraepithelial immune deficiency is associated with HPV 
and CIN. 
In a recent study from our own laboratory, Hughes et al. (1988) 
also reported a reduction in LC in all biopsies with HPV infection 
and /or CIN, although in CIN I and CIN II without koilocytes, the 
reduction did not reach significance. By analysing the differential 
expression of HLA -D region gene products on LC, they found that 
HLA -DR positive LC cells were reduced in all groups, but especially in 
CIN III. HLA -DP positive LCs were also reduced with the reduction 
being greatest in lesions showing koilocytosis alone, but HLA -DQ 
positive LCs were increased relative to normal in mild CIN lesions. 
Given that HLA -DQ expression may be involved in the generation of a 
suppressor T cell response (Navarette et al., 1985) this is an interesting 
finding. However, Drijkoningen et al. (1988) looking at 50 warts of 
hands, feet and genitals, found HLA -DQ epidermal LCs in similar 
numbers to those expressing HLA -DR, but with fewer HLA -DQ positive 
cells in the dermis. Further elucidation of the functional significance 
of the differential expression of different Class II antigens will be 
required before conclusions can be drawn. 
Using a range of markers for LC, Tay et al. (1987a) observed 
that several subpopulations of LCs were present in cervical epithelium 
and, in both WVI and CIN, a specific subset identified by the use of 
antibody to S -100 cytoplasmic protein was selectively and almost totally 
depleted. Similarly, McArdle and Muller (1986) recorded a decrease in 
LC in cervical WVI using anti S -100 on archival cervical biopsies, 
although their finding of increased S -100 activity and therefore LC 
numbers in CIN alone is in closer agreement with the earlier results of 
Morris et al. (1983). A very recent report from Barton and colleagues 
(1988) confirms the reduction of LC in patients with CIN + HPV using 
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both OKT6 and S -100 markers, but a total depletion of S -100 positive 
cells as suggested by Tay et al. (1987a) was not noted. 
Considering the presence of other cells of the immune system, 
Tay et al. (1987c) noted NK cells to be present in a few controls but in 
more than three quarters of biopsies showing CIN with or without HPV. 
The frequency and pattern of NK distribution was similar in all grades 
of CIN and the numbers of NK present were small and confined to the 
stroma. From these results, it was concluded that NK cells were 
unlikely to be primarily involved in the lysis of infected cells at the 
tumour site, but they might play a role in the prevention of stromal 
invasion. Similarly, in looking at macrophage density and distribution, 
the same workers concluded that although macrophage numbers were 
increased in CIN + HPV, they were not the APCs responsible for 
induction of the immune response (Tay et al., 1987d). 
The immunocytochemical results in WVI described above are 
summarised in Table 6, from which it can be seen that, in general, HPV 
is associated with a reduction in LC creating a localljimmunodeficient 
state. T cells may be depleted or increased, but often an increase in 
CD8+ is evident. Much remains to be elucidated, however, concerning 
the interplay of other cells. In particular, the expression of HLA -DR 
on keratinocytes which do not normally express this antigen, has been 
reported in regressing plane warts (Alba and Tagami, 1984), in common 
warts (Aubock et al., 1986) and in cervical WVI (Morris et al., 1983), 
although both Gatter et al. (1984a) and Chardonnet et al. (1986) failed 
to detect HLA -DR staining in various cutaneous wart lesions. 
The involvement of activated keratinocytes in the skin immune 
system has already been referred to, and it is interesting to note that 
the "chickenwire- like" appearance (Gawkrodger et al., 1987) of HLA -DR 
expression along cellular membranes in focal areas of keratinocytes, 
closely resembles the appearance of the surface antigen described by 





































































































































































































































































































































































































































































































































































































































































































































































































































































































































































- 65 - 
4.4 HPV Infections in Immunosuppressed Patients 
HPV infections are the second most frequent viral complications 
in immunosuppressed individuals after infections with herpesviruses. 
The high incidence of warts after more than a year of 
immunosuppression in renal allograft recipients (RAR) was first noticed 
by Spencer and Andersen (1970) with 42% of such patients showing 
cutaneous warts, and in Lothian this figure has increased to 87% of 
RAR after 5 years of immunosuppression (Rudlinger et al., 1986). 
Koranda et al. (1974) also noticed a similarly high incidence of warts in 
RAR which began appearing about 8 months after transplantation. 
Like Spencer and Andersen, these workers felt this represented a 
reactivation of latent virus rather than a primary infection. All of the 
warts appeared on sun -exposed areas, mainly on hands, but also on face, 
arms, legs and feet, and generally were of the plane wart type. 
Multiple flat warts in an RAR were shown by Pfister et al. 
(1979) to be caused by HPV -3, but in 1980, Lutzner and coworkers 
reported HPV -5 induced skin lesions in two such patients. In one of 
these, the lesions were of a warty type on the back of the fingers, but 
in the other patient HPV -5 was found in insignificant multiple pityriasis 
versicolor -like lesions of the arms and trunk and also in an ulcerated 
Bowenoid carcinoma in situ on his thumb. This was the first 
demonstration of the potentially oncogenic HPV -5 in any person other 
than EV patients, although Koranda et al. (1974) had one RAR with 
similar EV -like wart lesions which transformed with time into multiple 
squamous cell carcinomas. Of course, the HPV -type could not be 
determined at that time. Since then, HPV -5 DNA has been reported 
in plaque lesions from an RAR in Edinburgh (Rudlinger et al., 1986) and 
in "verrucous keratosis" lesions from three RAR in Minneapolis (Van der 
Leest et al., 1987). Very recently, a further three Edinburgh RAR with 
multiple squamous cell carcinomas have been found to harbour HPV -5 in 
their lesions . (Barr et al., 1989). Nevertheless, 
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the predominant type of wart seen in the Edinburgh study was the 
common wart and likewise in the Minneapolis study, HPV -2 was the 
virus type detected most frequently. Indeed, in the single malignant 
cutaneous neoplasm in this group, HPV -2 was found (Van der Leest et 
al., 1987), and recently in basal cell carcinomas from two 
immunosuppressed patients (one RAR, one with systemic lupus 
erythematosis (SLE)), HPV -2 was also reported (Obalek et al., 1988). 
Renal transplant patients suffer from an increased incidence of 
malignant tumours, particularly lymphomas and skin cancers (Kinlen et 
al., 1979). Koranda et al., (1974) noted that the skin cancers increased 
in incidence with time after transplantation, and were confined to areas 
of skin exposed to UV light. The duration of sunlight exposure further 
increased the incidence, just as it appeared to do in EV patients 
(Lutzner et al., 1983). 
The increased frequency of epidermal malignancies and viral 
infections in RAR result from compromised cutaneous 
immunosurveillance, in turn attributable to immuno- suppressive therapy 
(Marshall, 1974; Penn, 1975). There is experimental evidence to 
suggest that the APC capacity of LCs in RAR is reduced by 
azothioprine and steroids as shown by the failure of some patients to 
become sensitised to DNCB (ten Berge et al., 1981). 
In addition, the effectiveness of UV light in depleting LC of 
their surface markers including Class II antigens (Aberer et al., 1981) 
and the reduced LC density, disordered distribution and altered 
morphology observed on sun-exposed flexor surfaces in RAR led 
Sontheimer et al. (1984) to suggest that the combined effects of UV 
plus the mutagenic effects of azathioprine might lead to tolerance and 
tumour development. In recent years, azathioprine treatment has been 
replarM by cyclosporin which itself increased the risk of neoplasms, 
particularly non -Hodgkin's lymphoma and basal and squamous cell 
carcinomas (Brown et al., 1988). These workers noticed a reduction of 
CD1 expression on LC in a patient with psoriasis treated with 
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cyclosporin. Gabel et al. (1987) found decreased epidermal LC right 
from day 1 of treatment with cyclosporin and steroids in RAR, with a 
distortion of their distribution and a loss of dendrites, but were unable 
to distinguish between a decrease in HLA -DR expression and a decrease 
in number of cells. LC in HPV lesions in RAR remains to be 
investigated more thoroughly. 
A marked decrease in LC numbers has been recorded within the 
lesions of EV patients (Haftek et al., 1987), all of whom showed reduced 
CMI in terms of anergy to DNCB sensitisation, reduced mitogenic 
response and reduced T cell counts. However, no significant difference 
in LC density in normal skin from EV patients compared with controls 
was observed suggesting that in this disease, the initial defect is not in 
the LCs but more probably in some aspect of T cell function, which in 
turn would explain why inflammatory infiltrates are never seen in EV 
lesions (Haftek et al., 1987). 
In 1975, Morison noted an increased frequency of warts in 
patients with defects in CMI other than those who had been 
immunosuppressed for transplant purposes (Morison, 1975b). In 
particular, people with Hodgkins disease, malignant lymphoma and 
chronic lymphocytic leukaemia appeared to be at risk. Patients with 
genetic defects of CMI also have an increased susceptibility to 
development of multiple treatment -resistant warts (Lutzner, 1982) and 
of course the best studied of these groups are the EV patients. 
A vast increase in anogenital lesions associated with HPV has 
been detected recently in groups of immunosuppressed individuals. 
Forty -three per cent of renal allograft recipients in a recent study were 
found to have warts mainly in the anogenital region (Penn, 1986) and 
indeed, it has been said that immunodeficient patients are an in vivo 
laboratory in which to study the natural history of HPV and its 
oncogenic effects on the anogenital tract (Sillman and Sedlis, 1987). 
The risk of CIN in renal transplant patients is considered to be between 
8 -16 times that of the normal population (Sillman and Sedlis, 1987) and 
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in a recent local study, 53% of such patients had cervical abnormalities 
(Alloub et al., 1989). Although the HPV -DNA detection rate was 
similar for both transplant and control patients, HPV -16/18 was detected 
more than four times more frequently in the transplant group. In 
female patients with Hodgkin's disease, 46% had cervical abnormalities, 
many of which were HPV associated (Katz et al., 1987) and in HIV 
patients, extensive anogenital warts are common (Ken-W-411497) Forman 
and Prendiville, 1988). In this latter group, a significant reduction in 
the Class II expression of skin LC has been observed (Belsito et al., 
1984), either as a consequence of HIV infection or of the opportunistic 
infections such as HPV so commonly associated with HIV. It seems 
likely that the importance of HPV associated diseases in patients with 
AIDS will increase greatly as the number of patients and their length of 
survival increases. 
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5. Aims of this Study and Approaches Employed 
From the reports described above, it can be seen that much 
knowledge has been gained in recent years concerning the molecular 
biology of papilloma viruses and their associations with clinical lesions. 
Until recently, the host response to the infective agent was a neglected 
area, and this study was designed to examine the immune responses to 
HPVs in patients with dysplastic abnormalities of the uterine cervix. 
This thesis reports an analysis of cellular immunity assessed 
by studies of peripheral blood lymphocyte responsiveness to HPV proteins 
and to non -specific mitogens and an analysis of humoral immunity by 
indirect ELISA ,in an attempt to establish the role played by HPV in 
CIN. Virus structural proteins derived from HPV -1, HPV -2 and BPV 
were readily produced from wart tissue, and fusion proteins of specific 
HPV types were kind gifts. Attempts were made to supplement the 
sources of genital wart antigens by subcutaneous or sub -renal capsule 
implantation of infected tissue in nude mice. These in vitro assays 
were complemented by a project being undertaken by Dr. R. Hughes in 
the same laboratory, on epidermal Langerhans cells examined 
immunocytochemically in similar patients (Hughes, 1988; Hughes et al., 
1988). In the hope that the interactions of epidermal and systemic 
antigen -presenting cells, infected keratinocytes and specific lymphocytes 
could be clarified further with appropriate antibodies, in situ 
hybridisation methods for the detection of HPV using non -radioactively 
labelled cloned and synthetic probes were developed. 
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MATERIALS AND METHODS 
1. STARTING MATERIALS AND THEIR PREPARATION 
1.1 Viruses 
1.11 Bovine Papilloma Virus 
BPV -1 from a cheek fibropapilloma (obtained from the Edinburgh 
abattoir and stored at -70t until use) was purified by a modification of 
the method described by Gissmann and zur Hausen (1976). The tissue 
was chopped finely and ground in a mortar with sterile sand in 
phosphate buffered saline (PBS) containing 200 iu /ml penicillin and 400 
Ng /ml streptomycin. Grinding was continued until only small amounts 
of macerated tissue remained. Trypsinisation was avoided as this has 
been shown to disrupt virions (Pfister et al., 1977). The supernate was 
clarified by low speed centrifugation and virus pelleted by 
ultracentrifugation at 80,000g for one hour. The pellets were 
resuspended in PBS + 0.01 M EDTA (PE) by repeated suction through a 
needle and syringe. Virus was purified by mixing thoroughly with 40 %. 
caesium chloride in PE to give a refractive index (R.I.) of .1.3660. 
The mixture was ultracentrifuged at 110,000g for 24 hours at 18 °C and 
a single band could be seen. Fractions containing this band (with R.I.s 
from 1.364 to 1.366 corresponding to densities of 1.33 to 1.35 g /ml) 
were pooled and subjected to a second density gradient centrifugation. 
The dense band with a density of 1.33 -1.35 g /ml was removed and 
dialysed against several changes of PE overnight at 4 °C. A diffuse 
band containing more empty particles was seen in some preparations. 
The protein content of the purified virus preparation was estimated by 
the Lowry method (Lowry, 1951), and concentrations ranging from 
0.3 -0.5 mg /ml were obtained in different preparations. The virus was 
filter -sterilised aliquoted and stored at -70 °C. 
1.12 Human Papilloma Virus 
HPV -1 and HPV -2 induced lesions were identified clinically by the 
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staff of the Wart Clinics of the Department of Dermatology, Royal 
Infirmary of Edinburgh and particularly by Dr. M. Nolan and Dr. E.C. 
Benton who ensured that parings from each type of lesion were kept 
separately and placed in PBS with antibiotics for transportation to the 
laboratory. Purified virus preparations were obtained as for BPV -1 
using two cycles of density gradient ultracentrifugation (Fig 813 and c). 
The preparations assumed to be HPV -1 and HPV -2 were typed by 
Southern blotting following restriction endonuclease digestion by Dr. B. 
Barr, and within the limitations of the system were found to be pure. 
Purified HPV -1 preparations contained 0.2 -0.9 mg /ml, while pelleted 
but unpurified virus contained 0.7mg /ml. Purified preparations of 
HPV -2 contained 0.2 -0.4 mg /ml. 
HPV -11 isolated from a condyloma acuminatum and grown in human 
foreskin cells following implantation under the renal capsule of the nude 
mouse (Kreider et al., 1986) was the kind gift of Dr. J.W. Kreider, the 
Milton S. Hershey Medical Centre, Hershey, Pennsylvania. As a result 
of delay in transit, only a few intact particles were observed in the 
electron microscope (Fig 8d). 
1.13 Herpes Simplex Virus 
A clinical isolate of herpes simplex virus (HSV) type 1 cultured in 
Vero cells and plaque purified (Howie et al., 1986) was kindly provided 
by Mrs. J. Maingay at an infectivity of 6 x 107 pfu /ml. (plaque- forming 
units). It was inactivated by uy irrad ation of 300 mamps /cm2 for 
one hour before use. 
1.2 HPV Fusion Proteins 
1.21 Fusion Proteins of Late and Early Genes of HPV -1 
and HPV -2 
Three fusion proteins derived from the late genes of skin warts 







Extracts of HPV -1, HPV -2 and HPV-1 1 negatively stained with 
phosphotungstic acid. 
(a) unpurified HPV -1 
(b) purified HPV -1 
(c) purified HPV -2 Bar = 50nm 
(d) HPV -11 
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University of Birmingham). These were the C- terminus portions of 
HPV -1 a L2 protein (nucleotides 4855 -5581) and HPV -2 L2 protein, and 
the middle portion of the HPV -1 L 1 protein (nucleotides 5581- 6357). 
In addition HPV-1 a E2 C- terminus protein was also provided. Plasmid 
vectors of the pEX series were used to produce recombinants with 
E.coli K12 as the host strain. The fusion proteins were prepared from 
large scale mid -log phase cultures by lysozyme lysis and boiling in 
sodium dodecyl sulphate (SDS) and mercaptoethanol (2 -ME) followed by 
separation on Sepharose CL -4B (Doorbar et al., 1986). The aliquots 
received contained 0.15 mg /ml (HPV -1 aLl ), 0.3 mg /ml (HPV -1 aL2) and 
0.5 mg /ml (HPV -1 aE2; HPV -2L2) of protein in a buffer containing PBS 
and residual SDS. The SDS was removed by centrifugation at 4 °C and 
the supernates aliquoted and stored at -70 °C. 
1.22 Fusion Proteins of Early Genes of HPV -16 and HPV -18 
Fusion proteins of the E6 ORF of HPV -16 and HPV -18 and of the 
E4 ORF of HPV -16 were kindly provided through Dr. L. Crawford, 
Imperial Cancer Research Fund, London with the co- operation of his 
staff, Dr. L. Banks and Dr. T. Crook. These were produced as 
follows :- 
HPV-16 and HPV -18 E6 were synthesised in E.coli ÁR120 cells 
using pAS -1 constructs as described by Matlashewski et al. (1986) and 
Banks et al. (1987). The cells were extracted three times in 70% 
formic acid, boiled with dithiothreitol, lyophilised and separated by 
Superose 12 fast protein liquid chromatography. E6 control protein 
containing no HPV sequences was similarly prepared. HPV -16 E4 
galactosidase fusion protein and a control protein lacking HPV sequences 
were produced by transcription from pUR vectors followed by lysozyme 
lysis and separation on Sepharose CL -4B. (Matlashewski et al., 1986). 
The proteins were received at a concentration of 25µg /m1 and were 
suspended in a buffer of 0.02 %SDS, 50mM TrisHCl pH7.5 and 5% 
glycerol. They were aliquoted on receipt and stored at -70 °C. 
- 74 - 
1.3 HPV DNA 
1.31 Cloned HPV DNA 
HPV -1a DNA cloned into plasmid pBR322 (Burnett and Gallimore, 
1985) was used with permission of Dr. P.H. Gallimore from material 
originally supplied by Dr. T.S. Burnett, Department of Cancer Studies, 
University of Birmingham to Dr. R. Rudlinger. Cloned HPV -11 
(Gissmann et al., 1982b) and HPV -16 (Durst et al., 1983) also in pBR322 
were kindly made available by Dr. H. zur Hausen, Heidelberg, FRG. 
All cloned material was provided in transfected E.coli HB101 cells 
stored in 40% glycerol. 
The basic media for growth of the bacterial strain were LB 
(Luria -Bertani) broth containing 1% Bacto- tryptone, 0.5% Bacto yeast 
extract (both from Difco, East Molesey) and 1% NaC1, pH7.5 and 
LB -agar (1% agar in LB broth). Ampicillin was added at 50}ßg /ml to 
both liquid cultures and plates. 
HPV -DNA was produced by amplification of the plasmid in this 
rich medium using methods described by Maniatis et al. (1982), and are 
included for completeness. To obtain large scale colonies, one loopful 
of stored cells was plated onto LB -agar and incubated. A single colony 
was placed in 10m1 of LB broth, incubated and on the following day, 
0.1m1 of culture was inoculated into 25ml of the same broth in a 
conical flask and incubated at 37 °C with orbital shaking for 
approximately 4 hours until the optical density at 600nm (OD600) was 
0.6. This late log phase culture was transferred to a further 500m1 of 
broth and incubated with shaking for exactly 21 hours when the OD600 
was approximately 0.4. Chloramphenicol (2.5ml of 34mg /m1 solution in 
ethanol) was added and the cultures incubated for a further 
12 -16 hours. The plasmid was extracted from the cells by alkaline 
lysis. Washed bacterial cells in 100m1 of ice cold STE (100 mM NaCI 
+ 10mM Tris /HC1 pH8.0 + 1mM EDTA pH8.0) were resuspended in 10m1 
Solution I (50 mM glucose + 25mM Tris /HC1 pH8.0 + 10mM EDTA) 
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containing 5mg /m1 lysozyme (L -6876, Sigma Chemical Co. Ltd., Poole). 
After 5 -10 minutes at RT, 10m1 of freshly made Solution II (0.2N NaOH 
+ 1% SDS) was added and mixed. After a further 10 minutes on ice, 
7.5ml of Solution III (5M potassium acetate, pH 4.8) was added, the 
contents mixed sharply and again left on ice for 10 minutes. The 
suspension was centrifuged at 32,000g for 20 minutes at 4 °C so that 
bacterial DNA and debris formed a tight pellet. To the supernate was 
added a 0.6 volume of isopropanol for 15 minutes at RT. After 
centrifuging at 12,000g for 30 minutes, the pellet was washed with 70% 
ethanol and finally dried. 
The extracted DNA was purified on a caesium chloride gradient. 
The pellet was dissolved in 8m1 TE (10mM Tris /HCI p1 -18.0 + 1mM 
EDTA). One gram of CsCI per ml was added and 0.8ml of ethidium 
bromide (10mg /m1 stock, E8751, Sigma). The suspension was 
ultracentrifuged for 40 hours at 130,000g at 18 °C. Two reddish bands 
were observed, the upper one due to linear bacterial DNA and linearised 
plasmid DNA, while the lower one contained closed circular plasmid 
DNA. The lower band was collected by needle from the side of the 
tube. Ethidium bromide was removed with 1- butanol saturated with 
water. The lower aqueous phase was re- extracted 4 -6 times until all 
pink colour had gone and dialysed against several changes of TE. It 
was then aliquoted and stored at -70 °C. The amount of DNA was 
estimated spectrophotometrically at 260nm and 280nm. Between 
0.05 -0.1 mg /ml were obtained with purity ratios (0D260/0D280) of 
1.70 -1.96. Plasmid pBR322 lacking an HPV insertion was similarly 
amplified, extracted and purified to act as a control. The specific 
HPV sequences were not separated from the plasmid vector. 
1.32 Synthetic HPV Oligonucleotides 
Synthetic oligonucleotides were synthesised on an Oswel Gene 
Synthesiser in the Department of Chemistry, University of Edinburgh by 
Dr. Tom Brown, using B- cyanoethyl phosphoramidite chemistry. The 
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DNA was produced as 2pmol contained in 1 ml of distilled water and had 
-01-1 5' and 3' termini. It was purified by reverse phase high 
performance liquid chromatography (HPLC) and subsequently desalted by 
gel filtration. 
Synthetic oligonucleotides of 30 bases in length with sequences 
from within the E6 ORF of HPV -1 a, HPV -6b and HPV -16 were prepared 
following comparison of published sequence data (Danos et al. (1982) for 
HPV -1 a; Schwarz et al. (1983) for HPVb6 and Seedorf et al. (1985) for 
HPV -16). Alignment of the sequences to allow comparison of the E6 
proteins was described by Giri and Danos (1986) and it was decided to 
select the 30 nucleotides which occurred immediately downstream of the 
ATG start codon of each HPV type (Fig. 9). 
The entire GenBank database (12537 nucleotide sequence files) was 
searched for homologies to the chosen oligonucleotide sequences using 
the University of Wisconsin Genetics Computer Group software 
(Devereux et al., 1984) by Dr. Richard Bingham, Department of 
Veterinary Pathology, University of Edinburgh. Variable levels of 
mismatching were permitted, mismatches of 9 or more bases being 
assumed to be insignificant. Only two comparable sequences were 
found. These were (i) HPV -11 differing from HPV -6b in 4 bases, (see 
Fig. 9) and (ii) a sequence from within the mouse macrophage 
Fc- ó -RB -2 cDNA (Ravetch et al., 1986) which had seven mismatches 
when compared with the sequence selected for HPV -16. 
1.4 Specimens from Patients and Controls 
1.41 Blood Samples 
Ten to 20 ml of venous blood were obtained from patients 
attending the Lothian Area Colposcopy Clinic and collected in 
preservative -free heparin (H7005; Sigma; 0.1m1 of 1000 units /ml of 
sodium salt per 10m1 of blood), with the help of Mrs. Muriel Murray and 
the co- operation of the Colposcopy Clinic Staff. The patients were 
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HPV -la 
5' Base 107 
(ATG) GCG ACA CCA ATC CCC ACC GTC ACA CAC 
136 
CTT 
HPV -6b (ATC) 
105 
CAA ACT CCA AAT CCC TCC ACC TCT CCA 
134 
ACC 
HPV -11 (ATC) 
105 
CAA ACT AAA GAT CCC TCC ACG TCT CCA 
1J4 
ACA 
HPV -16 (ATG) 
107 
TTT CAG GAC CCA CAG GAG CCA CCC ACA 
136 
A.AC 
Fig 9. Oligonucleotide sequences of 30 bases in length selected for 
HPV -1 a, HPV -6b and HPV -16, and including HPV -1 1 for 
comparison. 
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asked several questions by Mrs. Murray including the occurrence of past 
or present warts and their site, smoking history and contraceptive use, 
from which she compiled a card index of patient details (Fig10). 
Information from the histological report of cervical biopsies obtained at 
the same time was readily made available by the pathologists involved, 
particularly through the kindness and help of Dr. Stewart Fletcher. 
This information was added to the card. Occasionally repeat specimens 
were required and were similarly obtained by Mrs. Murray. 
Ten to 30m1 of venous blood were obtained from members of staff 
of the Departments of Bacteriology and Dermatology and from the 
female staff of the Regional Virus Laboratory, City Hospital when 
control samples were required. Some samples were also obtained from 
a few patients with genital warts and a small group with recalcitrant 
hand warts attending clinics in the Department of Dermatology. 
1.42 Cervical Biopsies 
When biopsies were taken for histological purposes, an additional 
small punch biopsy from the transformation zone was removed for the 
current project. It was immediately snap frozen and transported to 
the laboratory in dry ice and stored at -80 °C, or collected in 2m1 of 
RPMI medium (see Section 2.12 below) to be used in cell cultures or in 
transplantation into nude mice. 
1.43 Sections of Paraffin -embedded Cervical Biopsies 
For in -situ hybridisation studies, sections of formalinfixed paraffin 
embedded cervical tissue were provided by the Department of Pathology 
with the permission of Professor C.C. Bird and the help of Dr. 
Fletcher, Dr. Kathryn McLaren and Mr. Kenny Rae and his staff. 
From requested biopsies, standard sections were cut and floated onto 
slides coated with 1% polyL- lysine or chemically silanated (vide infra). 
Pat No.: Visit No. 2 F 
u. 
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DcB 22/06/62 
Cons GES VRL No. 
Part medical history 
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.} ,, D. r 4 60..4 uF 
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Smoking in past 12 months 3 per day 
cou ̀ ts 
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ECA.; LL y.l lrwtt.r 'f oyc\ á eitl;n.Ce p trtc. tpiiiot.Linl o.bnmm,oá:t,i urUU-náV "AU rno--i oi 
Treatment 
3iy i g CvI 1-0,p(V).1o4d 
Disposal 
rt v+i.w o P r. 
zil91ge. 
Specimen 
BIoaa - 20 awl 
Fig. 10 Card layout used for compilation of patient details obtained 
at the time of specimen collection and from pathological reports. 
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1.44 Cervical Secretions 
Cervical secretions were obtained from a small number of patients 
attending the Colposcopy Clinic with the help of Dr. Rhona Hughes and 
Dr. Sheila Bain. Glass bottles containing 2m1 sterile distilled water 
were provided. This was introduced into a 5m1 syringe to which was 
attached a needle and a 10cm length of polyethylene tubing 
(19- 0040 -01, Pharmacia Ltd.) sterilised by ethylene oxide. The water 
was flushed into the cervix and the secretions aspirated into the syringe 
and then expelled into the original bijou. Secretions were transported 
to the laboratory as quickly as possible, aliquoted and stored at -20 °C. 
1.45 Rabbit anti -HPV Serum 
A preparation of purified HPV from pooled hand warts and shown 
by EM to be rich in virus particles was disrupted with 1% SD;; + 0.5% 
2 -ME, boiled for one minute and emulsified in Freund's incomplete 
adjuvant. It was inoculated subcutaneously into two sites on the scruff 
of a female New Zealand white rabbit. Four injections at fortnightly 
intervals with 1 ml of the preparation were given. The rabbit was bled 
from the ear two weeks later and found to have HPV antibodies. Four 
years later a booster dose of purified HPV -2 similarly disrupted, was 
administered in Freund's incomplete adjuvant as before and the animal 
was bled out two weeks later. 
1.5 Mice 
Homozygous nu /nu mice (nude mice) were obtained by the mating 
of nude males with heterozygous females of Balb /c background. A 
small colony was maintained at the Regional Virus Laboratory, City 
Hospital, Edinburgh. The mice were housed in a separate room at a 
constant temperature of 22 °C, but were not otherwise barrier 
maintained. They were fed on autoclaved small animal pellets (Special 
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Diet Services Ltd., Witham) and given sterile drinking water changed 
two or three times per week. More recently, 0.01 mg /ml trimethoprin 
and 0.05mg /m1 sulphamethoxazole were added to the drinking water 
(Kreider et al., 1986). Experimental mice were always caged with at 
least one other mouse, either another experimental nude sibling or a 
haired sibling. The mice survived well, regularly living until 6 -8 months 
of age when they succumbed to the wasting diseases frequently observed 
in nude mice. Occasionally, eye infections developed in individual 
animals, but no other microbiological problems were encountered. 
1.51 Human Foreskin Tissue for Implantation 
Human foreskin from children was obtained from Mr. Wiliam 
Bissett, Royal Hospital for Sick Children, Edinburgh. It was wrapped 
in moistened sofratulle gauze and transported to the laboratory in a 
sterile container. The foreskin was cut open, dermal tissue was 
scraped away with a sterile scalpel and the remaining skin cut into 
pieces approximately 2 x 1 mm in size. Foreskins were used for 
implantation in nude mice within 3 days. 
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2. METHODS 
2.1 In vitro Assays of Lymphocyte Recognition and Activation 
2.11 Antigen Preparation for LPA 
Purified antigens of BPV, HPV -1 and HPV -2 produced as described 
in Section 1.1 were treated further to reveal internal antigens. 
Detergent disrupted PV were prepared by mixing an equal volume of 
virus with freshly prepared 2% sodium dodecyl sulphate (SDS) and 2% 
2- mercaptoethanol (ME), boiling for 1 minute followed by ultrasonicating 
for 1 minute and diluting in RPMI. (SDS.ME PV). 
Glycine extracts of BPV and HPV -2 were prepared by disruption of 
purified virions in freshly prepared 0.1M glycine buffer, pH9.0 (Booth et 
al., 1979) followed by three cycles of freezing and thawing. The 
suspension was bench centrifuged and filter sterilised before use. The 
extract of BPV -1 was found to have a protein content of 0.4mg /m1 and 
that of HPV -2 was 0.9mg /ml. Glycine extracts of bovine skin and 
human keratoses were similarly prepared. 
Glycine extracts of cervical biopsy tissue were prepared to 
investigate the possibility of a relevant cell- associated antigen. The 
tissue was minced with scalpel blades, and the cells dispersed in 
collagenase- dispase solution (Boehringer- Mannheim Ltd.) for 11-2 hours 
at 37 °C. The cells were pelleted, washed with RPMI and resuspended 
in 0.5ml glycine buffer as above. After freezing and thawing 3 times, 
sonication for 1 minute and clarification by light centrifugation, the 
supernate was filter sterilised. Where possible, the protein content of 
the extract was measured and concentrations of 0.6- 3.7mg /m1 were 
obtained. 
2.12 Standard Lymphocyte Proliferation Assay 
Peripheral blood mononuclear (PBM) cells were separated from red 
cells on Lymphopaque gradients (Nyegaard, Oslo). They were washed 3 
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times with sterile PBS containing 0.2% heparin and resuspended in 5m1 
RPMI containing 15% autologous plasma (complete RPMI; made from 
RPMI 1640 (Northumbria Biologicals Ltd., Cramlington) containing 2mM 
L- glutamine, 5 x 10 -5M 2- mercaptoethanol (2 -ME), 100 iu /ml 
penicillin, 200 jig /ml streptomycin, 100 Ng /ml gentamycin and 2}1g /ml 
fungizone). On a few occasions 15% foetal calf serum (FCS) was 
added in place of autologous plasma. A h10 dilution of cells was 
counted (0.1m1 cells + 0.5ml red cell lysis buffer (made with 10m1 0.17M 
Tris /HCI pH7.2 and 90 ml 0.16M ammonium chloride) + 0.4ml 0.1% 
trypan blue in PBS) and the cells finally resuspended at a concentration 
of 1 x 106 /ml. 
Wells of sterile flat- bottomed microtitre plates (Falcon 3072; 
Becton Dickinson U.K. Ltd., Cowley) were inoculated with 200p1 of cell 
suspension and 2 -501 of mitogen or antigen was added. 
In general, quintuplicate wells were set up for each antigen. The 
mitogens used were concanavalin A (Con A; C2631; Sigma), 
phytohaemagglutimin (PHA; Wellcome Reagents Ltd., Beckenham) and 
pokeweed mitogen (PWM; Gibco Ltd., Paisley). The antigens included 
purified BPV, HPV -1 and HPV -2; glycine extracted BPV and HPV -2; 
unpurified HPV -1; SDS.ME BPV -1, HPV -1 and HPV -2; glycine extracts 
of bovine skin, human keratoses and cervical cells; fusion proteins as 
described in Section 1.2 and uv- inactivated HSV. The antigens were 
added at concentrations varying from 0.04- 25pg /m1 representing 10 -fold 
dilutions of stock preparations from 10 -1 to 10 -4. 
The plates were covered with Transpaseal TM self- adhesive plastic, 
a small hole was punctured over each well with a sterile needle and the 
plates were incubated in a humidified atmosphere of 5 %CO2 at 37 °C for 
varying times, although 7 and 8 days were most frequently used. For 
the final 18 -24 hours, 0.75pCi 3H- methyl thymidine (Amersham 
International, Little Chalfont) was added (10p1 of label in PBS) to each 
well. The cells were harvested using an Ilacon II or a Dynatech 
Automash 2000 cell harvester onto Titertek or What man filter discs. 
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After drying, the discs were placed in toluene based scintillation fluid 
and counted for 1 minute in a Packard Automatic scintillation counter. 
Lymphocyte proliferation was expressed as the stimulation index 
(S.I.) calculated by dividing the mean count in the presence of antigen 
by the mean count in the absence of any antigen. Where 5 or more 
wells per antigen dilution were set up, the highest and lowest counts 
were excluded and the mean, standard deviation (S.D.) and standard 
error (S.E.) for each group calculated. Where there was wide variation 
between wells, or where there were fewer than 5 replicate wells, none 
were excluded from the analysis. 
2.13 Addition of Lymphokines 
In order to stimulate any activated lymphocytes, interleukin -2 
(IL -2; Boehringer- Mannheim Ltd.) was added at concentrations ranging 
from 0.1% to 20% to both antigen- containing and control wells, either 
on day 0 or after activation may have commenced on days 2,3 or 4. 
Very occasionally, IL -1 produced in the Department of Pathology by Dr. 
A.E. Dewar, was added at a dilution of 1 in 40 at the beginning of the 
culture period to both antigen and control wells. 
Supernate from PBL cultured with antigen was added to fresh PBM 
in the presence of PV antigens to see if this was suppressive. 
2.14 Alteration of Antigen -presenting Cells 
Cervical biopsies from 10 patients were chopped and dispersed in 
collagenase -dispase as above, then pelleted, resuspended in 1 ml complete 
RPM1, washed once and counted. They were added to PBM generally 
at a concentration of 4% to control wells without antigen and to test 
wells containing various papilloma antigens. The cultures were 
harvested after 8 days. 
On a single occasion, the washed cells were purified on a Percoll 
(Nyegaard, Oslo) gradient of 70 %, 55% and 20% in RPMI. The 
gradient was spun for 20 minutes at 400g and the visible band at the 
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55/20 junction was removed, washed twice with PBS, resuspended in 
RPM1, counted and added to cultures at 4 %. 
On a few occasions, adherent cells were removed from PBM by 
placing 8 x 106 cells in complete medium in an etched plastic petri dish 
(Costar 3160; NBL). At 15, 30 and 60 minutes thereafter, the 
non -adherent cells were pipetted off, the adherent cells scraped off 
with a plastic scraper (Costar C3010; NBL) and added back to the 
non -adherent cells at varying percentages from 0.3 % -10 %. 
T- lymphocytes were purified from the non -adherent cells by 
passage over nylon wool columns (Julius et al., 1973). Adherent cells 
were scraped off the glass and added to the T cell population in 
concentrations ranging from 0.3 -5 %. The LPA was then set up in the 
standard way but included wells which contained T cells and adherent 
cells, T cells alone and adherent cells alone, each with and without 
antigen. 
2.15 Removal of CDS+ Cells by Panning 
Two ml of PBM containing 7 x 166 cells /ml were spread on a 
plastic petri dish which had been coated with 1ir10 anti -CD8+ 
monoclonal antibody (Dako T8) in filter -sterilised carbonate coating 
buffer pH9.6 (as used in ELISA tests, see section 2.21) overnight at 
4 °C. The cells were left in contact for 2 hours at 4 °C when the 
non -adherent cells were removed by pipette. The adherent cells were 
scraped off the plastic, washed gently several times, resuspended in 
complete RPMI and added in the ratio 3 x 105 to 1 x 106 to the 
non -CD8+ cells. Untreated PBM, CD8± depleted PBM, and 
reconstituted PBM were then used in a standard LPA. 
2.16 Subset Analysis before and after LPA 
Fluorescent flow cytometry was used to analyse the cell subsets 
involved in proliferative events following PV antigen exposure. The 
flow cytometer used was an EPICS C (Coulter) equipped with an argon 
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ion laser using 200mW power and emitting light at 488nm. Five 
thousand to 10,000 stained cells were analysed at a flow rate of 
400 -500 cells /s. 
On day 0, surplus cells after the LPA had been set up were 
divided into aliquots of 5 x 105 cells. The cells were washed in PBS + 
1% normal rabbit serum (NRS) pelleted at 150g for 10 minutes and 
stained as described by Neill and Miller (1987) with monoclonal 
antibodies to label all T cells (UCHT -1, Unipath Bedford; OKT3, Becton 
and Dickinson Ltd.), CD4+ and CD8+ (Dako T4 and T8) or NK cells (Leu 
7, Becton and Dickinson Ltd.). Ten microlitres of monoclonal used 
neat (UCHT -1 and T3) or diluted h2 in PBS + 1% NRS (T4, T8, leu 7) 
were added to the cell pellets, vortexed and held on ice at 4 °C for 30 
minutes. Cells were washed twice and 25 pl of a 1ín 40 dilution of 
FITC- conjugated sheep antimouse IgG F(ab')2 serum was added again for 
30 minutes on ice. Cells were again washed twice and finally 
resuspended in 1 ml of PBS + 1% NRS to which was added 100 pl of 
neutral formalin in PBS. For B -cell staining a one -step direct 
fluorescent method was employed, using an FITC- conjugated rabbit 
antihuman IgM antiserum. An incubation time of 30 minutes at 4 °C 
was again used. 
For analysis at the end of proliferation the cultures were set up in 
an identical manner to the LPA except that round bottomed plates 
(Cel -Cult; Sterilin Ltd; Feltham) were used to facilitate pelleting. At 
the end of incubation, the plates were spun on a Sorvall plate 
centrifuge at 4 °C for 5 minutes at 1000 rpm. The supernatant fluid 
was either discarded or collected for adding to subsequent LPA, the 
cells were resuspended, washed with PBS + 1% NRS and 8 it of the 
appropriate monoclonal or directly labelled antihuman IgM antiserum 
added. The cells were again mixed and held in the dark at 4 °C on 
ice. The staining was continued as described for cells in tubes using 
10 pl of conjugated anti -mouse serum and finally resuspending in 200 pl 
PBBS + 1% NRS plus 20 Jul 10% neutral formalin in PBS. The plates 
were covered with Transpaseal until analysed. 
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2.17 Attempts to Establish Lymphocyte Cell Lines 
Attempts were made to establish cell lines of lymphocytes 
activated by PV antigens using the method described by Lanzavecchia 
et al. (1982). Two million PBMs in 10m1 of complete RPM1 were 
placed in a small Falcon flask with 500}íl of 10 -2 glycine- extracted 
HPV -2. After 7 days, the cells were pelleted, resuspended in 200111 of 
100% Percoll onto which was layered a discontinuous Percoll gradient 
(60 %, 50 %, 40 %, 20% in RPMI) according to the method of Kurnicis 
et al. (1979). The gradient was spun at 3000 rpm for 10 minutes and 
lymphoblasts recovered as the visible band from the 40 -50% interface. 
The cells were washed twice with large volumes of PBS and resuspended 
in complete RPMI at a concentration of 2x105 /ml. Three per cent 
IL -2 was added at this stage and again when the cells were expanded 
by the addition of more medium. After 3 -4 weeks in culture, some 
cells were restimulated with antigen by mixing 5x105 blasts with 5x106 
autologous irradiated PBM (107 cells in 1 ml PBS were irradiated with 
2600 rads for 1 minute from a Caesium 137 gamma source of 3KiC in 
the Department of Zoology, University of Edinburgh). After adding 
250311 of 10 -2 glycine extracted HPV -2, the cells were dispensed in 8 
wells of a 24 well plate (Costar, NBL) and IL -2 was added. After 7 
days the blasts were again separated on a Percoll gradient. 
2.2 Assays of Antibody Production 
2.21 Enz me Linked Immunosorbent Assay (ELISA) to Detect 
Serum IgG to HPV 
The assay developed was a modification of the micromethod 
originally described by Voller and Bidwell (1976) and applied to the 
detection of BPV viruses (El Shazly et al., 1985). Purified PV virions 
(HPV -1, HPV -2 or BPV) disrupted with SDS.ME (see Section 2.11) were 
diluted in carbonate coating buffer pH 9.6 to a concentration of 1 -2 
µg /ml (made up with 1.5g Na2 CO3 10H20, 2.93g NaHCO3 and 0.2g 
NaN3 per litre). One hundred 11ls were dispensed into alternate wells 
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of flat -bottomed microtitre plates (ELISA grade; Nunc Immuno -Plate I, 
96F) and buffer containing 1% bovine serum albumin (BSA; Sigma) was 
added to the remaining wells as a background control. The plates were 
sealed and after incubating at 4 °C overnight they were washed four 
times with washing buffer (PBST i.e., PBS + 0.05% Tween 20 + 0.1% 
BSA + 0.02% NaN3) and then incubated with 100 pl per well of PBST 
containing 3% BSA at RT for 1 hour to block remaining combining sites 
on the plastic (Forghani and Schmidt, 1979). Washed plates were dried 
and were generally used the same or following day, but could be kept 
for up to 10 days at 4 °C. 
The plasma specimens to be tested were diluted 1 in 50 in PBST 
+ 1% BSA and 100)11 of each added to antigen coated and control wells, 
and incubated for 22 hours at 37 °. After four washes, 100u1 alkaline 
phosphatase conjugated anti -human IgG (1:500; A -3150; Sigma) diluted in 
PBST + 1% BSA was added for 2 hours at 37 °C. The plates were 
again washed, and 100}ß1 of substrate, para- nitrophenyl phosphate (pnpp; 
N9389; Sigma) prepared as 1 mg /ml in fresh diethanolamine buffer pH9.8 
without MgC12 (i.e., 80m1 distilled water plus 10m1 diethanolamine 
warmed to 37 °C and the pH adjusted with N HC1). The reaction was 
allowed to develop for 20 -30 minutes at RT before being stopped with 
100}11 of 3M NaOH. The absorbance of each sample was read 
spectrophotometrically at a wavelength of 410nm on a Dynatech 
platereader. 
A positive and at least triplicate negative controls were included 
on each plate. The positive control was from a healthy member of 
staff who consistently gave strong reactions to HPV -1 . and HPV -2 
antigens during the development of the test and the negatives were 
selected from colposcopy patients with no known history of warts, no 
koilocytes or warty atypia in histological sections, and who repeatedly 
gave very low absorbancies during the development of the test. 
The corrected absorbance for each test sample was calculated by 
subtracting the absorbance of the background control well from that of 
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the antigen- containing well. The ELISA Index (E.I.) was calculated by 
dividing the absorbancy of the test sample by the mean absorbance of 
the negative samples plus 3 standard deviations. 
2.22 ELISA to detect Secretory IgA in Cervical Lavage 
Specimens 
An indirect ELISA developed to detect secretory IgA in tears in 
ocular herpetic infection (Fox et al., 1984) was modified to investigate 
the presence of locally produced secretory IgA in the cervix. 
Microtitre plates were coated with SDS.ME HPV -2 at a concentration of 
ug /ml as described in Section 2.21. Cervical secretions, collected as 
described in Section 1.24 and stored at -20 °C, were doubly diluted in 
PBS + 5% NRS from 1 in 2 upwards, added to appropriate wells and 
incubated for 3 hours at 37 °C. After washing, 100 )Jl of a 1 in 100 
dilution of rabbit serum against human secretory component and 
conjugated with horseradish peroxidase (HRP; P166, Dako) was added and 
incubated for 45 mins at 37 °C. Ortho -phenylene -diamine substrate 
(P6912; Sigma) dissolved at a concentration of 0.4mg /m1 in freshly 
prepared citrate)phosphate buffer pH6.0 (5.6g citric acid + 22.5g 
Na2HPO4 per litre) was added after washing the plates for 
approximately 20 minutes and the reaction stopped with 100}ß1 4M 
H2SO4. The absorbancies were read spectrophotometrically at 490nm. 
Because baseline values of positivity were difficult to establish, 
secretions were considered to be reactive when they gave absorbancies 
0.2. As negative controls, a 1 in 100 dilution of plasma from the 
same patients was included wherever possible. 
2.3 Histochemical Studies 
2.31 Preparation of Slides and Sections 
Since most of the histochemical investigations involved in situ 
hybridisation (ISH) with HPV -DNA probes, it was essential to have good 
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tissue adhesion to slides. This was achieved at first by the coating of 
the slides with 1% poly -L- lysine (P7886; Sigma). Two or three drops 
of poly -L- lysine solution were placed on cleaned glass slides and two 
slides pulled across each other at right angles to spread the drops. The 
slides were allowed to dry by draining. Following the publication of an 
effective method of tissue adhesion achieved by chemical silanation of 
slides (Tourtellotte et al., 1987), most slides for ISH were prepared in 
this way. The slides were first washed for 30 minutes in 1 M HC. , 
washed in distilled water and dipped in 95% ethanol for 30 minutes. 
After wiping dry, they were soaked for 3 hours in Denhardt's solution 
(0.02% each of Ficoll (F2637; Sigma), polyvinyl pyrrolidone (P -5288; 
Sigma) and BSA fraction V in water), dipped briefly in water, 
transferred to a 3 in 1 mixture of ethanol:acetic acid for 20 minutes 
and air dried. The slides were then dipped in 0.1M triethanolamine at 
pH8.0, acetic anhydride was added to a concentration of 0.25% and 
mixed vigorously for 10 minutes. After two washes in distilled water 
and one in 95% ethanol, the slides were again air dried, then left 
overnight in 1% y- aminopropyltriethoxysilane ( A3648 ; Sigma) p113.45 
at 70 °. After extensive washing in distilled water the slides were 
baked at 100° overnight. To activate the slides, they were held in 10% 
glutaraldehyde in PBS for 30 minutes, rinsed briefly in water and 
stabilised by treating with 0.1M sodium metaperiodate for 15 minutes at 
RT and rinsed in PBS. Activated slide could be stored for up to 8 
weeks at RT. 
A much quicker method of silanation was described by Burns et 
al. (1987) and by Maddox and Jenkins, (1987). This involved soaking 
clean slides in acetone or methanol followed by immersion in 2% If - 
aminopropylt.riethoxysilane solution (Tespa; A3648, Sigma) in acetone for 
5 minutes at RT. After a wash in distilled water the slides were left 
to dry overnight and could be stored on the bench for several weeks. 
Most histochemical studies were carried out on paraffin sections. 
These were conventionally cut 5p sections and mounted on treated 
- 89 - 
slides. They were generally held at .56°C for at least one day 
thereafter and stored at RT until used. Occasional cryostat sections 
were cut from snap -frozen biopsy tissue. Semi -serial sections, 8u 
thick were cut on a Slee cryostat in the Department of Dermatology 
and mounted on treated slides. Some were stored at 20 °C without 
fixation, wrapped carefully in Saran -wrap TM, while others were fixed 
for 10 minutes in acetone and air dried before storing at 20 °C. 
2.32 Labelling of HPV Probes for Hybridisation 
2.321 Labelling of cloned probes 
The labelling of SV -40 circular DNA was originally described 
using DNA polymerase I by Rigby et al. (1977). In the present study, 
a modification of this well established method of "nick translation" using 
a combination of DNA polymerase I and DNASE I was carried out using 
the BRL Nick Translation kit (8160SB, BRL Ltd) according to 
manufacturer's instructions, using a biotinylated nucleotide with an 11 
atom spacer arm linking biotin to the C -5 position of the pyrimidine 
ring (biotin -11 -dUTP; BRL Ltd). Briefly, unlabelled nucleotides were 
mixed with approximately 1 pg of cloned DNA of HPV -1 a, HPV -1 1, 
HPV -16 or pBR322, biotin -11 -dUTP and sterile distilled water in 
recommended proportions in a 1.5ml Eppendorf tube held in ice. A 
1:10 volume of DNA polymerase I /DNAse I was added and mixed, spun 
briefly and incubated at 15t in a water bath for 90 minutes. The 
reaction was stopped with 300 mM EDTA pH 8.0. 
Unincorporated nucleotides were separated from the labelled 
DNA by exclusion chromatography through Sephadex G -50 (Pharmacia). 
Initially columns were prepared in 5 ml syringes plugged with glass 
wool. The sephadex, swollen by autoclaving and washed with TE 
(section 1.31) was loaded into the syringe, allowed to settle and washed 
again with several changes of TE. The whole DNA sample (50 pl) was 
loaded onto the top of the gel together with 100 pl of TE washings 
from the Eppendorf tube. A flow rate through the column of 
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0.5m1 /min was established and approximately 24 fractions of 3 -5 drops 
were collected. Later on, pre -packed disposable Nick TM columns 
(Pharmacia) were used (see Section 2.322 below). 
Two microlitre aliquots of each fraction were spotted onto 
nitrocellulose filter (Schleicher and Schull, Dassel, W. Germany) allowed 
to air dry and baked in a vacuum oven at 80 °C for 30 minutes. The 
filter was stained using the BRL DNA detection system (8239 SA, BRL) 
according to manufacturer's instructions. Briefly, the filter was 
rehydrated for 10 minutes in Buffer 2 (3% BSA in Buffer 1 (0.1M 
Tris-ICl pH7.5 containing 0.1M NaC1, 2mM MgCl2 + 0.05% 
Triton -X- 100)). The biotinylated probe was amplified using streptavidin 
(2}ßg /ml in Buffer 1; 3 ml per 100cm2 filter) for 10 minutes at RT 
followed by three 5 minute washes in large volumes of Buffer 1 and 
detected with biotinylated alkaline phosphatase (lpg /ml in Buffer 1) for 
10 minutes at RT. After two washes in Buffer 1 and two washes in 
Buffer 3 (0.1M TriskICI pH 9.5 + 0.1M NaC1 + 50 mM MgC12), the 
filter was placed in a polythene bag and freshly made substrate was 
added (nitroblue tetrazolium (NBT), 75 mg /ml in 70% dimethylformamide 
and 5- bromo -4- chloro -3 indolyl phosphate (BCIP), 50mg /m1 in 
dimethylformamide in the proportions 33 }il NBT + 2411 BCIP in 7.5ml 
Buffer 3). The bag was sealed and colour development took place in 
the dark within 1 hour. The reaction was stopped with 20mM Tris- 
HCI pH7.5 + 5mM EDTA. Labelled DNA was present in an early peak 
while unincorporated nucleotides gave a longer weaker trail. Fractions 
giving the strongest signal were pooled, aliquoted and stored at -70 °C. 
2.322 Labelling of synthetic oligonucleotide probes 
The use of the enzyme terminal transferase for labelling 
oligonucleotides at the 3' end has recently been suggested to be more 
efficient and less expensive than labelling with polynucleotide kinase at 
the 5' end, at least for radiolabelled probes (Lin et al., 1987) and it 
was decided to try a similar enzyme system to enable the linkage of 
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biotin -11 -dUTP to the 3' end of the oligonucleotide. This method had 
the added advantage of being a single step procedure which renders 
labelled fragments resistant to exonucleases. To ensure the addition of 
only one nucleotide at the end of each molecule, a labelled di -deoxy 
nucleotide is recommended (Amersham International plc). In the 
absence of a biotinylated di -deoxy residue, it was realised that 
heterogeneous extension of 3' ends might occur (Roychoudhury et al., 
1976). 
Using the Amersham 3' end labelling kit (N4005; Amersham) and 
biotin -11 -dUTP, the following reagents were mixed in a 1.5ml Eppendorf 
tube held in ice : 2.5}ßl oligonucleotide (equivalent to approximately 5nM 
of DNA), 12.5}1 sterile distilled water, 5p1 buffer (containing sodium 
cacodylate, cobalt chloride and dithiothreitol and provided ready for 
use). 25}ßl biotin -11 -dUTP and 1011l of terminal transferase. The 
reaction mixture was gently aspirated several times and incubated for 2 
hours at 37 °C in a water bath. The enzyme mixture was loaded 
directly onto a disposable Nick TM column containing Sephadex G -50 
DNA grade and equilibrated with 50mM Tris /HCI pH 7.5 containing 
150mM NaCI, 10mM EDTA and 0.1% SDS. The fractions (100 -200}1l) 
were collected, spotted onto nitrocellulose and the labelled 
oligonucleotide peak detected as described above. Fractions giving the 
strongest signal were pooled, aliquoted and stored at -70 °C. 
2.33 In Situ Hybridisation (ISH) 
2.331 ISH using cloned HPV probes 
Paraffin sections on coated slides were dewaxed by 2 x 10 
minute washes in warm xylene, rinsed in absolute alcohol for 2 x 10 
minutes, rehydrated through 75 %, 50% and 25% alcohol each for 10 
minutes, and finally rinsed in distilled water. 
Target DNA was unmasked by a series of steps following the 
method described initially by Brigati et al. (1983), modified by Lewis 
et al. (1987) and adapted as follows :- 
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(a) 0.02M HC1 for 10 mins followed by 10 mins rinse in PBS. 
(b) 0.01% Triton -X -100 in PBS for 90 secs followed by rinse in 
PBS. 
(c) 0.2 mg /ml Proti :'ease K (p 039 0, Sigma) in 50mM Tris/ 
HC1 pH 7.4 containing 5mM EDTA for 15 mins at RT 
followed by 2 x 5 min washes in PBS + 0.2% glycine to 
stop the enzyme reaction. 
(d) 20% acetic acid at 4 °C for 15 secs, followed by post - 
fixation in freshly prepared 4% paraformaldehyde in PBS 
for 5 mins. 
(e) 2 x 5 min washes in PBS + 0.2% glycine. 
(f) Dehydration through alcohols, 10 min each, to absolute 
alcohol followed by air -drying. 
The probe was added at a final concentration of 400ng /ml to the 
high stringency buffer described by Ungar et al., (1986) in their rapid 
ISH method for cytomegalovirus (CMV). The buffer contained 45% 
formamide (deionised by mixing with mixed -bed ion -exchange resin 
(Bio -Rad Ag 501 -X8, 20 -50 mesh) for 30 mins followed by double 
filtration through filter paper. (Maniatis et al., 1982)), 5 x SSC 
(where SSC = 0.15M NaCI + 0.015 sodium citrate), 25mM sodium 
phosphate pH 6.5, 1 x Denhardt's solution, 250 }ig /ml sheared herring 
sperm DNA (Boehringer- Mannheim) and 10% (W /V) dextran sulphate 
(Pharmacia). Twenty to 541 aliquots of probe were spotted onto 
sections which were then covered with a plastic coverslip cut from an 
autoclavable polypropylene bag. The slides were placed on a metal 
tray and probe and section were denatured together by floating on a 
water bath at 90 °C for 10 minutes. The tray was transferred briefly 
to a 37 °C water bath and the slides placed in moist boxes at 42 °C for 
18 or 42 hours. 
After hybridisation, the coverslips were removed by gentle 
agitation of the slides in a bath of 2 x SSC for at least 10 minutes. 
This was followed by stringent post -hybridisation washes of 2 x SSC at 
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60 °C for 10 minutes, followed by 0.2 x SSC for 10 minutes, 0.2 x SSC 
at 42 °C for 20 minutes followed by 0.1 x SSC for 10 minutes, and a 
final rinse in 2 x SSC. Occasionally, a shorter series of less stringent 
washes (3 x 5 minutes in 2 x SSC) was used. 
Hybridised DNA was detected using the BRL -DNA detection 
system according to manufacturer's instructions as follows :- 
Slides were washed in Buffer 1 for 10 minutes at RT followed 
by a 20 minute wash in the same buffer containing 3% BSA (Buffer 2) 
to block non -specific binding. The biotinylated DNA was amplified by 
streptavidin and biotinylated alkaline phosphatase and detected with 
NBT /BCIP substrate as described above in Section 2.321. The slides 
were placed in a moist box in the dark for 1 -2 hours. Although the 
manufacturers claim that maximal colour development is usually 
obtained within 4 hours, it was found that periods greater than 2 hours 
led to excessive background staining. The reaction was stopped by 
immersing in 20mM Tris /HCI pH 7.5 + 5mM EDTA. The slides were 
usually mounted in 50% glycerol in PBS pH 8.2 or in glycerol -gelatin 
(10g gelatin dissolved in 60m1 distilled water by heating and added to 
70m1 glycerol, with Thiomersal (0.25 %) added as a preservative) 
generally without counterstaining, although occasional counterstaining 
with 2% methyl green was used. 
2.332 ISH using synthetic Oligonucleotide probes 
One of the aims in developing synthetic oligonucleotide probes 
was to find a quicker method of ISH which was at least as sensitive. 
The protocol developed therefore arose from simplification, shortening 
and deletion of parts of the method described above for cloned probes. 
The most satisfactory procedure was found to consist of a 
pre- hybridisation protocol limited to 0.02 M HCl for 10 minutes and 
Proteinase K (0.2mg /r4 for 15 minutes at RT with the enzyme reaction 
being stopped by 0.2% glycine in Tris- buffered saline (TBS; 5mM 
TrisAl -IC1 pH 7.4, 150 mM NaCI) followed by dehydration through 
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alcohols and airdrying. Probe was added in the proportion 1 in 10 
(approximate concentration of probe in buffer was 250ng/m1) to the 
same high stringency buffer and denaturation was carried out as 
described above. Hybridisation was again at 42 °C but was limited to 2 
hours. Post -hybridisation washes were either under high or low 
stringency conditions as described and detection of bound DNA was 
again using the BRL -DNA detection system. 
2.323 ISH using synthetic oligonucleotide probes 
and immunogold silver staining (IGSS) 
A silver enhancement reaction to improve the sensitivity of non- 
radioactive methods of ISH was described by Burns et al., (1985) for the 
detection of the Y chromosone in intact cells, using a polyclonal goat 
antibiotin layer, followed by peroxidase conjugated rabbit antigoat and 
di- amino -benzidine (DAB) substrate, with the signal being amplified by 
silver precipitation. The availability of totally new reagents made 
possible further improvement to this approach to detection. Samples 
of monoclonal mouse anti -biotin (M743) and of colloidal gold coated 
rabbit anti -mouse immunoglobulins (G385) were kindly provided by Dako 
Limited. The detection of bound biotinylated oligonucleotides was 
achieved with the following protocol :- 
After post- hybridisation washes in SSC, 25µl of mouse anti -biotin 
(1 in 20 in TBS + 1% BSA) was applied for 45 minutes at RT. The 
slides were washed for 2 x 5 minutes in TBS, and non -specific reactions 
were blocked with 20% NRS in TBS for 10 minutes. 25 microlitres of 
rabbit anti -mouse coated with colloidal gold were added at a dilution of 
1 in 50 in TBS + 1% BSA for 1 f hours at RT. The slides were washed 
in distilled water for 10 minutes and the deposited gold particles were 
enlarged using Intense TM II silver enhancement kit (Janssen marketed 
through ICN Biomedicals Ltd., High Wycombe). Equal volumes of 
enhancer and initiator solutions were mixed according to manufacturer's 
instructions and immediately applied to the sections. Silver 
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precipitation to give visible particles round deposited gold was observed 
to occur under the microscope within 10 minutes and the reaction was 
stopped by immersion in distilled water before "self- nucleation" resulted 
in high background staining. 
2.34 HPV- Antigen Detection 
HPV capsid antigen was detected on paraffin sections using an 
immunoperoxidase protocol developed in the Department of Pathology. 
Sections were dewaxed and rehydrated. Endogenous peroxidase was 
blocked by incubating the slides in 3% H2O2 in water for 15 minutes 
followed by a 5- minute water wash. The sections were trypsinised 
using freshly made 0.1% trypsin + 0.1% CaC12 in distilled water for 15 
minutes at 37 °, washed in water for 10 minutes and in TBS + 2% NPS 
(normal pig serum) (TBSP) for 5 minutes. Blocking of non -specific 
binding of the swine second antibody was carried out using 20% NPS in 
TBS for 10 minutes. Rabbit antiserum to SDS- disrupted BPV -1 (Dako) 
was applied as a 1 in 20 dilution in TBSP for 1 hour at 37° or 
overnight at 4 °C. After two 10 minute washes in TBSP, swine 
antiserum to rabbit immunoglobulins (2196; Dako) at a dilution of 1 in 
30 was applied for 30 minutes at RT, and after a further two 10 
minute washes, anti -rabbit PAP (peroxidase -antiperosidase complexes; 
Z113; Dako) diluted 1 in 100 was added for 30 minutes at RT. After 
washing as before, reactions were detected following the application of 
DAB substrate (13033; BDH) made by injecting 5m1 of 50mM Tris -HC1 
pH 7.5 into a 5mg ampoule of DAB. After thorough shaking to 
dissolve the DAB, the contents were added to a further 20m1 of Tris 
buffer in a universal and 14l of 6% H2O2 was added a minute before 
applying the substrate to the sections. Development was allowed to 
proceed for a maximum of 10 minutes before the reaction was stopped 
by washing with tap water for 5 minutes. Slides were examined in 
aqueous mountant without counterstaining. 
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2.35 Double Staining Methods 
Paraffin sections of skin warts and cervical dysplasias were 
stained for both HPV capsid antigens and specific DNA. The antigen 
detection was carried out as described above (2.34) and resultant nuclei 
containing antigens stained brown. Slides were then prehybridised by 
either the long protocol with cloned DNA or the short protocol for 
synthetic oligonucleotides, hybridised for 18 hours or 2 hours 
respectively and detected with the BRL -DNA detection system, or with 
immunogold and silver enhancement for synthetic probes only. 
Generally no counterstains were applied before finally mounting the 
sections in glycerol -gelatin. Very occasionally 2% methyl green for 1 
minute was used. 
Antigen staining and ISH were attempted on cryostat sections 
using similar protocols. In addition, cryostat sections were stained for 
the presence of Langerhans cells using the method described by Carr et 
al. (1986) and adapted by Hughes et al. (1988): the monoclonal antibody 
DAKO -T6 (M721; Dako) was applied for 45 minutes at RT at a dilution 
of 1tn 20 in TBSR (TBS + 2% NRS), following blocking of endogenous 
peroxidase with 0.3% H2O2 in methanol for 15 minutes and of non- 
specific binding with 20% NRS in TBS for 20 minutes. 
Rabbit antimouse immunoglobulins conjugated to horseradish 
peroxidase (P161; Dako) at a dilution of 680 in TBSR were applied for 
15 minutes at RT and after two 10 minute washes in TBSR, DAB 
substrate, made up as described in Section 2.34 was allowed to react 
for 3 -5 minutes. The reaction was stopped by washing in tap water. 
2.4 Attempts to Induce HPV Proliferation in Nude Mice 
2.41 Subcutaneous Implantation of Cervical Biopsies 
Cervical biopsies of varying grades of dysplasia obtained from 
the Colposcopy Clinic and transported to the Regional Virus Laboratory 
in RPMI, were implanted subcutaneously into 38 adult nude mice (25 
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female and 12 male; aged 37 -110 days, x = 63 + 20 days). The 
biopsies were cut into approximately 1 mm2 pieces and held in a drop of 
medium in the end of a 16 -guage needle while the mice were briefly 
anaesthetised with ether. The skin of the dorsal flank was held with 
forceps, an incision was made with the needle and the biopsy injected 
into the subcutaneous space with a bleb of air. The inoculation sites 
were observed weekly during the lifetime of the animal. When the 
animal showed signs of wasting it was killed with ether, and any lesion 
excised and placed in formol saline. 
2.42 Implantation of HPV- infected Foreskin under the Renal 
Capsule 
Human foreskin from young boys was prepared as described in 
Section 1.51. Two or three pieces were suspended in 0.1 ml of 
HPV -11 suspension for 1 hour at 37° as described by Kreider et al., 
(1986). Adult mice were anaesthetised with Nembutal (Ceva Ltd., 
Watford; 0.1 ml of 1ín10 dilution in warm normal saline per l Og of body 
weight) inoculated intraperitoneally. A small paravertebral subcostal 
incision was made and the kidney exposed by gently squeezing the sides 
of the mouse. The renal capsule was nicked and a single fragment of 
HPV -11 exposed foreskin inoculated into the space from a pasteur 
pipette. The wound was closed with sutures (17mm taper -cut 
"Mersilene" sutures; Ethicon Ltd., Edinburgh) if necessary or simply by 
spraying the edges with "Nobecutane" (Astra Pharmaceuticals Ltd., 
Watford). The wounds had healed within a few days and mice were 
observed weekly for signs of growth of the implants. When moribund, 
the mice were killed and developing cysts were removed. They were 
divided into several pieces with one being placed in formol saline for 
histology and the remainder being chopped further for transfer to 
further mice or for EM examination. 
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1. Lymphocyte Proliferation Assays 
1.1 Virus -derived Antigens 
In preliminary studies, mononuclear cells from 15 patients 
showing varying degrees of CIN in cervical biopsies were examined in 
LPA using two BPV- derived antigens, namely, CsCI purified BPV (CsBPV 
at 30 pg /ml, 3 pg /ml and occasionally 0.3 pg /ml representing 10 -1, 
10 -2 and 10 -3 dilutions of stock virus) and detergent- disrupted purified 
BPV (SDS.ME /BPV at similar concentrations). Cells were harvested at 
various times from 5 -9 days after stimulation and the counts analysed 
as described in the Methods (Section 2.12). Table 7 shows that 8 of the 
15 patients were positive on at least one time point with most positive 
on days 8 and 9; mean counts in wells with antigen varied considerably 
from patient to patient by this late stage and standard errors tended to 
be nearer 20% rather than the 10% generally considered acceptable. 
Nevertheless it was felt that weak positive reactions might be missed if 
cells were harvested too early and a compromise of 8 days after 
stimulation was set for further investigations with virus -derived 
antigens, although a few experiments were analysed at 6 and 7 days. 
In an attempt to reduce the variations in counts in replicate 
wells and the wide range and variations within samples, cultures from 9 
people were set up in duplicate with one set being "fed" an extra 100 
ul of complete RPMI after 5 days. No improvement in variation in 
counts was noted. 
1.11 Healthy Members of Staff 
PBM from thirteen members of staff (11 female and 2 male) 
were mixed with various papilloma virion antigens in a standard LPA. 
Cells were harvested at 7 or 8 days after stimulation. The results 
(Table 8) show that 4 people (30.8 %) responded to PV antigens. Both 
Subjects 1 and 2 had small finger warts which were resolving at the 
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and Subject 4 had a tiny wart on the thumb which had appeared and 
disappeared over several years. It was possible to test 
PBM from Subjects 1 and 2 on several occasions and link the positive 
response obtained to the presence of their small warts (Fig. 11). Such 
a correlation was not possible in Subjects 3 and 4. 
When PBM from the same group of subjects were analysed for 
their reponsiveness to PV antigens at different times after in vitro 
culture, 4 people gave positive responses (Table 9). Like Subjects 2 and 
4, Subject 1 had a tiny hand wart at the time of testing while Subject 
8 had no knowledge of any wart infections. Most of the other members 
of the group, despite their negative responses, remembered having had 
skin warts in the past. 
As a consequence of their positive responses, Subjects 1,2, 3 
and 4 were used several times in subsequent experiments (vide infra). 
1.12 Patients with Recalcitrant Warts 
A group of 10 patients, who had mosaic -type common warts 
on their hands or feet of more than 12 months' duration and resistant 
to at least 6 months of treatment were recruited as part of a study on 
the possible enhancement of the immune response during treatment with 
inosine pranobex (Imunovir TM, Edwin Burgess Ltd; Princes Risborough). 
Heparinised blood was taken by Dr. E.C. Benton, Dept. of Dermatology 
on entry to the trial, after one month of placebo or inosine pranobex 
treatment, and again one month after treatment had stopped. 
PBM from this group were stimulated with glycine- extracted 
HPV -2 and purified HPV -2, and stimulation indices(S.I.) were calculated 
after 6 days in culture. Table 10 shows that 5 patients (50 %) responded 
to at least one concentration of one antigen on one occasion, but the 
stimulation indices were low (except for the first specimens of patients 
CB4 and CB5). The pattern of response showed no correlation with the 
clinical state of their lesions. By two months, patients CB 1, 2, 8 and 
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Fig 11 Lymphoproliferative response to skin wart antigens in two healthy 
members of staff around the time of infection 
-100 b- 
Table 9 Lymphoproliferative response to PV antigens in healthy 
laboratory personnel at various time points 
Subject Specimen 
No. 
Antigen S.I. after various days in culture 
3-4 days 5-6 days ' 7-8 days 
1 A unp H1 . 1.1 1.1 
gly H2 . 1.2 1.0 
2 B unp H1 . 2.5 1.1 
gly H2 . 2.3 1.3 
3 B Cs H2 1.0 0.9 1.1 
C Cs H2 1.0 . 1.1 
D Cs H1 1.2 1.2 0.7 
Cs H2 1.1 0.8 0.9 
4 B Cs H2 14.0 4.5 3.8 
C Cs H1 0.7 1.1 1.1 
,5 
Cs H2 0.7 0.9 0.9 
C Cs H2 1.4 0.7 0.9 
D Cs H1 . 0.4 0.9 
Cs H2 . 0.4 0.8 
6 A Cs H2 1.0 0.9 1.6 
B Cs H2 1.0 . 1.4 
t_____ 
7 A Cs H1 1.5 0.7 1.2 
Cs H2 0.8 0.9 1.4 
8 A Cs H1 2.7 0.8 1.1 
Cs 82 1.6 0.7 1.2 
9 A Cs H2 1.0 1.5 1.5 
10 A Cs H2 1.2 0.8 0.9 
11 A Cs H2 0.6 0.6 0.9 
12 A Cs H1 1.2 1.0 0.5 
Cs H2 1.0 1.0 0.7 
13 A Cs H1 1.6 1.6 0.8 

















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































- 101 - 
and 10 showed no change (Table 1 1). Nevertheless, in the following 
month, patients CB 3, 8 and 9 were cured of their warts and 
interestingly all three had been given the active drug. Of the 
inosine pranobex- treated group only CB4 failed to show improvement, 
whereas in the placebo- treated group only CB2 and CB5 showed any 
clinical signs of improvement in their warts, as measured by a reduction 
in area covered by the lesions. 
Experiments in the 1970's had suggested that healthy patients 
with long- standing warts have depressed CMI responses as measured by 
lymphocyte migration inhibition to non -specific mitogens (Morison, 
1975c). The response of the "Imunovir Trial" patients to concanavalin A 
(Con A), phytohaemagglutinin (PHA), which are both T cell mitogens, 
and pokeweed mitogen (PWM), a B -cell stimulator, was therefore 
measured in an LPA assessed at 6 days and occasionally at 3 days. 
Table 12 shows that all patients responded positively at all stages to all 
mitogens tested. The variation in S.I. between different dilutions of 
mitogen and between specimens was considerable, but no evidence of a 
depressed non -specific CMI was found in these patients when lymphocyte 
stimulation was used as a measure, whether or not the patients were 
receiving active treatment. Although 6 days is likely to be beyond the 
peak response for non -specific mitogens and may account for the low T 
cell responses in patient CB4 specimen 3, and CB6 specimen 3, the few 
results obtained at 3 days do not all show a peak at this stage (CB8 
specimen 2, CP10 specimen 2; Table 12). 
When the treatment code was broken, it was evident that in 
the group receiving inosine pranobex, only patient CB4 failed to show 
improvement by the month after treatment, whereas in the placebo 
group, 4 out of 5 failed to show some improvement in the same period. 
1.13 Patients attending the Colposcopy Clinic 
PBM from 92 patients (including 11 of those described in 
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diagnosed at the time of sampling or had been present in the preceding 
year or two, were tested in an 8 -day LPA using BPV, HPV -1 and HPV -2 
antigens. Of the 92 patients, 23 gave positive S.I.s with at least one of 
the antigens and at one or more concentrations of that antigen. 
The detailed analyses for the positive responders are given in Table 13. 
From the data presented, it can be seen that the S.I.s vary considerably 
and that stimulation with an antigen from one type of PV was not 
always accompanied by stimulation with another. Furthermore, no single 
concentration of antigen was found to be optimal and it was necessary 
to try both a range of concentrations and a range of antigens in order 
to obtain positive results. No positive S.I.s to bovine skin antigens were 
obtained. In Table 7 and Table 13 the mean cpm, standard deviation 
and standard error are all included for completeness but in subsequent 
Tables only the mean cpm and SE are presented. 
While more positive results were obtained with the purified 
antigens (19/69; 27.5% of those treated) than with SDS.ME disrupted 
antigens (6/31; 19.4 %) or using unpurified virions (3/16; 18.8 %) or 
glycine extract (4.27; 14.8 %) there were a few patients who reacted 
only to disrupted antigens (e.g. patients 86574 and 85568 in Table 13) 
and not to the purified antigen. 
The S.I.s are plotted in graph form in Fig. 12. This figure 
includes the several different antigenic preparations used for each virus 
and therefore shows the number of positive results rather than the 
number of positive patients. However, only the optimal concentration 
of a particular preparation for each patient is given. 
Of the 23 positive responses, 14 came from patients with 
histological evidence of koilocytes and this represents 31.1% of the K+ 
group. Nine were from patients without koilocytes, with only 19.1% of 
the K- group giving positive responses. This difference is just 
significant (X2 = 3.94; p < 0.05). Positive responses were obtained in 
patients with all grades of CIN, with no significant difference between 
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Interestingly, while no correlation with koilocytosis was found, 
the positive cases came almost exclusively from those with a history of 
skin warts (Table 15). Out of 68 who knew they had or had had warts, 
21 (30.9 %) responded in the assay, compared with only 2/24 
(8.3 %) with no acknowledged history. This difference is highly 
significant (X2 = 10.42; p < 0.01). 
An analysis of 82 patients with CIN for whom full information 
was available showed that the youngest age group (20 -29 years) 
contained the highest proportion of positive responder (7/21; Table 16). 
When information regarding smoking habits was examined, it was noted 
that 43% of smokers in the oldest age band ( >40 years) responded to 
papilloma antigens despite the response rate in smokers of all ages 
being similar to that in non -smokers (Table 16). The number of 
patients in each group is too small, however, for these results to be 
significant. 
A further 54 patients were examined during 1987 and 1988 
with a similar range of antigens and lymphocyte proliferation was 
assessed at 6 -8 days. Ten patients (18.5 %) gave a positive response 
with eight of these responding to purified HPV -1 and HPV -2 including 
two who also responded to glycine extracted HPV -2. A further 2/30 
responded only to unpurified HPV -1. All patients who responded had a 
past history of hand or plantar warts and indeed 3 had finger warts at 
the time of examination. 
1.14 Summary of Results on Lymphocyte responsiveness to PV antigens 
While 30% of healthy laboratory staff responded to PV 
antigens in vitro with positive results showing some correlation with the 
presence of unobtrusive hand warts, 50% of patients attending a 
Dermatology Clinic because of long- standing warts had low levels of 
memory T cells capable of responding in LPA. In this group however, 
no correlation was observed between a positive response and clinical 
improvement in their lesions. Contrary to earlier studies, these patients 
-103a- 
Table 15 Influence of skin wart history on the outcome of LPA against 
papilloma antigens in patients with CIN 
Skin wart history No. of - 
patients 
No. with 
S.I. > 2.0 
Presence (K +) or absence 
(K -) of koilocytes in 
positive responders 
Past or present 
warts 68 21 (30.9 %) 13 K+ 8 K- 
No known history 24 2 (8.3 %) 1 K+ 1 K- 
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did not show depressed LPA responses to non -specific mitogens. In a 
group of 92 Colposcopy Clinic patients, 25% responded to PV antigen(s) 
in LPA, a similar percentage to that found in staff members. While no 
correlation was found between positive responses and the degree of 
dysplasia nor between responsiveness and the presence of koilocytes, 91% 
of the responders had a history of past or present skin warts. It seems 
likely that the LPA assay was detecting exposure to common skin wart 
types rather than any association with cervical papilloma infection. 
1.2 Cervical Tissue -derived Antigens 
A glycine extract of autologous cervical tissue from 18 
patients attending the Colposcopy Clinic and showing varying degrees of 
dysplasia was produced as described in Section 2.11 of the Materials and 
Methods. It was considered that such extracts might contain 
virally- induced cell- associated antigens. Normal tissue from a different 
area of the transformation zone was obtained in three patients. The 
protein concentrations of these extracts ranged from 3.5 -90 pg /ml. It 
can be seen from Table 17 that only one of the eighteen responded 
positively to the glycine extract. The patient (87471) gave no other 
positive responses in this specimen but a second specimen 6 months 
later gave positive S.I.s in LPA with HPV -16E6, HPV -18E6 and 
HPV -16E4 fusion proteins as antigens (vide infra). In one patient 
(87121) there was a large reduction in response to the extracts of both 
"abnormal" and "normal" cervix, possibly due to a toxic effect of the 
extract. Because of the difficulties in obtaining matching bloods and 
tissue from histologically normal and abnormal areas, no further 
specimens could be examined in this way. 
1.3 HPV Fusion Proteins 
1.31 Fusion Proteins of Late and Early Genes of HPV -1 and HPV -2 
Small amounts of L1, L2 and E2 fusion proteins of HPV -1 
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specimens comprising 11 specimens from 5 patients with recalcitrant 
warts, one specimen from a laboratory member (Subject 2) and three 
specimens from colposcopy patients were tested with some or all of 
these antigens at concentrations adjusted to 3 -30 pg /ml. Only one 
positive reaction to an HPV -1 fusion protein (HPV -1 LI) was noted, in a 
colposcopy patient who had had a plantar wart ten years before. Two 
positive responses to HPV -2 L2 were observed : in patient 87058 who 
had previously had cervial dysplasia without evidence of koilocytes and 
who had a wart on her thumb at the time of testing and in patient 
CBI who had mosaic warts on both feet at the time of testing (Table 
18). The few very low S.I.s obtained may reflect a toxic reaction to 
residual SDS in the antigen preparation. 
Thus it can be seen that 3/8 patients responded to a late gene 
fusion protein and, despite the presence of contaminating 13- 
galactosidase sequences, the results showed some agreement with the 
history of skin warts. The use of highly purified LI or L2 fusion 
proteins might therefore be suitable for specific LPA testing against 
those HPV types which produce a complete replicative cycle. More 
work witih well defined groups of patients is required. 
1.32 Fusion Proteins of Early Genes of HPV -16 and HPV -18 
The lymphoproliferative response to HPV -16E6 and HPV -18E6 
was assessed in 48 patients attending the Colposcopy Clinic (mean age 
31.6 + 7.0 years) and in 15 healthy female members of staff (mean age 
30.1 + 7.6 years), after 7 days in culture and at earlier time points in 
those patients from whom sufficient mononuclear cells were obtained. 
Against a background of culture medium as mock antigen 8 patients 
responded to one or both proteins (Fig. 13) but the responses were low 
with S.I.s in the range of 2.04 -5.39 being recorded. None of the staff 
responded and none of the patients nor the staff showed positive 
responses at 3 or 5 days. 
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Fig.13 Lymphoproliferative response to HPV -16- E6 and HPV -18 E6 fusion proteir 
in patients with CIN after 7 days in culture Mio HPV -16 E6 vuim HPV -18 E6 1 Control E6 
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produced but lacking any HPV sequences was similarly assessed in 29 
patients and all staff. Since only one patient and none of the staff 
responded (Table 19), the control protein was then used as a baseline 
for responsiveness to the specific fusion proteins. By this analysis, 
seven patients (24 %) and three laboratory control (20 %) responded to 
HPV -16E6 and /or HPV -18E6 after 7 days in culture. S.I.s were again 
low, ranging from 2.06 to 4.34 (Table 20). Only two patients (P12 and 
P31; Fig. 13 and Table 20) showed positive responses against both 
baselines. 
Similar analyses were carried out using HPV -16E4- 
13- galactosidase fusion protein and a control ß- galactosidase protein 
similarly produced. Against a background of culture medium PBM from 
two patients gave S.I. y2.0 to the HPV- specific fusion protein (Fig. 14). 
However responses to the control protein were obtained in five patients 
(Fig. 14) and additionally in one laboratory control after 7 days in 
culture and in another after 3 and 5 days in culture (Table 19). 
Against a baseline of the ß- galactosidase response, PBM from only one 
patient showed an S.I. > 2.0 to HPV -16E4 (P36; Table 20). The 
significance of the background responses to residual p- galactosidase is 
discussed. 
It can be seen from Table 20, that patients who responded to 
fusion proteins in LPA presented with widely differing histological 
lesions. No correlation between S.I. and the degree of dysplasia nor 
the presence of koilocytes was obvious. Of the 48 patients, 33 had a 
past history of hand or foot warts and a further 7 had small common - 
type warts at the time of testing. Similarly in the control group, 
eight had had a previous skin wart infection and four currently had 
small warts. Six of 23 patients and 2 of 11 controls from whom 
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Fig 14 Lymphoproliferative response to HPU -16 E4 fusions protein in patients 
with CIN after 7 days in culture 
HPU -16 E4 i a Control E4 
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1.4 Adaptations to the standard LPA 
1.41 Addition of Lymphokines 
The lymphokine IL -2 was added to proliferative assays with 
PBM from 68 specimens from 42 people. This included 32 specimens 
from 30 colposcopy patients, 26 specimens from the 10 patients with 
recalcitrant common warts and 10 specimens from 2 members of staff. 
By titrating the effect of IL -2 in the range 0.1%, 0.3 %, 1%, 3% and 
10% in samples from both members of staff and two colposcopy 
patients, it was found that 10% and 3% generally caused stimulation of 
the baseline 'Nil' response whereas concentrations less than 3% had 
little effect either on the baseline or on antigen- exposed cells. In 
subsequent investigations on the effect of IL -2 on responsiveness to PV 
antigens, concentrations of 3 %, 5% and /or 10% were used. It can be 
seen from Table 21 that the addition of 10% IL -2 at 2 -4 days or 3- 
5 % IL -2 on day 0 caused less background stimulation than addition of 
10% IL -2 on day 0. However, the numbers of positive S.I.s obtained 
with PV antigens in the presence of IL -2 were not very different in 
each group when compared with the stimulation caused by IL -2 alone 
(Table 21). 
The eleven specimens in which the presence of IL -2 produced 
an increased response with papilloma viral antigens are detailed in Table 
22. Five specimens were from colposcopy patients and six were from 
people with cutaneous warts. No consistent patterns were obtained to 
suggest that addition of IL -2 on a regular basis would increase the 
sensitivity of detection of a weak proliferative response to papilloma 
antigens. 
The second highest S.I. in the presence of IL -2 came from a 
colposcopy patient who had a thumb wart at the time of testing 
(87058). A positive response was also very obvious in the absence of 
IL -2 with the L2 fusion protein of HPV2 (see also section 1.31). 
Despite testing 19 specimens from colposcopy patients with HPV -16 and 
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gave a response with HPV -18E6 and IL -2 which was more than twice 
that of the IL -2 baseline. On several other occasions, IL -2 boosted 
the fusion protein response very slightly and in one or two specimens 
reduced it. Such reduction was also noted in 6 of the 68 specimens in 
this trial which had given S.I. 2.0 to a variety of papilloma antigens 
and which became negative in the presence of IL -2. In several of the 
colposcopy patients to whose cells IL -2 was added 2 -4 days after E6 
fusion proteins there was little response above background with one 
exception : an S.1 of 3.0 was recorded with the E6 control protein plus 
IL -2 added at 3 days in specimen 88082 (repeat of 87485 six months 
later) but only when assessed after 5 days in culture. 
Interleukin -1 (IL -1) was added at a dilution of 1 in 40 in 
RPMI to LPA from 3 specimens. In none of them was a positive 
response in the presence of IL -1 recorded. When added to a variety of 
PV antigens it caused no effect on the resulting S.I., although in Subject 
1 (specimen C) it reduced the response to unpurified HPV -1 to half that 
obtained in the absence of IL -1 and in 86733 it similarly reduced the 
response to a glycine extract of HPV -2. Although IL -1 can promote T 
and B cell mitosis (Mims, 1987), this is not its main action and it was 
not considered worthwhile to add it to subsequent cultures. 
1.42 Alteration in Number and Type of Antigen Presenting Cells 
Attempts were made to alter the percentage of antigen 
presenting cells introduced into lymphocyte culture in the presence 
of antigen in the hope that more stimulation might be obtained. This 
was tried on 8 occasions with PBM from 7 people (6patients and 1 
member of staff). Adherent cells were removed from PBM by 
adherence for up to 1 hour on glass (4 assays) or etched plastic (1 
assay) with addition back into the non -adherent cell population of 
concentrations ranging from 1% - 10 %. On three further occasions, not 
only were adherent cells removed on glass, but the non -adherent cells 
were enriched for T cells by passage through a nylon wool column. The 
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results, as presented, in Table 23 can be seen to be negative with one 
exception : specimen 86151 (patient with CIN III, K- and no known 
history of skin warts) gave strongly positive responses when adherent 
cells were added at a final concentration of 1% and 2% to cultures 
containing purified HPV -1 at three different concentrations. These 
results will be discussed. 
Autologous cervical epithelial cells disaggregated from biopsy 
tissue by collagenase dispase digestion were added directly to PBM from 
13 patients at a concentration of 4% (and also at 16% in specimen 
86733). The results are summarised in Table 24. With two exceptions 
(86797 and 87017), the cervical cells had little effect on the baseline 
response with no added antigens, giving S.I.s in the range from 0.8 to 
1.8. In specimen 87017 the cervical cells caused a reduction in S.I. to 
40% of the baseline response, possibly suggesting a toxic effect after 
Percoll purification of the cervical cells resulting in a reduction of S.I. 
in response to unpurified HPV -1 and glycine- extracted HPV -2. 
Specimen 86797 (from a patient with no dysplasia) was the only 
specimen to give a positive response with cervical cells alone. It was 
also one of the two which gave a positive response to papilloma antigen 
alone (S.I. = 3.5 with unpurified HPV -1; specimen 86833 gave S.I. of 2.0 
with same antigen; both specimens analysed after 6 days in culture). 
Nevertheless, the presence of cervical cells reduced the S.I. of HPV -1 
containing wells to 68% of the index without cervical cells. 
In two patients adherent cells were removed by attachment to 
glass for 1 hour and autologous cervical cells added back in place of 
them to the non -adherent population. n one case the non -adherent 
cells had been enriched for T cells by passage over nylon wool. In 
neither specimen was stimulation obtained with adherent or cervical 
cells in the presence or absence of papilloma antigens. However, the 
effectiveness of the depletion and reconstitution, for example by the 
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1.43 Attempts to Demonstrate a Suppressive Effect of PV Antigens 
In addition to those patients who responded positively to PV 
antigens in LPA, a considerable number gave S.I. < 0.5 to one or more 
concentrations of one or more antigens tried: in 174 colposcopy 
patients tested with purified, unpurified or glycine extracted papilloma 
antigens, 37 (21.3 %) gave reduced responses. (Any additional specimens 
giving reduced responses with SDS- disrupted antigens only were excluded 
because of possible toxicity from residual SDS); in 50 colposcopy 
patients tested with purified E6 fusion proteins, 17 (34 %) gave reduced 
responses, with similar responses to E4 being excluded because of the 
possible confusion from the presence of B- galactosidase. Thus 54/224 
(24.1%) gave S.I. <. 0.5 to at least one PV antigen. The S.I.s ranged 
from 0.17 - 0.49 but the majority lay between 0.40 - 0.49. Supression 
of the response is subject to other influences on the immune system 
such as the effect of smoking. However, only 60% of those giving 
reduced responses admitted to smoking 2 -30 cigarettes per day at the 
time of testing . 
The reduction in S.I. was not considered to be a toxic effect 
of the antigens per se since many specimens gave non -remarkable 
results and approximately 25% gave positive responses. That both the 
positive results and the 'reduced' responses may be extremes of normal 
will be discussed. Nevertheless, it seemed possible that the reduced 
responses might be due to a suppressive effect and several experiments 
were carried out to try to elucidate this. 
The effect of adding E6 fusion proteins to lymphocytes 
stimulated with Con A was examined at various times in 9 specimens 
from 6 members of the laboratory and 4 specimens from 4 colposcopy 
patients (Table 25). In the first group of seven specimens analysed at 7 
days it was noted that in five the addition of high concentrations of 
purified E6 of HPV -16 or HPV -18 caused an increase in the S.I. 
compared with Con A alone (Table 25, Section A). This prompted a 


















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































the Con A response at various time points from 3 -7 days. A 
progressive increase in response to Con A in the presence of PV antigen 
occurred over this time span in all six specimens tested (Table 25, 
Section B). Overall, in 4/13 (30.8 %) specimens the S.I. with Con A was 
more than doubled by the addition of HPV -16E6 (specimens 87519, 
87520, 6 -A and 11-A) and in 1/4 (2.5%) it was more than doubled by the 
addition of HPV -2 (specimen 11 -A). These results are shown graphically 
in Fig. 15. While the higher S.I.s at 7 days were thought to represent a 
shift in the Con A response due to an inhibitory effect of the PV 
antigen, the peak response (5 days) was not altered. 
Because Con A is a non -specific mitogen of all T cells, it was 
considered appropriate to look for a similar effect in cells stimulated 
with HSV. UV inactivated HSV was added at a multiplicity of 1 pfu /cell 
and HPV -16E6 or purified HPV -2 was added in addition. The results 
from specimens from four laboratory members known to respond to HSV 
are shown in Fig. 16. No consistent pattern was obtained and any 
effect of PV antigen on the HSV response must be considered minimal. 
These results will be discussed. 
To test whether a soluble factor was produced during 
incubation of PBM with PV antigens, supernate was collected from 
cultures of subject 4 at 4, 5 and 7 days after exposure to antigen. 
Subject 4 was chosen because of her previous positive responses to 
HPV -2 and HPV -16E6 (specimen 4 -B, Tables 8 and 9; specimen 4 -F, 
Table 25). Supernates were added to a subsequent specimen of PBM in 
culture on day 0 and the cells harvested on day 5. Unfortunately in 
this specimen, no positive response to HPV -2 or HPV -16E6 was recorded 
(S.I. of 0.93 and 0.78 respectively) and no effect was observed with any 
of the supernates. While this system is worth further study, the 
logistics of obtaining large enough volumes of blood on at least two 
occasions in close succession from people who had had previous positive 
results were daunting and no other specimens were treated in this way. 
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Fig 15 Alteration in lymphoproliferative response to Con A in the presence 
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Fig 16 Effect of HPV antigens on lymphoproliferative response to HSV 
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responses and whether early positive responses (such as that shown by 
Subject 4, specimen F, Table 25) could be explained by the function of 
CD8+ cells, these cells were removed from PBM by panning. 
Untreated PBM, CD8+ depleted PBM and reconstituted PBM were all 
exposed to Con A, purified HPV -2 and HPV -16E6 fusion protein in a 
standard LPA assessed at 3 and 7 days in 3 people (Table 26). 
Recent work in this laboratory has shown that panning is only 
partially successful in removing CD8+ cells while cell sorting by EPICS 
analysis was considerably more effective. (Dr. James Vestey, personal 
communication). Nevertheless, it was found in all three patients that 
the removal of CD8+ cells markedly reduced the Con A response at 3 
days and their replacement at least partially restored it. This was the 
expected result for a non -specific T cell mitogen. By 7 days, the 
removal of CD8+ with suppressor activity resulted in a maintained high 
S.I. 
In the three people studied, reactions to PV antigens in whole 
PBM were minimal (with the exception of subject 6 -B who showed a 
positive response to HPV -16E6 at 7 days). Nevertheless, partial 
removal of CD8+ cells reduced the HPV -16E6 response in Subject 3 -C 
at 3 days to almost half and similarly in Subject 6 -B at 7 days. The 
HPV -2 response in Subject 3 -C was similarly reduced at 7 days. These 
results do not support adequately the suggestion that CD8+ cells exerted 
a suppressive effect on the T cell response, although much more work 
with more efficient CD8+ depletion in people who have been shown to 
respond positively to PV antigens is required. 
1.44 Subset Analysis 
Sufficient PBM were obtained from several specimens to 
attempt to investigate the effect of papilloma antigens on the 
percentage of lymphocyte subsets at various times after stimulation. 
Monoclonal antibodies to Ti and T3 as pan -T markers, T4, T8 and 
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in an indirect fluorescent assay in an EPICS cell sorter. B cells were 
stained directly with fluorescein- conjugated anti -human IgM raised in 
sheep. 
The T1 marker gave exceedingly variable and low results, 
while on the few occasions on which T3 was used, 63 +8% of the cells 
analysed were stained. In an investigation of T cell response to HSV 
antigens was carried out in this laboratory, the percentages of cell 
types staining with the same monoclonal were found to be 60 +7% for 
T3, 44 +10% for T4, 23 +4% for T8 and 11 +2% for B cells (Dr. James 
Vestey, personal communication). The percentages of cells stained in 
the current study were slightly lower and more variable particularly for 
the T4 marker. This may have been due to the storage of fixed cells 
after staining for up to 12 days before they could be analysed. 
Although freshly separated PBM should be robust, it appears that 
cultured cells are particularly fragile and storage after fixing leads to a 
loss of stain as well as disruption of the cells themselves. 
As a result of the variation in staining, no conclusions could 
be drawn from the results. However it was interesting to note that in 
Subject 2 -F (Table 27), despite positive S.I.s being obtained at 6 and 8 
days with glycine- extracted HPV -2 and unpurified HPV -1 in the 
presence of IL -2, the percentage of T8 cells decreased with time 
suggesting that they were not involved in the proliferative response. 
On the other hand, when a specimen from Subject 4 who had previously 
shown positive responses to several papilloma antigens was analysed on 
days 4, 5 and 7 after exposure, an increase in T8 was noted on day 4 
in the presence of purified HPV -2 and HPV -16 fusion protein, matching 
with positive S.I.s at this point. No similar increase in T8 was noted 
in the Nil control or in Con A stimulated cells. The percentage of T8 
was reduced by day 5 in the presence of HPV -2, although it was still 
somewhat higher with HPV -16E6 and again matched with a positive but 
falling S.I. to HPV -16E6. By 7 days the percentages were comparable 
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analysis even before 4 days might be relevant and specimens from 5 
colposcopy patients were therefore examined after 2 or 4 days in 
culture. In one patient a high T8 percentage was noted after 2 days 
in a culture stimulated with purified HPV -2. By 7 days the HPV- 
2 stimulated cells were showing an S.I. of 2.2 in LPA. Obviously these 
are preliminary results complicated by the variable staining patterns 
obtained with stored cells, but the use of the EPICS in analysis of this 
kind will be discussed. 
Interestingly in several of the specimens examined after 2- 
3 days in culture, two populations of cells could be identified with each 
marker, on the basis of size differentiation. It was thought that the 
larger cells might represent activated cells and would stain 
preferentially with the anti -Tac marker. However, specimen 86003 
which demonstrated these two populations appeared to have fewer anti - 
Tac positive cells distributed between the two cell types than specimens 
in which the cells were more homogeneous. The granularity of the 
larger cells was increased as might be expected in cells preparing for 
division. 
1.45 Summary of Results of Adaptations to the Standard LPA 
The addition of IL -2 to lymphocyte cultures in the presence of 
papilloma antigens, either structurally derived or bacterially produced 
fusion proteins, did not improve the sensitivity of the LPA. Addition 
at a later stage of culture appeared to be no more effective than 
addition at day 0. While positive responses in the presence of IL -2 
were sometimes observed, the effect was not consistent and no obvious 
pattern appeared. 
Alteration of the antigen presenting cells by increasing the 
concentration of adherent cells in the cell population failed to improve 
the sensitivity of the reaction. Similarly, adding cervical epithelial 
cells as potential APC or replacing the adherent cells with cervical 
cells failed to increase responsiveness. 
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In 25% of cases, PV antigens caused a depression rather than 
a stimulation, with S.I.s reduced to < 0.5. The addition of HPV -16E6 
fusion proteins or HPV -2 appeared to potentiate the ConA response such 
that by 7 days the response had not fallen so far from the 5 day peak; 
this effect, however, was not so readily demonstrated by adding 
papilloma antigen to cells already mixed with HSV, nor was a soluble 
factor demonstrable at several time points after culture of a responder's 
PBM in various papilloma antigens. 
A method for lymphocyte subset analysis using cells cultured 
and stained in microtitre plates was developed, and in two cases the 
results suggested that an increase in CD8+ cells after 2 -4 days in 
culture might be associated with the positive S.I.s in LPA. 
Much work needs to be done in this area, but the greatest 
need firstly is to find consistently good responders in the basic LPA 
test. 
1.5 T -Cell Lines 
Six attempts to produce a line of cells specifically responsive 
to papilloma antigens were made when sufficient PBM were available 
after the standard LPA had been set up. When only a few million 
cells were available, they were set up at 2 -3 x 106 /ml in wells of a 24- 
well plate, and when more than 2 x 107 were available, Falcon flasks 
were used. Different antigens were tried for stimulating the bulk 
cultures. 
Three specimens from colposcopy patients were set up, 
including one which responded to glycine- extracted HPV -2 especially in 
the presence of IL -2 (to give an S.I. of 34.83 with HPV -2 and IL -2), 
one which responded to the late fusion protein of HPV -1 (L 1 H 1), and 
one which unfortunately failed to respond in LPA to the unpurified 
HPV -1 to which the excess cells were exposed. After 7 -8 days in 
culture, bands of T lymphoblasts were obtained at the 40 -50% interface 
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of a Percoll gradient, but none were successfully expanded in the 
presence of IL -2 and quickly died out. 
Two specimens from patients in the inosine pranobex trial 
were similarly treated. One specimen from a patient who had rapidly 
resolving common hand warts was stimulated with purified HPV -2 while 
the other, whose mosaic hand and foot warts had not improved, was 
stimulated with glycine- extracted HPV -2, to which he had given a 
strongly positive response (S.I. = 13.54) one month earlier. 
Unfortunately, neither patient responded with a positive S.I. to these 
antigens at the same time as the cell -line cultures were started and no 
blasts were obtained when the cells were separated on a Percoll 
gradient. 
The sixth specimen came from a member of staff (subject 2, 
specimen 4) and as shown on Table 8, she responded to several PV 
antigens at this time. Twenty million PBM in í Omis of complete 
RPMI were stimulated with 5001 of glycine extracted HPV -2 at a 
concentration of 10}ßg /ml. T- lymphoblasts were seen as two small 
bands at the 40 -50% interface of a Percoll gradient after 7 days, and 
these were slowly expanded in culture over the next three weeks in the 
presence of 3% IL -2. They were then mixed with autologous irradiated 
PBM in the ratio of 105:106 and restimulated with the same antigen. 
However, when separated one week later on Percoll, no band of 
lymphoblasts was observed, the majority of cells were small and could 
not be maintained. Possibly a higher concentration of IL -2 would have 
allowed more rapid expansion in culture and given this developing cell - 
line a better chance. 
As with adaptations to the standard LPA, it was realised that 
a good and regular responder had to be found first before trying again. 
It was easier to obtain a supply of autologous PBM for irradiating 
from laboratory members than patients, and with hindsight, subject 4 
might have been suitable. However, even she did not respond 
consistently to any single PV antigen making it difficult to be sure of 
- 117 - 
the optimal antigen to use or its concentration. 
2. Antibody Production 
2.1 Plasma IgG against Virion Antigens 
2.11 Healthy Members of Staff 
Initially ELISAs were carried out using glycine- extracted BPV 
as coating antigen at a concentration of 4pg/ml, by the method 
described in Section 2.21 of the Methods. This produced strong 
positive reactions with rabbit antisera against SDS- disrupted BPV -1 from 
both a commercial supplier (Dako) and from a rabbit immunised in this 
Department. However, with human sera from laboratory personnel, 
absorbance s were low and were never more than twice the background 
absorbance obtained with a glycine extract of normal bovine skin at a 
similar protein concentration. 
Subsequently, using purified HPV -1 or HPV -2 as antigen, 
disrupted with 2% SDS and 2% ME and at a concentration of 1- 2ug/ml, 
results were obtained which were considerably above the background 
absorbance obtained with an extract of human keratoses, enabling 
antibody positive and negative plasma specimens to be distinguished. A 
baseline was obtained using a plasma sample (86011) from a colposcopy 
patient with no history of skin warts, no cervical dysplasia nor 
koilocytosis, a negative response to various PV in LPA and who 
consistently gave very low absorbances on repeated testing. The cut- 
off was assessed on each run from the mean of at least three negative 
wells plus 3S.D., and titres were taken as the last dilution giving a 
higher absorbance than the cut -off. 
The results of four titrations over a three month period on 
three members of staff using disrupted HPV -1 as antigen are shown in 
Fig. 17. It can be seen that in both subjects 1 and 2, the mean 
absorbance at a dilution of 1:3200 was still greater than the cut -off of 
0.31 whereas in subject 3, the 1:50 dilution gave a mean absorbance 
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Fig 17 Antibody response to disrupted HPV -1 in three healthy members 
of staff measured by ELISA 
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HPV -2 in five laboratory members are shown in Table 28. 
2.12 Patients with Recalcitrant Warts 
Ten patients enrolled in the inosine pranobex described in 
Section 1.12 of the Results were tested for antibodies to HPV -2 at the 
time of enrolment in the study, after one month of treatment and after 
a further month without treatment. All specimens were tested at the 
same time. Only 4 of the 10 had antibodies at the time of entry into 
the trial and, no others had developed antibodies by the end (Table 29). 
Indeed, the borderline titres obtained in CB8 and CB9 in the early 
specimens were not detected in the final specimen. Only CB3 showed 
a boost in antibody titre and it is of interest to note that this patient 
received the active inosine pranobex. Although it took a further 
month for resolution of his multiple warts on hands and feet, there had 
been a dramatic clinical improvement between the first and second 
visit. 
2.13 Colposcopy Patients 
Plasma from 282 patients attending the Colposcopy Clinic 
were tested at a dilution of 1:50 for the presence of antibodies against 
purified SDS.ME disrupted HPV -1, HPV -2 and BPV in the standard 
indirect ELISA. ELISA Indices (E.I) were calculated from at least 
duplicate assays by dividing the absorbance.: of the test sample by the 
mean absorbance of at least three negative wells plus 3S.D. The E.I. 
allows some quantitative comparison of results obtained at a single 
screening dilution in different runs. One hundred and forty four 
(51.1%) were found to have antibodies (i.e., E.I.31) to at least HPV -1 
or HPV -2 with 73 (50% of the total) having antibodies to HPV -1 only, 
64 (45.1%) to both HPV -1 and HPV -2 and only 7 (5.8% of the 139 
tested) having antibodies to HPV -2 alone (Table 30). These results 
suggest that, despite SDS.ME disruption of virions, predominantly 
type- specific epitopes were being recognised by the humoral immune 
system. 
-118a- 
Table 28 Antibody titres to HPV -1 and HPV -2 by ELISA in healthy laboratory 
staff 
Subject - Specimen History Titre 
HPV -1 HPV -2 
1 A Recent hand wart > 3200 > 1600 
2 A Past plantar hand wart > 3200 400 
3 A Past hand wart 50 200 
4 A Recurring tiny hand wart < 50 200 
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No correlation was found between the presence of HPV 
antibodies and koilocytosis or the degree of CIN. Approximately 50% 
of patients within each grade of dysplasia had antibodies, and equal 
numbers of those with and without koilocytes were positive. (Table 
30). One hundred and two (70.8 %) of the patients with antibodies 
knew they had had skin warts. On the other hand, equal proportions 
of those who gave a past history and of those who had no known 
history actually had detectable : antibody. (Table 31). 
Positive E.I. using disrupted HPV -1 as antigen ranged from 
1 -19.49 whereas with disrupted HPV -2 as antigen, the highest mean 
E.I. was 2.89. These results are shown in Fig.18. The greater 
antibody response both in size and in numbers may reflect the greater 
exposure to antigen following HPV -1 induced lesions with a high virion 
content. When purified disrupted BPV was used as the coating 
antigen and antibodies to this assayed in 55 patients, very low 
absorbanc . s (< 0.13) suggesting negligible exposure to BPV, were 
obtained in all patients. Nevertheless, the same patients 
demonstrated absorbanc ..;s ranging from 0.23 to 1.21 (E.I. =0.02 -7.52) 
against HPV -1 and from 0.24 to 0.56 (E.I. =0.08 -2.61) against HPV -2. 
The significance of these results will be discussed. 
2.2 Plasma IgG against Specific Gene Products 
Although only small quantities of fusion proteins were 
available, a few attempts were made to see if antibodies to potential 
gene products could be detected using the standard indirect ELISA. 
All four fusion proteins of HPV -1 and HPV -2 provided by 
Dr. John Doorbar were tested (i.e. HPV -1, L1, L2 and E2 and HPV -2 
L2) on a small group of specimens previously tested with disrupted 
HPV -1 and HPV -2 antigens. While concentrations of HPV -1 and 
HPV -2 L2 in the range 30 -50 pg /ml gave many high absorbanct,s 
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Fig 18 ELISA indices using HPV-1 and HPU -2 antigens in patients with 
varying degrees of CIN 
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gave little more than background levels (0.11 + 0.07), concentrations 
of 3- 5p1 /ml gave a wide scatter in the range 0.10 -1.10. 
Nevertheless, there was no correlation with the results previously 
obtained. When plasma from colposcopy patients, laboratory staff 
and patients with recalcitrant common warts were tested with all four 
fusion proteins at concentrations of 3- 5ug /ml, wide variations in 
absorbance were again obtained but no pattern emerged. Frequently 
the absorbance with HPV-1E2 was higher than with the late gene 
products, but this was also found in specimens from people who would 
not be expected to respond to HPV antigens including a twoyear old 
child. It seemed likely that reactions were being detected in many 
people to residual E.coli protein sequences translated with the HPV 
fusion protein. 
A similar situation was found when "crude" HPV -16E6 and 
HPV -18E6 preparations were used. Plasma from several people gave 
high absorbancies when the proteins were used at similar 
concentrations, but identical reactions were obtained with HPV -16E6 
and HPV -18E6 suggesting that some antigen common to both 
preparations was being recognised and not the papilloma product 
itself. Again upstream E.coli sequences may be involved. 
Very little of the highly purified HPV -16E6, HPV18 -E6 and 
control protein was available for ELISA. Preliminary assays using 
antigen coated at 0.35pg /ml and plasma from subject 1 and 3 
colposcopy patients were set up. Similar absorbancies over most 
wells suggested that the concentration of fusion protein was too low, 
allowing nonspecific attachment of plasma proteins during the 21 hour 
incubation period, despite previous blocking with 3% BSA. Ten 
plasmas from colposcopy patients, plasma from subject 1 and from 
two children under 5 years of age, were tested against HPV -16E6, 
HPV -18E6 and then control protein coated at 2.41l /ml. Negligible 
absorbancies (0.01 -0.27, X =0.07+ 0.06) were obtained from HPV -16E6 
and HPV -18E6 although 5 colposcopy patients and one child gave 
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much higher absorbance s with the control protein (z = 0.58 + .20). 
Unfortunately, no further antigen was available to explore this system 
further. 
2.3 Secretory IgA in Cervical Washings 
The presence of secretory IgA was investigated in 24 
specimens of cervical washings using an indirect ELISA with SDS.ME 
disrupted HPV -2 as antigen and rabbit antihuman secretory component 
conjugated to horseradish peroxidase as the detecting reagent for 
bound sIgA. 
The first secretions were collected in 2m1 of distilled water 
and diluted from 1 in 2 to 1 in 256 for the test. A prozone effect 
was observed in all specimens, presumably due to the presence of 
proteolytic enzymes in the secretion, a blocking effect of excess 
mucus or to sub -optimal salt concentrations in the first dilutions. 
Subsequent specimens were collected in 1 ml of distilled water and 
tested at dilutions starting from 1 in 20 to circumvent this problem. 
Since plasma does not contain secretory IgA, background absorbances 
were calculated in each run by including at least 6 wells with plasma 
from the same patients or from laboratory staff where the 
appropriate plasma was not available. The cut off was taken as the 
mean + 3S.D. of the baseline. To detect free secretory component, 
washings at the starting dilution were added to uncoated wells. High 
absorbances in these wells suggested a direct binding of the conjugate 
to secretory component attached to the solid phase. 
Most of the samples gave absorbances lower than the 
cut -off at all dilutions tested. However, 8 samples (33 %) gave 
higher absorbances. E.I. were calculated for these samples by 
dividing the absorbance of the specimen by the cut -off absorbance 
obtained in the same assay, and these are detailed in Table 32. It 
can be seen that 6/8 were positive at the starting dilution with the 
-121 a- 
Table 32 Presence of secretory IgA in cervical washings in 8 patients 
attending the Colposcopy Clinic 




E.I. Titre E.I. at this 
dilution 
88134 CIN I K+ 32 1.80 > 256 1.30 
88135 CIN I K+ 32 1.80 > 256 1.85 
88137 CIN III K- 32 1.85 64 1.40 
88230 No biopsy 20 1.59 50 1.05 
88231 CIN II K+ 20 1.10 20 1.10 
88232 CIN III K- 20 3.12 50/100 1.95/0.95 
88233 CIN III K- 20 0.78 50 1.24 
88234 CIN III K+ 20 0.59 50/100 2.05/1.05 
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remaining two showing a prozone even at 1 in 20. Positive reactions 
were not confined to patients who showed evidence of koilocytosis on 
histological examination. Free secretory component was detected in 
three of the 24 specimens on initial testing, and in two others (88134 
and 88135, Table 32) it was detected following storage of the 
specimen at 4 °C during which time the specific anti -HPV -2 secretory 
IgA disappeared. 
These preliminary results suggest that an indirect ELISA to 
measure specific secretory IgA in cervical washings could be 
developed. Standardisation of the starting dilution of specimens used 
would be required, preferably by estimation of the protein content of 
each sample. 
3. Histochemical Studies 
3.1 ISH with Cloned Probes 
Adherence of the sections during pre- hybridisation processing 
was found to be one of the biggest technical difficulties encountered 
and was solved by a combination of slide- coating and careful control 
of protein digestion. The first successful ISH results were obtained 
using slides coated with 1% poly -L- lysine but approximately 30% of 
the sections tested were lost before hybridisation could be completed. 
The chemical silanation method of coating slides described in early 
1987 by Tourte lotte and co- workers proved far superior to 
poly -L- lysine and, provided the slides were used within 8 weeks of 
activating, 100% adhesion of sections was obtained. The quick 
silanation method of 2% aminopropyl triethoxysilane in acetone (Burns 
et al., 1987) was also much more efficient than poly -L- lysine, but 
with the few specimens treated with this method, occasional 
sections were still lost. 
Proteinase K was used to unmask target DNA by partial 
digestion of cellular proteins. A standard concentration of 0.2mg /m1 
was eventually chosen because higher concentrations left islands of 
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separated cells attached to the slide and the morphology of the 
section as a whole was lost. Lower concentrations occasionally 
yielded falsely negative results and also gave more background 
staining. 
Having established a satisfactory method, (see Methods, 
Section 2.331) sections from seven skin lesions, paraffin embedded 
after fixation in formalin or Bouin's solution were examined (Table 
33). While a hyperkeratotic hand wart (specimen 1) gave strong 
positive reactions on many occasions and was used subsequently as a 
positive control, HPV infection in two other skin warts (specimens 2 
and 3) was detected only by the presence of HPV antigen, (vide infra) 
HPV -DNA, or under low stringency suggesting the presence of a 
different type of HPV. The extensive spread of HPV -DNA- 
containing cells in specimen 1 is shown in Fig. 19(a) and at higher 
magnification (b) the density of stain suggests very high copy number. 
With an HPV -16 probe (c), no positive nuclei were observed. By 
contrast, the distribution of positive nuclei in the vulva! wart 
(specimen 7) was patchy (Fig. 20a) and, as noted by Chou et al., 
(1987) preferentially found in the crevices of the epidermis (Fig. 20b). 
HPV antigen in this specimen was confined to the upper layers in the 
crevices (vide infra). 
The method was then applied to paraffin sections of ten 
cervical biopsies, mostly showing moderate to severe dysplasia and 
obvious koilocytosis when examined histologically. Three stained 
positively in a few nuclei with the HPV -16 probe, while one other 
was weakly positive on one occasion and a fifth was weakly positive 
with the HPV -11 probe (Table 34). HPV antigen was not detected in 
any of the seven tissues stained (specimens 9 -13 and 17). Although 
all seven patients had antibodies to HPV -1 and /or HPV -2, only two 
had given a positive reaction in LPA (specimen 11 gave an S.I. of 
2.95 to purified HPV -1 and specimen 17 gave an S.I. of 3.57 to 
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Fig 19 
In situ hybridisation in skin warts : sections of a hyperkeratotic hand 
wart Specimen 1) hybridised with 
a) biotin labelled cloned HPV -1 DNA, showing extensive nature of 
infected cells x 50 
b) biotin labelled cloned HPV -1 DNA showing intranuclear localisation 
of stain within stratum granulosum x 160 






In situ hybridisation in vulvar warts : sections (Specimen 7) hybridised 
with cloned HPV -11 DNA showing 
a) patchy distribution of positive nuclei x 50 
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of HPV -11 or HPV -16 sequences in tissue sections and the LPA result 
with a number of different antigens. The sensitivity of 
biotin -labelling is generally considered to be lower than that of 
radioactively labelled probes (Syrjanen et al., 19871)) and it was felt 
that the method used here was not sensitive enough to allow adequate 
comparison with the results of immunological assays. 
3.2 ISH with Synthetic Oligonucleotide Probes with 
Streptavidin- biotin Amplification 
The three synthetic probes from the E6 region of HPV -1 a, 
HPV -6b and HPV -16, prepared as described in section 1.32 and Fig. 9 
in the Methods were applied to paraffin sections of skin and genital 
wart tissues mounted on silanated slides to assess their usefulness in 
in situ hybridisation reactions. A shorter prehybridisation processing 
was required because of the small size of the probe and, as suggested 
by Lin et al. (1987) the 16 -18 hour hybridisation stage was replaced 
by a 2 hour incubation at 42 °C. The results are presented in Table 
35. Two skin warts which stained strongly with the HPV -1 E6 probe 
(Fig. 21) acted as positive controls for future experiments. Specimen 
1 had already been easily characterised with the cloned HPV -1 probe, 
while specimen 18, which had been cross -cut and was mounted on 
untreated slides, tended to disintegrate to small positive fragments 
with the cloned probe. With the oligoprobe and shorter processing, 
disintegration and loss of section only happened occasionally. HPV 
antigen was detected in both these specimens and also in two of 
three additional skin warts. These were both keratotic forearm 
warts only one of which stained positively with the HPV-1E6 probe. 
This reaction although strong, was not found on subsequent testing, 
suggesting perhaps that only a small focus of infection had occurred 
within this keratotic nodule which had required histological 
confirmation of its warty nature. 
Of four genital warts, three hybridised with the HPV -6bE6 
probe (specimens 7, 22 and 23) and one with HPV -16E6 (specimen 25), 




In situ hybridisation in skin warts : sections 
(Specimen 1) hybridised with 
a) biotinylated HPV -1 E6 oligoprobe 
b) biotinylated HPV -16 E6 oligoprobe 
and of a simple plantar wart (Specimen 
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while a specimen of anal tissue with no histological evidence of 
papilloma infection was negative (specimen 24). Examples of the 
hybridisation reaction in the vulvar wart and an anal wart are shown 
in Fig. 22. Interestingly, specimen 7 had previously been quite 
strongly positive with the HPV -11 Boned probe (see Fig 20), while 
the two anal warts from the same patient (specimens 22 and 23) had 
been negative and weakly positive respectively with the HPV -11 
probe. These results suggest that some cross -hybridisation between 
HPV -6b and HPV -11 had occurred. One sample of vaginal warts 
(specimen 25) from a renal transplant patient, was found to harbour 
HPV -16 sequences detectable with both HPV -16E6 oligoprobe and the 
cloned probe. The patient had had a vulvar carcinoma one year 
earlier in which HPV -16 was detected by Southern blot (Rudlinger et 
al., 1986; see also specimen 27, Table 35). An anal wart taken two 
years after the vaginal wart from the same patient hybridised with 
both HPV -6óE6 and HPV -16E6 oligoprobes (specimen 26). A collage 
of photographs showing sections of specimen 26 hybridised with cloned 
HPV -16, HPV -16E6, HPV -1E6 and no probe is shown in Fig. 23. It 
can be seen that the distribution of positive cells is quite different in 
the HPV -16E6 and the HPV -16 stained sections, but this may reflect 
cutting at different times thus providing sections from different parts 
of the block. 
In a further group of five anogenital lesions, four were 
positive with either HPV -6bE6, cloned HPV -11 or both, results which 
largely agreed with those obtained using cloned HPV -6b and HPV -11 
probes individually. 
Thirteen specimens of cervical lesions were examined using 
HPV oligonucleotide probes (Table 36), including one (specimen 41) 
from the same patient as specimens 25 -27 in Table 35. This 
moderately dysplastic lesion without obvious koilocytosis also contained 
sequences which hybridised to HPV -16E6. Three of the remaining 
twelve lesions also hybridised with HPV -16E6, two of which were 
Fig 22 
In situ hybridisation in genital warts hybridised with biotinylated HPV -6b 
E6 oligoprobe : 
a) Specimen 7, showing scattered well- stained nuclei x 1 
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Fig 23 
In situ hybridisation on sections of an anal wart (Specimen 26) showing 
a no staining, without probe x 50 
b) no staining, with HPV -1 E6 oligoprobe x 50 
c) positive nuclei in small patches of epithelium, in parabasal layers 
with HPV -16 E6 oligoprobe x 50 
d) positive nuclei in one area only, of surface epithelium, with cloned 
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detectable with the cloned HPV -16 also. In addition HPV -6bE6 
sequences were also found in two (specimens 9 and 12). These three 
specimens were all from CIN lesions of moderate severity showing 
koilocytosis. Only one, however, came from a patient whose PBM 
had responded in LPA to a disrupted PV antigen (speciment 17). 
Despite positive S.I. to HPV -16E6 and HPV -18E6 in two patients 
(84732 and 88057), HPV -16/18 sequences were not detected in the 
biopsies. A further specimen from a mild lesion with koilocytosis 
(specimen 36) hybridised with the HPV -6bE6 probe although a weak 
reaction with the HPV -16 cloned probe was also noted. PV antigen 
was not detected in any specimen. The positive reactions with 
HPV -16E6 in specimens 41 and specimen 12 are shown in Fig. 24. 
No correlation could be found between detection of HPV 
sequences and the degree of dysplasia, nor between the presence of 
HPV -DNA in cervical lesions and a responsiveness in the peripheral 
blood of patients to PV antigens of various types. The detection of 
HPV sequences in 5/13 (38.5 %) of lesions with CIN is low and 
suggests that the sensitivity of the hybridisation system is still too 
low. 
3.3 ISH using Synthetic Probes with an Immunogold Detection System 
The recent introduction of a monoclonal anti -biotin antibody 
(Dako Ltd.) coupled with the use of the immunogold- silver staining 
(IGSS) technique developed by Holgate et al., (1983) provided an 
alternative detection system to the biotin -streptavidin -biotinylated 
alkaline phosphatase. A two stage indirect technique using rabbit 
anti -mouse immunoglobulins absorbed to colloidal gold was used and 
bound gold particles were enhanced by the precipitation of silver 
onto the gold to give a black reaction product (Fig.25). 
Two cutaneous warts (Specimens 1 and 18) gave positive 
reactions with this method with HPV -1 E6 oligoprobe and two genital 
warts (Specimens 7 and 23) were positive with HPV -6bE6. Of eight 
"12. ba- 
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Fig 24 
In situ hybridisation on sections of cervical lesions using synthetic 
oligonucleotide probes 
a) Specimen 12 with HPV -16 E6 probe x 125. Showing densely 
stained cells in lower layers and a focus of positive cells in the 
stratum spinosum. 
b) Specimen 12 with HPV -16 E6 probe x 320. Showing isolated 
positive cells at higher magnification. 
c) Specimen 41 with HPV -16 E6 probe x 125. Showing some 
non -specific basal layer staining and a few positive surface cells 
(arrow). 
Fig 25 
Diagrammatic representation of ISH- detection systems used 
a) Method 1: DNA -biotin /streptavidin /biotinylated alkaline phosphatase 
- NBT /BCIP 
b) Method 2: DNA -biotin /anti- biotin /gold- conjugated anti -mouse /silver 
enchancement. 
Biotin - streptavidin - biotinylated alkaline phosphatase detection systen 




Biotin with spacer 
arm 
Hybridised oligonucleotide - 
1-1-1.1)-1 Bound DNA 
- antibiotin- IGSS detection system 
Silver precipitate 
Gold particle 
Rabbit anti -mouse Igs 
Mouse anti- biotin 
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cervical lesions, four gave positive results with HPV16E6 (specimens 
17, 34, 38 and 39, Table 36) only one of which had been recorded 
with streptavidin -biotinylated alkaline phosphatase (specimen 17). All 
other conditions of the assay were the same. While inadequate 
reagents were available to test the anti -biotin and IGSS system 
further, it was felt that in this small series, it showed a greater 
sensitivity and was quicker to perform since the silver enhancement 
stage took approximately 10 minutes compared with 1 -2 hours for the 
NBT /BCIP substrate to develop. Great care had to be taken, 
however, to stop the reaction before auto -catalysis of the silver 
occurred leading to the deposition of a non -specific precipitate. Fig. 
26 shows specimen 39 in which two areas of the biopsy stained well 
with HPV -16E6. Their distribution can be seen in (a) while the 
dense black silver precipitate is more readily visible at higher 
magnifications ((b) and (c)). HPV-6bE6 oligoprobe gave minimal 
staining in one tiny corner of the biopsy (d) and at higher 
magnification, this is apparent as a pale grey deposit. This may 
represent a small focus of infection with a second virus, HPV -6b, or 
it may represent the level of non -specific "grey" background expected 
with this developing reagent. Fig. 27 shows specimen 34, which, like 
specimen 39 was negative with streptavidin -biotinylated alkaline 
phosphatase detection. A long stretch of epithelial cells in the 
granular and spinous layers contained positive nuclei of varying 
intensities. No such reactions were observed with the HPV -6bE6 
probe. 
3.4 ISH on Cryostat Sections 
In the hope that double staining techniques could be 
rlPVAl ̂ pPd linking the detection of HPV -DNA with other cell markers 
such as the presence or absence of Langerhans cells, cryostat sections 
from 26 cervical biopsies and two skin warts were processed using 





ISH of cervical lesions (ON II, k +, specimen 39) hybridised with 
HPV -16 E6 (a, and b) and HPV -6b E6 (c and d) and detected with 




ISH of cervical lesion (with no dysplasia or koilocytosis 
recorded; 
specimen 34) hybridised with HPV -16 E6 oligoprobe and 
detected with 
anti -biotin and IGSS x 125 
Fig 28 
Double staining reactions for HPV- antigen (brown) and HPV -1 DNA 
(blue) using streptavidin - biotinylated alkaline phospatase and NBT /BCIP 
for detection. 
a) Specimen 1 x 16 
b) Collage from basement membrane to stratum corneum x 50. 
(DNA shows as pale nuclei and antigen /antigen + DNA 
nuclei stain densely). 
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different slide coatings. Acetone fixation, while useful for antigen 
preservation, was insufficient to retain cellular integrity during 
subsequent processing for hybridisation. Carnoy's fixative (3 parts 
ethanol : 1 part acetic acid, freshly made) is considered to give the 
best hybridisation efficiency (Haase et al., 1984) but strong 
background staining was frequently observed with the biotinylated 
probes and amplified streptavidin detection system. Preservation of 
sections was more adequately achieved by fixing with 4% 
paraformaldehyde in vanadyl sulphate (Lewis et al., 1987) and 
non -specific staining was reduced using their recommended detergent 
digestion rather than enzymic digestion. However, 4% 
paraformaldehyde in vanadyl sulphate proved unsuitable as a fixative 
for Langerhans cell markers. Further attempts to perform ISH on 
cryostat sections were therefore abandoned. 
3.5 Double Staining 
It was also of interest to link the detection of HPV -DNA 
with PV- specific antigens and it was originally hoped that antisera to 
individual gene products as well as antiserum to the group specific 
capsid antigen might be available. The technique was developed 
using rabbit polyclonal antiserum to disrupted BPV particles and 
biotinylated probes with streptavidin amplification as described in the 
Methods sections 2.34 and 2.35. Nuclei containing antigen stained 
brown and those containing HPV DNA stained bluish, while those 
containing both viral capsid antigen and nucleic acid stained a dense 
brownish -purple. This is shown in Fig. 28 in specimen 1, a typical 
HPV -1 containing wart. The brown nuclei presumably contain large 
amounts of PV particles whose protein coats are undigested by the 
pre -hybridisation conditions and into which the probe has been unable 
to penetrate. The production of viral capsid proteins in the upper 
layers of the epidermis with nucleic acid replication down to the 
parabasal layers is readily seen. 
- 129 - 
Double staining was also achieved with the antibiotin /IGSS 
detection system and in Fig. 29a the grey DNA -containing nuclei 
contrast with brown antigen- containing nuclei again in specimen 1. 
In genital warts such as specimen 7, far less antigen is detected 
although DNA containing cells in the lower layers are obvious 
(Fig. 29 b). Two cervical lesions which had previously been shown to 
contain HPV -16 by at least one method, but which did not contain 
antigen when tested separately, were stained for nucleic acid and 
antigen in the same section. They showed scattered grey nuclei of 
varying intensity containing HPV16 DNA, but only non -specific brown 
stain distributed cytoplasmically in superficial cells, confirming the 
result obtained with separate staining for nucleic acid and capsid 
antigen. 
4. Mice 
4.1 Subcutaneous Implantation of Cervical Biopsies 
The 35 mice which were inoculated subcutaneously with 
small fragments of cervical biopsy tissue all survived well (26 -265 
days, x = 96 + 45 days) with 29 (76 %) surviving more than 2 months. 
Fourteen of the implants could not be seen macroscopically at any 
stage after implantation, while a further 12 were visible for the first 
few weeks but decreased in size as the tissue was broken down. In 
the remaining 12 (6 female and 6 male), the implants were visible, 
without growing any larger, throughout the life of the animal (39 -125 
days), x = 83 + 38 days). Histological examination of five of the 
implants showed no tumours in any although granulation tissue 
resembling a fibroma was observed in one (original biopsy showed no 
dysplasia or koilocytes histologically). A lesion with two small 
nodules and derived from a CIN I K + biopsy which remained in situ 
for 102 days was obtained. Histologically it showed two abortive 
- 129q- 
Fig 29 
Double staining reactions for HPV antigen (brown) and HPV DNA (grey) 
- IGSS detection of oligoprobes using anti -biotin 
a) Specimen 1 
b) Specimen 1 
c) Specimen 7, vulvar warts showing scant antigen. 
.o 
v 
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foci containing stratified squamous epithelium with sloughed 
vacuolated and sometimes degenerate squamous looking cells, 
surrounded by fibrosis. One implant which remained visible for 119 
days was passaged through two further mice for a total of 244 days 
without increase in size. Subsequent passage was unsuccessful and 
no biopsy remained for histology. 
4.2 Implantation of HPV- infected Tissue under the Renal Capsule 
Four cervical biopsies were implanted under the renal 
capsule of female nude mice, but no trace of them was found when 
the animals were killed 43, 93, 107 and 186 days later. 
Human foreskin which had been suspended in mouse grown 
HPV -11 was implanted under the renal capsule of 8 nude mice. Of 
the 7 which survived, four produced no lesions during the 3 -6 months 
that they survived thereafter. The remaining three all produced hard 
white cyst -like lesions, readily visible within 5 -6 weeks of 
implantation (Fig. 30). All three were examined histologically. One 
appeared to be a dermoid cyst possibly of murine origin, while the 
other two showed thickened, papillomatous epidermis. They both 
appeared to be cystic keratinising neoplasms derived from human 
squamous epithelium, with keratin debris being sloughed into the 
centre of the cyst. Koilocytic cells were present (Fig 31). In 
addition, EM examination of negatively stained suspensions from both 
cysts revealed occasional viral particles in each grid square examined 
(Fig. 32). Further foreskin fragments have being suspended in the 
clarified supernate from these cysts and implanted under the renal 
capsule of further nude mice. 
-13Oa- 
Fig 30 
Visible cyst on nude mouse 5 weeks after implantation of human 
foreskin infected with HPV-1 1 under the renal capsule. 
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Fig 31 
Section of papillomatous cyst derived from HPV-1 1 infected human 
foreskin implanted under the renal capsule of a nude mouse (stained 
H + E). 
- 
Fig 32 
Negatively stained HPV particles from papillomatous cyst from nude 
mouse 
Magnification x 70,000 
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DISCUSSION 
Introduction 
The studies reported here confirm that a systemic response to 
epithelial HPV infection can occur, but they demonstrate that the 
response is weak, irregular and type- specific. Discussion of the results 
is divided into five sections. The first section covers the use of 
lymphoproliferation assays (LPA) as a measure of the cell immune 
response to HPV and is followed by a discussion of possible pathways of 
development of this response. The value of tests of systemic antibody 
responses in HPV infections is discussed in Section 3, with the 
suggestion that further investigation of local antibody production would 
be valuable. In Section 4, technical problems associated with in situ 
hybridisation methods are outlined, the production and optimum length 
of synthetically produced probes and labelling of them are discussed. 
The different techniques used in this study are compared, and the value 
of detecting HPV nucleic acid in association with other markers of 
infection or of immunological reaction to HPV is explored. The 
continuing need for an adequate in vitro replication system for HPV is 
discussed in Section 5. 
The final section of this Discussion covers the multi -factorial 
process of tumour development from initiation through promotion in the 
presence of different risk factors to overt progression. 
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1. Lymphocyte Proliferation Assays as a Measure of Systemic 
CMI to HPV 
The use of LPA as an in vitro measure of CMI to different 
viruses is well documented and was first used in the 1970's to study the 
cellular response to skin viruses (Lee and Eisinger, 1976 to HPV; Wilton 
et al. 1972 to HSV) and in this laboratory the technique has been used 
to study exposure and response to CMV in patients with cervical 
Noll, í9Q4; 
dysplasia kANeill and Norval, 1985). 
A valid assay of CMI must be sensitive enough to be assuredly 
positive for a high proportion of known infected individuals.Tn Lee and 
Eisinger's work with purified extracts from pooled warts, most patients 
with skin warts of short duration or with previous infections did respond 
although the mean S.I. was low. Similarly low blastogenic responses 
have been found with other viruses where persistence is common, e.g., 
Hepatitis B surface antigen (Tong et al., 1975) and CMV (Neill & 
Norval, 1985), and indeed patients with warts of more than one year's 
duration responded very poorly with a mean S.I. of only 1.4 in Lee and 
Eisinger's study. In the current investigation, 5/10 (50 %) of a group of 
patients with recalcitrant warts of more than one year's duration 
responded to a glycine extract of purified HPV -2, purified HPV -2 virions 
or both (Table 10) with S.I. ranging from 2.1 to 13.5, and if a single 
antigen at only one concentration is considered, then these ten patients 
gave a mean S.I. of 2.3 + 4.0 (with the high S.D. being due to one very 
high result) to 9}ßg /ml of glycine extracted HPV -2 and a mean S.I. of 
1.3 + 1.1 to 4pg /ml of purified HPV -2. These results confirm the very 
low responses obtained in patients with long- standing warts, but, 
together with the increase in S.I. around the time of cure in two 
healthy laboratory staff with hand warts, suggested that the system was 
robust enough to use to investigate the CMI to HPV in patients 
attending the Colposcopy Clinic. 
While it would have been easier to use a standard dose of 
- 133 - 
antigen, it was found in preliminary experiments that some people 
responded to a higher dose and others to a lower dose. Where PBM 
were limited, one or two concentrations of antigen in the range of 1 -30 
pg /ml were used and where cells were adequate, a wider range of 
concentrations covering four ten -fold dilutions of antigen was used. 
Antigen concentrations of 10 pg /ml and 30iug /ml were used in this 
laboratory in LPA studies with HSV -1 (Vestey et al., 1988ü)while a 
concentration of 6 Jg /ml for HSV -2 was found adequate by Iwasaka et 
al., (1983) in their studies. A standard dose of 1 pg /ml however was 
used by Drummond et al. (1985) in their LPA with BKV antigen and in 
other LPA in their laboratory (Donnenberg et al., 1984). The range of 
antigen concentrations available and tried in the current study therefore 
seems appropriate and no single concentration emerged as optimal. 
Not only was there considerable variation in individual responses 
to different concentrations of antigen, but also in the response to 
different antigens. Of 92 colposcopy patients assayed in the first part 
of this study, 25% responded to at least one papilloma antigen 
preparation derived from BPV, HPV -1 or HPV -2 virions, while one 
patient whose cervical biopsy showed CIN III and koilocytes 
histologically, had an S.I. of 12.7 using CsCl- purified BPV as antigen 
and 14.7 using SDS.ME - disrupted BPV, another (also CIN III but 
without koilocytes) gave an S.I. of 1.3 with the CsCI - purified BPV and 
10.7 with SDS.ME - disrupted BPV. It is perhaps surprising that any 
patient should react to purified virions of BPV, although Lancaster & 
Olson (1982) showed that 2/10 milk samples contained enough BPV 
particles to be detected in the electron microscope. SDS is toxic to 
lymphocytes and in some patients the use of SDS.ME disrupted antigen 
led to cell death, but occasionally as in the two patients mentioned 
above, dilution of the antigenic preparation eliminated this problem and 
revealed a specific response. 
The lymphoproliferative response to non -specific mitogens 
reaches a peak after 3 -5 days in culture, while stimulation due to viral 
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antigens such as HSV and CMV peaks around 5 -6 days (Neill and Norval, 
1985; Vestey et al., 19880). Lee and Eisinger (1976) used a 6 day 
incubation in their papilloma virus assay, but in preliminary experiments 
in this study an 8 day assay was found to yield more positive 
responses (Table 7). This led to standard errors of 10-2.5% between 
quintuplicate wells and in later experiments, a 7 day incubation period 
was used with slight improvements in the standard error. The 
consistency of the response could not be significantly improved by 
feeding the cultures with additional medium at 5 days, (see Results 
Section 1.1), nor by adding IL -2 either on day 0 or day 4 (Results 
Section 1.41). Possibly the variations observed for different 
concentrations and different antigens reflect a borderline response due 
to a limited number of memory T cells in peripheral blood. This could 
explain why some patients with a past history of warts appeared to 
respond on one occasion but not on the next. 
In the colposcopy patients, 91% of those who responded to PV 
antigens had a history of past or present skin warts, mainly on their 
hands and feet. The response was frequently to purified HPV -1 and 
HPV -2 virions and, since the majority of cutaneous warts are associated 
with these types, this result is perhaps not surprising. Nevertheless, 
detergent disruption is considered to reveal group specific epitopes, and 
it had been hoped that a response associated with cervical HPV 
infection might be revealed using this approach. Given that 75% of 
the patients tested remembered having had skin warts in the past, it 
would have been difficult to differentiate responses to cervical and 
cutaneous HPV infection and interestingly, the only three people who 
responded to antigens prepared by disruption in the absence of a 
response to purified antigen all gave a history of current wart infection 
(two with condylomata acuminata and one with a hand wart; cervical 
histology CIN III K +, no dysplasia past K+ and CIN III K- respectively). 
It can be concluded that the lymphoproliferative responses detected here 
using virion derived antigens reflect skin wart infection rather than an 
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association of HPV with CIN. 
It is evident therefore that an LPA to study the association 
between cervical dysplasia and immune responsiveness to HPV requires 
typespecific antigens. Yet virus production in CIN lesions is very low 
and often undetectable. Not only would it be difficut to prepare 
sufficient amounts of viral antigen for satisfactory in vitro assays, but 
such antigens might be unlikely to illicit an immune response. On the 
other hand, early proteins from the E6 and E7 ORFs have been detected 
in both cervical carcinoma tissue and cultured cervical carcinoma cells 
(see Introduction, Section 2.32). Possibly with monoclonal antibodies 
sufficient quantities of E6 or E7 could be purified from bulk cultures of 
cervical cells, but currently it is simpler to produce fusion proteins by 
the transcription and translation of fragments of PV DNA containing the 
appropriate ORFs attached to an expression vector in competent 
bacterial cells, or to produce synthetic peptides from the know sequence 
data. 
It was possible to test a few specimens with fusion proteins of 
L 1, L2 and E2 of HPV -1 and to L2 of HPV -2. Because E2 proteins 
have not been detected in warts, it was thought that this fusion protein 
would act as a control for the later antigens particularly since 
contaminating ß- galactosidase sequences were still present (Doorbar, 
personal communication). While only three positive responses out of 15 
specimens from 9 patients were obtained, some agreement with the wart 
history given was found. One patient responding to HPV -L1 had had a 
plantar wart 10 years previously, one responding to HPV -2 L2 had long 
standing mosaic plantar warts while the highest response (S.I. = 29.0 to 
HPV -2 L2, see Table 17) came from a colposcopy patient with a past 
history of warts and a current thumb wart. More highly purified 
proteins removing the problems of p- galactosidase contamination and 
residual SDS toxicity might therefore be suitable for specific LPA 
testing against those HPV types which produce a complete replicative 
cycle, and would be worth trying particularly in patients with current 
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active lesions or in those whose warts had recently resolved. The 
recent findings by Stanley et al. (1988, personal communication) that a 
monoclonal antibody against HPV -16 L1 stained nuclei of koilocytes in 
cervical lesions containing HPV -16 would suggest that an HPV -16 L1 
fusion protein might be worth trying in colposcopy patients. 
Fusion proteins of E4 and E6 of HPV -16 and of E6 of HPV -18 
were used in the study reported here. Eight positive responses to 
highly purified E6 proteins were recorded in 48 colposcopy patients and 
none in a group of 15 age matched healthy female members of staff 
(Fig 13), but the extent of proliferation was slight and of the five 
positives who were also tested with control antigen, only two gave S.I. 
more than twice that obtained with control antigen alone. While 
protein products of E6 have been found in cervical tumours and in 
transformed cervical cell lines (see Introduction, Section 2.32), they are 
not always detected (Lehn et al., 1985; Pater and Pater, 1988) and the 
E6 polypeptide may be expressed only at very low levels (Banks et al., 
1987). Recent work suggests that the E7 protein is abundant although 
it has a half -life of about 1 hour (Smotkin and Wettstein, 1987). 
Nevertheless its abundance suggests it may be a better target for 
immune responsiveness and it would be interesting to test E7 fusion 
proteins in a similar assay. 
The protein product of E4 is expressed in large quantities in 
HPV -1 warts (Croissant et al., 1985; Doorbar et al., 1986) but its 
significance in other HPV infections is unknown. Although an E4 
protein of MW 10,000 was reported in CaSki cells (Seedorf et al., 1987), 
little evidence was found in the current study for immune reaction to 
HPV -16 E4. Slight stimulation occurred at 3 or 5 days of culture in 
5/25 colposcopy patients and 1/15 controls when the control 
'- galactosidase fusion protein was used as antigen (Fig 14 and Table 
20), but lymphoproliferative responses to the specific HPV -16 E4 
sequence were not recorded after 7 days in culture. 
Although the positive responses obtained in this study with fusion 
- 137 - 
proteins were weak and few, they are encouraging enough to suggest 
that HPV infection does produce antigens to which T cells can respond. 
By using only highly purified fusion proteins from the most appropriate 
ORFs, (such as L1 or L2 for productive infections, E4 for HPV -1 
infections or E7 for HPV -16 containing lesions), more positive responses 
might be obtained. 
It is of course possible that fusion proteins do not have the 
correct conformation to replace natural HPV determinants in in vitro 
tests and synthetic peptides from within HPV -16 L1 and E6, predicted 
on the basis of structural similarities with previously defined 
T- lymphocyte determinants (Rothbard and Taylor, 1988) have been tried 
in LPA. Women with CIN I -III and healthy donors having no apparent 
HPV- associated disease have responded, with individuals of different 
HLA -DR types appearing to respond to different regions of HPV -16 L1, 
depending on the peptide's ability to bind to a particular MHC allele 
(Dr. George Strang, personal communication). This approach, based on 
related studies to investigate CMI to influenza virus (Townsend et al., 
1986) is well worthy of further study. 
Since the majority of T cells interact with altered cell surfaces, 
the response of T cells to potentially HPV- infected cells was studied 
using a glycine extract of cervical tissue in 18 colposcopy patients 
(Table 17). Only one patient responded by giving an S.I. to an extract 
prepared from a biopsy of abnormal tissue which was between 3 and 4 
times higher than the S.I. obtained with an extract of normal cervical 
tissue. It would have been useful to have known the HPV status 
within all biopsies used in this part of the study, but this was not 
possible. It would also have been valuable to have obtained normal 
and abnormal pieces of tissue in all cases to eliminate reactions to 
other foreign antigens in the tissue. Paired biopsies were however only 
available from three patients. Nevertheless it would be interesting to 
extend these investigations to study extracts of cervical tissue with and 
without HPV infection from the same patient. It is of note that the 
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patient who gave a positive response also responded to HPV -16 and 
HPV -18 E6 fusion proteins in LPA six months later and indeed one year 
later, clinical examination showed no dysplasia but revealed 
inflammation and infection with Candida in the cervix. One might 
speculate that a CMI response to infected cervical cells led to the 
release of early antigens of HPV -16, and the development of responding 
T cells, detectable in vitro at a later date. Adequate destruction of 
the infected cells would explain the lack of dysplasia at the most 
recent visit. However the presence of Candida infection suggests 
careful follow -up is required, in case the local immunosuppression 
associated with Candida infections (Witkin, 1987) should allow HPV 
infection to take hold once more. 
A complex network of co- operative interactions mediated by 
secreted molecules is involved in any cell- mediated immune response 
and includes interleukins, helper and suppressor factors and interferons. 
Interleukin -1, a potent chemoattractant for T cells, is secreted by 
macrophages or dendritic cells. It triggers activation and proliferation 
of not only T and B cells but also other cells such as osteoblasts and 
fibroblasts, resulting in wide -ranging effects in vivo including fever and 
wound -healing. In in vitro assays such as the LPA used here where T 
cells are already in close contact its effects are less likely to be 
observed. On the other hand, IL -2 is essential for the continued 
proliferation of activated T cells, with CD4+ activated by IL -1 being 
the major source of IL -2, but with each effector class of T cell being 
capable of clonal expansion in its presence. (Watson et al., 1983). 
Certainly the addition of IL -2 to PBM in the absence of antigen 
produced stimulation with S.I.ab. 2 in 32/68 people tested showing that 
many had activated T lymphocytes already present - in peripheral blood. 
When compared with the background IL -2 response, however, specific 
stimulation due to HPV -1 or HPV -2 antigens was noted in 11 specimens 
(Table 22) and only in two of these was a positive S.I. to HPV obtained 
without added IL -2. Both of these specimens came from patients with 
current warts : one from a colposcopy patient with a thumb wart and 
the other from a patient with recalcitrant mosaic warts. Interestingly, 
resolution did not occur in the latter during the six months of 
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observation of the trial of inosine pranobex. The time of resolution 
of the wart in the colposcopy patient is unknown. 
In contrast, fifteen other specimens which gave a positive S.I. in 
the presence of HPV antigen were not significantly boosted by the 
addition of IL -2. Nevertheless these results show that in some pople 
(9/68, 13% in this study), T cells can be specifically activated by the 
presentation of HPV -1 or HPV -2 capsid antigens and that proliferation 
can be amplified to significant levels by the addition of IL -2. In the 
remaining people, despite a past history of skin warts from most of 
them, insufficient T cells must have been activated for IL -2 to be 
effective. It was therefore considered that alterations in APC might 
yield more positive responses. 
An alternative source of APC in the form of autologous cervical 
epithelial cells disaggregated from biopsy tissue by collagenase-dispase 
treatment, was included (Table 24), but this was largely unsuccessful in 
the 13 specimens in which it was tried. Certainly in a study of the 
presentation of HSV antigens to lymphocytes, human epidermal cells 
separated from the dermis by suction blister and dissociated with trypsin 
were more potent than PBM in inducing lymphoproliferative responses to 
HSV -1 antigens in LPA using PBM (Braathen and Thorsby, 1983; Bagot 
et al., 1985; Vestey et al., 1988b). In the more recent papers, the 
HSV -1 antigen was UV inactivated and epidermal cells were incubated in 
its presence before being added as stimulator cells to PBM (Bagot et 
al., 1985) or the non -adherent PBM population (Vestey et al., 1988b). 
Prior incubation of the cervical epithelial cells in culture medium 
containing HPV antigens might have been a useful addition to the 
method used here. Similarly, the use of epidermal cells from suction 
blisters and antigens from cutaneous HPV types in assessing the 
lymphoproliferative capacity of PBM in patients with present or recently 
resolved skin warts would be well worth trying. The results obtained 
in such a study would provide a better basis for examining the response 
to proteins from HPV types associated with cervical dysplasia. 
- 140 - 
In HSV infection of the skin, the virus becomes latent in sensory 
neurones in the area of local innervation of the skin in which the 
primary infection occurred. Reactivation of the latent virus can lead 
to fresh infection of epithelial cells (recurrence) with the development 
of a clinical lesion (recrudescence) in some cases (Wildy et al., 1982). 
Recurrent lesions in guinea pigs were shown by Iwasaka et al. (1983) to 
be associated with the induction of suppressor cells and soluble 
suppressor factors. The suppressor factors could be detected in the 
supernates of LPA and were effective in inhibiting both the 
lymphoproliferative response to HSV -stimulated immune cells and 
Con A- stimulated normal lymphoid cells. In the present study it was 
only possible to test on one occasion the effect of LPA supernates 
collected on days 4, 5 and 7 of the LPA on autologous PBM exposed to 
HPV antigens or Con A. No response was obtained. However 
Iwasaka et al. (1983) added supernate at a final concentration of 50% in 
their test while in the present study it was added at a much lower 
concentration (5 %). It would be well worth repeating this assay with 
much higher concentrations of supernate, but the logistics of obtaining 
large enough volumes of blood on at least two occasions in close 
succession from people who had had previous positive results were 
daunting. 
The effect on the Con A response of adding papilloma antigen 
at the same time as Con A was assessed in 13 specimens (Table 25 and 
Fig R5). In 4, the S.I. with Con A was more than doubled by the 
addition of HPV -16 E6 when analysed at 7 days. This was thought to 
represent a slowing -up of the Con A response due to an inhibitory 
effect in the presence of PV antigen and certainly when the effect was 
analysed at earlier time points, the S.I. to Con A + HPV -16 E6 or 
HPV -2 at 3 days was generally less than the response to Con A above. 
Nevertheless, the peak response to Con A was not altered. Little 
effect was found on adding HSV and HPV antigens together (Fig 16). 
It seems likely that the time scale of such experiments was too short. 
It would have been better to have allowed a potential suppressor 
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response to develop and then added cells from the first experiment to 
fresh autologous PBM in the presence of antigen. Such a method was 
used to detect suppressor cells induced by lepromin in patients with 
lepromatous leprosy (Mehra et al., 1980) and by BCG antigen in healthy 
individuals vaccinated with BCG ( Mustafa and Godal, 1985). In the 
latter study, the induced suppressor cells appeared to inhibit BCG 
induced IL -2 receptor expression on the fresh T cells. As with 
supernates, such experiments with HPV would require careful planning 
and willing volunteers with consistent positive responses. 
The virus -specific suppression of immunity to HSV -2, resulting in 
clinical recrudescences has been suggested to be CD8+ mediated 
(Sheridan et al., 1982) and to involve the production of suppressor 
factors (Sheridan et al., 1985, 1987). The suppressor factor interfered 
with IFN and IL -2- mediated NK cell activity and while the 
prostaglandin, PGE was necessary, it was insufficient to account for this 
activity (Sheridan et al., 1985). It has recently been shown in this 
laboratory that the removal of CD8+ lymphcytes by panning increased 
the S.I. obtained in LPA during recrudescence of HSV -1 facial lesions ( 
Vestey et al., 1988a). In the three specimens on which this was tried 
in the current study, no increase in S.I. was observed by the removal of 
CD8+ cells although the Con A response was markedly reduced at 3 
days by CD8+ depletion and potentially restored by their replacement. 
However panning is only partially successful in removing CD8+ cells. 
In 9 subjects tested in this laboratory (Dr. James Vestey, personal 
communication), panning reduced the CD8+ percentage in PBM from an 
average of 22% to 14% while reconstitution in the ratio of 3:10 
increased the percentage to 41%. Cell sorting by EPICS analysis was 
found to be considerably more effective, reducing the CD8+ population 
to appL oxithately 2 %. With such efficient depletion methods it would 
be worth repeating these experiments using different HPV antigens. 
Flow cytometry was also used to investigate the type of T cell 
present at the end of lymphocyte culture in the presence of HPV 
- 142 - 
antigens (Results, Section 1.44). The method developed included 
staining the cells in the plates in which they had been cultured. This 
was not only straightforward and practical to perform, but it was more 
economical with cells, requiring 2 x 105 cells per well compared with 
5 x 105 cells per tube. However, it became apparent that the 
cultivated cells were particularly fragile. Unless they were analysed 
immediately after staining, they tended to become disrupted and to lose 
attached stain. This fragility has been confirmed in further 
experiments in this laboratory (Mr. W. Neill, personal communication). 
The larger volumes of buffer used to wash the cells when they are 
stained in 3 x f" tubes and the ease with which they can be 
resuspended might allow more consistent results to be obtained at the 
end of the culture period, more than compensating for the advantage of 
retaining the cells in the culture plate and the commensurate savings in 
reagents. 
In two specimens there was a suggestion that CD8+ cells were 
increased in the first few days of the LPA (Table 27). If this could 
be verified, it might suggest that the activation of a small number of 
memory T cells would generate an early CD8+ response with the release 
of a suppressor factor inhibiting further proliferation without adequate 
proliferation of the CD8+ cells for stimulation to be observed. In 
studies using PBM from patients with recrudescent genital HSV lesions, 
Sheridan et al. (1987) showed that an inhibitor of lymphokine activity 
was produced within 24 hours of culture in the presence of 
UV- inactivated HSV, either as a product of activated CD8+ cells (OKT8 
and OKIa markers) in the presence of monocytes (OKMI marker) or of a 
single cell expressing all three surface markers. Lehner et al., (1982) 
also found that in Rhesus monkeys immunised with streptococcal antigens, 
suppressor cells reached a peak at 2 days with maximal suppressor factor 
secretion on day 3, while helper cells peaked at 4 days. In addition, Fox 
et al. (19864 noted that when CD8+ cells were cultured in PWM 
for 6 days in the presence of IL -2, they exhibited very little 
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proliferation despite secreting suppressor factor. Additional suppressor 
cell growth factors in addition to IL -2 from cells of CD4+ lineage were 
required for proliferation. The kinetic relationship of immunoregulatory 
circuits in in vitro tests, while different for different antigens, needs 
further exploration and this will be particularly difficult with HPV 
antigens where reactions are weak and difficult to elicit. 
2. Possible Pathways of CMI Development in HPV Infection (see Fig 33) 
T cell responses are triggered only if antigen is presented 
properly by APC. For example, in rabies infection, the virus may hide 
in neuronal cells for considerable periods before the cells are destroyed, 
and antigen is released and then taken up by APC. In the intervening 
period, no CMI responses are detectable. (Zinkernagel et al., 1985). 
In HPV infections, there is increasing evidence that in common warts, in 
non -regressing cutaneous warts of various types and in HPV and 
CIN +HPV lesions of the cervix, Langerhans cells are reduced in numbers 
and in morphology (see Introduction, Section 4.322), suggesting that their 
ability to act as APC will be diminished. A lack of presentation of 
antigen would prevent most of the cascade of reactions dependent on 
IL-1 production by APC and IL -2 production by helper T cells (reaction 
1, Fig 33). 
Nevertheless some stimulation of Th (reaction 2) does frequently 
occur in HPV infections since the induction of B cells is usually 
dependent on T cell help (except for the rare T- independent antigens) 
and specific HPV antibodies are detected (reaction 4) in approximately 
50% of any group tested (see Introduction, Section 4.1). Furthermore 
massive lymphocyte infiltration with spontaneous resolution of whole 
crops of HPV -3 induced plane warts would support the occurrence of 
reactions 5 and 7, and 6 and 8. Cytotoxic T cell responses could 
explain the speed with which the resolution of plane warts occurs. 
Indeed the satellite cell necrosis observed by Iwatsuki et al. (1986) in 
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Fig. 33 Possible pathways of CMI development in HPV infection 
Abbreviations 
LC = Langerhans cell TDH = Delayed hypersensitivity T cell 
Th = Helper T Lymphocyte B = B lymphocyte 
Is = Suppressor T lymphocyte MI = Macrophage 
Tc = Cytotoxic T lymphocyte Ker = Keratinocyte 
NK = Natural killer cell 
PC = plasma cell 
= MHC Class I 
11 = MHC Class II 
Y = antibody 
= secretory IgA 
IL -1; IL -2 = interleukins 1 and 2 
ó -IFN = i- interferon 
PG = Prostaglandin, type E2 
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such regression is the hallmark of a cytotoxic reaction, although these 
workers concluded that, since the cellular infiltrates contained cells 
other than Ts cells, regression was a complex phenomenon with 
interleukins and IFN modulating a DH -like reaction, characterised by the 
associated inflammation during regression. The persistence for several 
years of TDH to HPV has been shown by in vivo skin testing of several 
groups of patients (Viac et al., 1977a,bcnd 1975) with 75% of patients 
with past warts, 56% of patients with present warts and only 7% of 
control with no wart history showing positive reactions (Thivolet et al., 
1977). 
In order to detect specific Tc reactions in vitro, it may be 
necessary to amplify them by clonal expansion in a mixed 
lymphocyte /target cell interaction using mitomycin -C treated infected 
cells in culture with autologous PBM for several days (Roitt et al., 
1985) followed by an isotope release assay to show Tc. It would have 
been interesting to have tried this approach in colposcopy patients in 
whom adequate biopsies and matching blood samples were available. 
This kind of approach was taken by Tagami et al. (1985) when they 
added PBM to one -week old explants of wart -derived epidermal cells. 
Affinity for infected cells but not for normal cells was shown by 
autologous PBM and subtyping of the cells involved was said to be 
underway, with Ts (CD8 +) cells outnumbering Th (CD4 +). 
When HPV infects the basal cell of the epidermis it does so in 
tiny quantities, causes no CPE in these cells and, with limited 
transcription even in suprabasal layers, it may appear in vivo as weakly 
antigenic. Exposure of the immune system to such small doses of 
weak antigens produces tolerance, maintained by the action of 
suppressor cells which are triggered at a much lower antigen 
conrPntration than helper T cells (Roitt et al., 1985). The need to 
develop suppressor cellular circuits to regulate the immune response is 
not necessary for acute cytopathic viruses where the immune response 
fades away after elimination of viral antigen (Zinkernagel et al., 1985), 
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but HPV does not fit into the category of an acute cytopathic virus. 
Within the suppressor circuit, some Ts may become memory cells 
capable of being reactivated following subsequent contact with antigen 
and maintaining a tolerised state. The finding of CD8+ cells in 
spontaneously regressing plane warts and described above does not 
support the concept of Ts memory cells subsequently suppressing the 
response to future contact with HPV -3 since re- infection with HPV -3 
after such regression is unknown (Tagami et al., 1985). Rather, it 
supports the presence of cytotoxic cells destroying infected cells with 
the release of viral antigen stimulating a peripheral antibody response 
which offers protection from subsequent attack by the same virus. 
Although other HPV types do not appear to act in such a dramatic way 
as HPV -3, Becker et al. (1985) have shown that oral papillomas contain 
a local increase of CD8+ cells to reduce the T4:T8 ratio to 1 together 
with an increase in macrophage numbers. 
The administration of the immunosuppressive drug, cyclosporin A, 
lowers the threshold for induction of tolerance? particularly when given 
at the same time as antigen, and blocks the cell sequences normally 
triggered by antigen (Roitt et al., 1985). While it suppresses IL -1, 
IL -2 and y- IFN production, Ts production, by an IL -2 independent 
pathway is spared (Bennett and Norman, 1986). It is easy to imagine, 
then, that with continuing treatment with cyclosporin A and exposure to 
ubiquitous HPVs, renal transplant patients will become more tolerant and 
this can explain the more rapid development of HPV lesions in them. 
In addition, steroid treatment with or without azathioprine exert an 
effect on TDH cells further increasing immunosuppression. (ten Berge 
et al., 1981). 
Suppressor T cells can be assayed by the capacity to inhibit 
primary lymphocyte transformation by lectins (Roitt et al., 1985). This 
was tried in the current study, but although a shift in the Con A 
response was obtained in the presence of HPV antigens in laboratory 
personnel whose lymphocytes had proliferated in the presence of such 
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antigens, a true inhibition was not observed. This may be a reflection 
on the sensitivity of the system and is worth repeating with blood from 
people giving good stimulation with skin HPV antigens and having a 
history of warts in the recent past. 
Both suppressor and cytotoxic cells are currently detected by the 
same marker (CD8 +) and this has led to controversy over the very 
existence of antigen specific suppressor cells. Nevertheless, the 
phenomenon of suppression undoubtedly exists and Batchelor et al., 
(1989) have recently suggested that the functional phenotype of CD8+ 
cells was dependent on the idiotype of the presenting T -cell receptor. 
Martz and Howell (1989) have recently hypothesised, furthermore, that 
too much importance has been attached to the lytic function of 
cytotoxic cells and they suggest that Tc are the specific viral control 
cells requiring direct contact with infected cells and capable of halting 
viral replication prelytically or by lymphokines in the absence of 
cytolysis. 
Natural immunity in the form of NK activity (reaction 10, Fig 
33) in PBM against specific HPV- containing target cells has been shown 
to occur (Maleje i k et al., 1987), both in patients with Bowenoid 
papulosis and anogenital carcinoma, and in EV patients with skin 
tumours (Malejc._4.k et al., 1989). NK cells are effectors of natural 
immunity in the absence of prior stimulation and they play a role in 
regulating tumour development as well as in combatting virus -infected 
cells. It is therefore not surprising to find increased NK activity 
against HPV infected cells and it would be interesting to extend these 
observations for example, to patients with common warts or to renal 
transplant recipients with unusual HPV lesions. 
Additional factors have to be considered in the progression of 
the response to HPV infection. It is generally accepted that virus 
enters the skin through a wound, yet in the healing of that wound, 
immune cells are active and may influence the response to the virus. 
Th cells are found in the dermis in the early stages after damage, and 
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LC in the epidermis are activated by both intrinsic (serum proteins) and 
extrinsic (bacteria, viruses) factors (Morhenn, 1988). 
The production of IL -1 by LC leads to proliferation of dermal 
fibroblasts, the release of somatomedin C and the resultant mitosis of 
keratinocytes to effect a repair. The activated T cells produce ä -IFN 
which can act on keratinocytes to induce MHC Class II expression 
(mainly HLA -DR) enabling the keratinocytes to act as APC themselves 
and augmenting the local immune response (Morhenn and Nickoloff, 
1987; see reaction 11 Fig 33 ). However, y-IFN has the opposing 
property of augmenting the levels of prostaglandin E2 (PGE2; see 
reaction 9 Fig 33) which can switch off IL -2 production (Nickoloff 
et al., 1986). An increase in prostaglandins could therefore diminish 
the immune responsiveness to HPV infecting at the time of wound 
repair. Such an action could explain why recalcitrant warts are so 
common on the hands which we subject to frequent minor injuries and 
might be particularly HPV cervix where 
repeated epidermal damage and repair can occur. In addition, the 
inhibitory effect of prostaglandins could be augmented cyclically in 
women by hormones acting like gluco -corticosteroids which similarly 
suppress regulatory proteins such as IL -1 and IL -2 (Gifford and Flick, 
1987). Both prostaglandins and glucocorticoids can also inhibit tumour 
necrosis factor (TNF), an important effector molecule in the 
non -specific tumoricidal activity of activated macrophages. In view of 
the recent evidence that HPV -16 transcription and transformation can 
be increased by dexamethasone (Gloss et al., 1987; Pater and Pater, 
1988) it would appear likely that hormonal influences could both 
positively promote HPV infection and at the same time switch off an 
immune response to it. 
The cellular nature of CMI can be more definitively analysed 
immunocytochemically with the wide range of monoclonal antibodies now 
available and indeed, in a study in Cambridge of HPV infection and 
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dysplasia, a panel of 23 different monoclonals of immunological and 
viral markers has been employed (Dr. Margaret Stanley, personal 
communication). Nevertheless, such studies need to be accompanied by 
functional analysis of the involved purified cell populations, but this 
presents almost insurmountable logistical problems, ethically and in 
terms of the amount of material available from an individual patient. 
The result is the current plethora of data which cannot yet be put 
together in a cohesive way. Figure 33 is an attempt to show the 
reactions described above which might be involved in the response to 
HPV infection. 
Tumours which develop as a result of HPV arise because 
infected cells have escaped the destructive mechanisms of 
immunological controls and been encouraged to grow by tolerance, by 
suppression of T and B responses, by soluble factors and in some cases 
by genetic influences where there is a basic failure to induce an 
effector T cell response of any kind. 
The defects of non -specific CMI noted in many patients with 
warts through weaker intradermal tuberculin tests (Brodersen et al., 
1974), depressed LPA responses to mitogens (Morison, 1975c) and 
decreased T cells levels (Chretien et al., 1978) have prompted the use 
of immunostimulants in their treatment. Regression of warts after 
treatment with immune adjuvatrts such as DNCB and vaccination with 
autogenous vaccine have both been reported (Chardonnet et al., 1985). 
For example, repeated intradermal innoculation of formalin- inactivated 
HPV particles led to the acquisition of specific cellular responsiveness 
and an accelerated regression in 10/22 patients with multiple or 
recurring warts (Viac et al., 1977a). Interferon has been successfully 
used in the treatment of various types of warts. Topical IFN -oc was 
shown to be effective for condylomata (Scott and Csonka, 1979) and 
systemic IFN -ot can reduce the growth rate of laryngeal papillomas 
(Steinberg and Abramson, 1985). 
More recently, inosine pranobex has been used as an 
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immunopotentiating agent in the treatment of genital warts. Two 
French reports suggested that inosine pranobex was remarkably effective 
in treating vaginal and cervical condylomata (Malgouyat, 1983) 
particularly when used in conjunction with CO2 laser therapy (Sadoul 
and Beuret, 1984) and a more recent report suggested it was especially 
effective in genital warts of long duration (Mohanty and Scott, 1986). 
The French trials, however, were not controlled trials and long -term 
treatment was required. The data is not yet analysed from the on- 
going double -blind placebo- controlled study of the use of inosine 
pranobex ( "Imunovir ") being carried out in the Department of 
Dermatology here in patients with recalcitrant common warts. 
Nevertheless, in the group of 10 patients on whom LPA was carried 
out, 3 out of 5 of the treated group were cured within 3 months 
whereas none of the warts in the placebo group had resolved, although 
two showed slight improvement. However, by 7 months after the 
commencement of treatment, 4 patients who had received the active 
compound and 3 who had received placebo, were cured. It will be 
interesting to see if the early improvement with "Imunovir" is reflected 
throughout the trial group. A high regression rate in the treated group 
would support the concept that, in many cases of HPV infection, the 
cells of the immune system are primed, but not adequately and the 
cascade of subsequent events is not generally triggered, but when the 
response is amplified by immunotherapy, it can be effective in bringing 
about resolution. 
3. Humoral Responses to HPV Antigens 
Early studies showed that antibody could be detected in 25 -50% 
of people with current or past warts with higher percentages of 
positives (67 -100 %) when people with regressing lesions were considered 
(see Introduction; Section 4.1). It was expected that recent advances 
with more sensitive techniques such as ELISA or Western blotting, 
coupled with the use of type specific antigens would life this figure 
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much higher. Nevertheless, Pfister and zur Hausen (1978) found only 
50% of youngsters and 45 -55% of adults with cutaneous warts, 53% of 
patients with genital warts and 40% of patients with various 
carcinomas to have antibodies to HPV -1 using ELISA and RIA tests; 
Pyrhonen et al. (1980) found 44% of patients with common warts to 
have 1 gG antibodies and 71% to have 1gM both measured by ELISA; 
Kienzler et al. (1983) found only 39% of patients with myrmecia to 
have antibodies to HPV -1, and Li et al. (1987ç)found 60% of women 
attending a colposcoy clinic to have antibodies to HPV -6b L1 fusion 
protein by Western blotting. 
In the current study too, an approximate 50% positivity rate was 
found in each group with SDS.ME - disrupted HPV antigens. Overall, 
51-1% of colposcopy patients tested had antibodies to HPV -1, HPV - 
2 or both and within each grade of dysplasia, approximately 50% of 
patients had antibodies irrespective of whether koilocytes were present 
or not. This finding, supported by a history of skin warts in over 70% 
of those patients with positive ELISA results suggests a response to an 
HPV other than that producing the cervical lesion and supports the 
concept that a type- specific reaction to a skin wart infection is being 
detected in these patients. 
While disruption of virions by SDS.ME is thought to reveal a 
group -specific antigen to which animal antisera with cross -reactivity can 
be prepared (Jenson et al., 1980), it is possible that in vivo these 
internal common antigens may not be exposed to the immune system. 
That the ELISA described here does indeed detect type- specific antigens 
is shown by the fact that some patients reacted with HPV -2 and not 
with HPV -1 (Table 30). The 64 patients who had antibodies to both 
HPV -1 and HPV -2 had probably had infections caused by both viral 
types, although some degree of cross- reactivity due to the use of 
disrupted particules may be a contributory factor. No cross -reactivity, 
however, was apparent with disrupted BPV. 55 patients gave negligible 
absorbancies (< 0.13) with disrupted BPV used at similar concentrations 
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to the HPV -1 and HPV -2 antigens where absorbancies ranged from 0.23 
to 1.21 for HPV -1 and from 0.24 to 0.56 for HPV -2. These variations 
in absorbancies may reflect differences in exposure to antigen. In 
HPV -1 lesions, much more virus is produced and, since resolution is 
often accompanied by haemorrhage and thrombosis into the substance of 
the wart (Bunney, 1982), it is assumed that antigen is released with 
subsequent development of antibody. HPV -2 lesions produce much less 
virus as determined by EM examination and rarely show such impressive 
regression. Exposure to BPV wóuld be much less. 
These results are at variance with the results reported by Baird 
(1983) using disrupted BPV -2 particles in a similar indirect ELISA. 
Baird reported higher antibody levels as measured by higher absorbancies 
in the sera of more than 90% of patients with anogenital warts or 
invasive cancinoma and in more than 60% of patients with CIN. The 
comparison was made with the absorbancies of sera from a group of 
children and from a group of symptomless adult females. However, 
even in his cancer group who showed the highest levels of antibody the 
mean absorbance was just over 0.2 and it is questionable whether such 
small differences and low absorbancies can be considered significant. 
A similar study was carried out by Beiss et al. (1987) in an effort to 
extend Baird's work. 38% of women with flat condylomas or CIN were 
shown to have antibodies to disrupted BPV -2 when compared to subjects 
with no history of genital lesions or abnormal cervical smears. 
However in this study the cut -off for positivity was only one standard 
deviation above the mean absorbance of the control group. Had the 
cut -off been set even at 2SD above the mean, only 18% of the patients 
would have been positive. It seems unlikely that the detection of a 
reaction to genus- specific antigens not exposed on the virion surface 
should have much bearing on the presence of cervical HPV lesions 
per se, but rather reflect the ability to mount an antibody response to 
the normally hidden common antigens of any HPV type. This suggests 
that processing of HPV perhaps with lysosomal degradation must 
occasionally occur. 
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ELISA systems can be amplified by increasing the number of 
layers applied. For example, the enzyme- linked second antibody can 
be replaced by a biotinylated antibody and binding of this to the 
primary antibody- antigen amplified by enzyme linked streptavidin or 
even further with streptavidin- biotin bridges. Since streptavidin can 
bind four biotin molecules, this method allows three -fold amplification. 
It is perhaps naive however to expect that by increasing the 
sensitivity of the test, higher detection rates of antibody to HPV 
antigens will be found. If the cellular responses described in the 
previous section are valid for HPV, then there will be many cases of 
infection in which the host response is cut short and a detectable B 
cell response will not follow. 
Most of the ELISAs carried out in the current study used virion 
derived HPV antigens. Indeed the few attempts to use fusion proteins 
were wholly unsuccessful and other workers have also found problems 
with the method (L. Gissmann; L. Banks, personal communications). It 
is likely that the fusion proteins from HPV -1 and HPV -2 (HPV -1 L1, L2 
and E2 and HPV -2 L2) were not sufficiently pure to give specific 
results. Denison and colleagues (1988) noted that extensive 
preabsorption of sera with large amounts of bacterial lysate was 
necessary to overcome the problem of antibodies directed against E.coli 
proteins. Although the HPV -16 and HPV -18 E6 fusion proteins 
provided here were highly purified and devoid of contaminating 
sequences, too little was available to develop a reproducible assay. 
Immunoblotting systems using filter -bound HPV fusion proteins 
reacted with serum specimens and detected by a variety of systems 
comparable to those used for ELISA may prove more useful. Already, 
antibodies to the late gene products of HPV -6b have been detected in 
patients with genital warts and to early gene products occasionally (Li 
et al., 1987rr.Jenison et al., 1988; see Introduction, Section 4.1). Work 
in this area is progressing in several centres, but care will be required 
in interpreting the data obtained since the conformation of 
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immunoreactive epitopes may be destroyed in Western blots. In 
addition, very careful definition of the particular fusion proteins used 
will be required if responses to type specific and genus specific epitopes 
are to be distinguished. 
While the systemic humoral response may only be detected or 
even activated in approximately 50% of infected people, the local 
antibody response particularly to HPVs infecting mucocutaneous sites 
may be more relevant. Most B lymphocytes at mucosal surfaces are 
dedicated to IgA synthesis, and much IgA in the mucosa exists in 
polymeric form to protect it from proteolytic enzymes (Underdown and 
Schiff, 1986). To transport the IgA from the site of synthesis to the 
mucosal lumen requires the synthesis by epithelial cells of a 70,000 MW 
transmembrane glycoprotein termed secretory component, which binds to 
the IgA molecule almost irreversibly and then acts as a shuttle to 
conduct it across the epithelial barrier. When released, IgA has much 
of the secretory component still attached making it more able to resist 
proteolytic cleavage and more resistant to pH changes (Underdown and 
Schiff, 1986). 
The existence of a local secretory immune system in the 
endocervix providing the major source of immunoglobulins in cervical 
mucous was shown by Rebello et al., (1975). High levels of sIgA to 
chlamydia and HSV were found using a radio -immuno assay in cervical 
secretions from patients with malignant atypia or dysplasia (Kalimo 
et al., 1981). Interestingly, the persistent production of 
anti -chlamydial IgA in the secretions supported the presence of latent 
or chronic infection while in HSV infections, sIgA appears to be an 
important factor in reducing the duration of cervicovaginal excretion of 
HSV (Merriman et al., 1984). It therefore seemed valuable to look for 
specific sIgA to HPV in cervical secretions from colposcopy patients. 
The simple but sensitive indirect ELISA recently described by Fox et 
al., (19861) to detect sIgA in tears was adapted for use with cervical 
secretions. Although high absorbancies were obtained in one third of 
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the specimens tested, when compared to the absorbancies obtained with 
matching plasmas, no quantitation of the results was carried out. 
Several of the specimens contained considerable amounts of mucus and 
one or two were slightly bloodstained. Removal of the mucus by 
enzymic degradation, or by spinning through or by including a high 
concentration of salt followed by filtration through an inert sea sand 
and glass wool bed, might have been worth including in the preparation 
of the specimens. This latter method apparently gave good recovery 
of soluble proteins from cervical secretions (Fleetwood et al., 1984). 
It would also have been useful to have estimated the protein content of 
each specimen in an effort to standardise the specimens used. Perhaps 
an ELISA based on an anti -secretory component- capture assay would 
have allowed more specificity despite variation in samples. 
Anti -secretory component coated on to the wells of the plate would 
capture sIgA in the specimen some of which, if specific for HPV 
antigens, could be detected by successive incubations with disrupted 
HPV, rabbit anti -HPV and enzyme -linked anti -rabbit serum. Detection 
of sIgA is an area worthy of further study, in order to understand when 
and how local immune responses to HPV develop, and interestingly, a 
very recent publication reports the use of an indirect ELISA for 
HPV -IgA as a useful marker of the presence of CIN +HPV (Diliner et al., 
1989). 
4. In situ Detection of HPV 
One of the first reports of hybridisation to detect viral DNA 
came from Orth's laboratory where it was found that the replication of 
CRPV in rabbit tumours, as shown by the binding of an 3H labelled 
probe, was restricted to the upper layers, with increased grain density 
as keratinisation of the cells progressed (Orth et al., 1971). A similar 
picture was shown for human cutaneous warts (Orth et al., 1980). 
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Improvements in the efficiency of ISH by increasing the diffusion of 
probe, by optimising the temperature of hybridisation, by stabilising the 
hybrids during post- hybridisation treatments and by hybridising in the 
presence of excess c DNA (Brahic and Haase, 1978) led to much wider 
application of the technique. 
Non -radioactively labelled DNA probes, prepared by nick 
translation in the presence of biotinylated d -UTP were first described 
by Langer et al. (1981), but to prevent ste i c hindrance in detecting 
bound biotinylated probes, a spacer arm between biotin and the 
pyrimidine ring had to be inserted. Various lengths of spacer arm 
were tried and while an increase from 4 to 11 atoms enhanced target 
detection four -fold, further increase in length were no more efficient 
and an 11 atom linker was selected as optimal (Leary et al., 1983). 
Probes labelled in this way were successfully used to detect viral 
genomes in cultured cells and in paraffin embedded tissues (Brigati 
et al., 1983). It was noted that to achieve efficient and reproducible 
hybridisation, consistently good tissue adhesion and a high degree of 
premeability of cells, while maintaining morphological integrity, were 
essential. 
These two aspects have been frequently mentioned as problem 
areas in subsequent papers on ISH and required close attention in the 
study undertaken here. An almost complete loss of sections occurred 
on untreated slides, for example, and even slides coated with 
poly -L- lysine, which is frequently used in immunocytochemistry to 
improve adhesion (Huang et al., 1983), were often inadequate. The 
chemical silanation of slides coated with Denhardt's solution 
(Tourtellotte et al., 1987) was efficient and no sections at all were lost 
from slides used within 8 weeks of activiation. The effectiveness is 
due to strong covalent bands between aminoalkyl groups and aldehyde 
which can withstand repeated washings with inorganic solvents. 
Nevertheless, it is a lengthy procedure and the quicker, simpler and 
cheaper method of immersing clean slides in a 2% solution of 
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3- aminopropyl triethoxysilane in acetone (Burns et al., 1987) or 
methanol (Maddox and Jenkins, 1987) was almost as effective and is 
therefore more likely to be adopted by other users. 
A high degree of permeability is achieved by treatment of 
sections with 0.2M HCl and by proteinase K digestion. However it has 
been suggested that excessive acid may depurinate DNA (Pardue, 1985) 
and this stage is now being omitted by some workers (Syrjanen et al., 
1987) but was included in the current study. The concentration of 
proteinase K found to be most effective in maintaining integrity of the 
sections was 0.2mg /ml, within the range recommended by Brigati et al. 
(1983). The activity of the enzyme will vary with the batch and the 
conditions under which it is stored and used, but it is interesting to 
note that Beckmann et al. (1985) required 4mg /m1 of Pronase B, and 
Syrjanen et al. (19876) noted significant increases in hybridisation signals 
by increasing the concentration to 1 mg /ml with only a slight 
in cell morphology, when studying HPV in condylomata 
with biotinylated probes. 
A simple detection method using antibiotin antibody followed by 
fluorescein -labelled conjugate (Brigati et al., 1983) has been used, but 
amplified systems such as anti- biotin or avidin followed by anti -avidin 
as primary and secondary antibodies, followed by preformed complexes 
in which many biotinylated horseradish peroxidase molecules are cross - 
linked to avidin in a three dimensional assay (Hsu et al., 1981) have 
been favoured (Brigati et al., 1983; Beckmann et al., 1985). To 
circumvent background staining due to endogenous peroxidase, alkaline 
phosphatase detection systems have been used (Ungar et al., 1986; Burns 
et al., 1987; Lewis et al., 1987; Syrjanen et al., 1987') and indeed the 
only commercially available HPV typing kit utilises biotinylated HPV 
probes with an avidin /biotinylated alkaline phosphatase detection system 
(Vira typeTM; Gibco -BRL, Paisley). 
The vitamin biotin is widely distributed in tissues, especially 
liver, kidney, adipose tissue and mammary gland. In addition, it is 
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synthesised by gut flora and excess is excreted. It might therefore be 
expected that non -specific attachment of the detection system could 
occur. However, endogenous biotin is not found in high levels in skin 
and it is thought that the thorough washing stages in hybridisation 
remove this small molecule (MW of biotin being 244). It is possible to 
block endogenous biotin by saturating with excess avidin followed by 
biotin, which, with only one binding site, is no longer available for 
further reaction (Wood and Warnke, 1981). In the current study, 
background staining in formalin -fixed paraffin embedded sections with 
biotin or its detection reagents was rarely a problem. The pattern of 
non -specific staining observed occasionally with bipolar nuclear staining 
and /or cytoplasmic staining of basal and parabasal layers was readily 
distinguished from the more regularly stained nuclei of cells of the 
upper layers when specific probes were used. By contrast, in current 
investigation of respiratory virus detection with biotinylated 
oligonucleotides, endogenous biotin has been found to be a problem in 
cultivated cells grown in serum- containing medium and fixed in 
paraformaldehyde. Use of the steroid hapten digoxigenin (Boehringer 
Mannheim) as an alternatve non -radioactive label may circumvent this 
problem. 
More than ten years ago, Brahic and Haase (1978) suggested that 
reducing probe size to approximately 50 nucleotides should increase 
diffusion and efficiency of hybridisation three fold. In some studies 
with HPV -DNA detection probe size has been reduced by the 
incorporation of DNAse to the nick translation system, to 60 -160 
nucleotides (Naghashfar et al., 1985) and to 200 -400 nucleotides (Stoler 
and Broker, 1986; Collins et al., 1988), but no comparisons with 
untreated probes have been carried out. An alternative approach exists 
for nrnheç where the sequence of DNA is known, in the form of 
synthetic oligonucleotides. This approach to the diagnosis of viral 
disease was first suggested by Richman et al. (1984), but it has taken 
several years for evidence of its usefulness to be forthcoming. 
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Robertson et al. (1987) used a .50-mer probe complementary to the 
measles virus nucleocapt .d gene to identify persistent measles in 
lymphocytes from patients with autoimmune chronic active hepatitis. 
A smaller probe (21 -mer) was used by Lin et al. (1987) for the 
detection of hepatitis B DNA in serum by dot -blot hybridisation and was 
found to give an equally sensitive, but quicker and simpler assay than 
that using a conventional nick -translated cloned probe. The short 
probes anneal more rapidly to their targets (Meinkoth and Wahl, 1984). 
Indeed, Jablonski et al. (1986) suggested that short oligos to HSV and 
hepatitis B virus covalently and cross -linked to alkaline phosphatase 
reached maximum hybridisation to target DNA fixed on nitrocellulose 
filters in 15 minutes. 
Many diagnostic virology or pathology laboratories do not have 
the expertise, large -scale bacterial culture systems and containment 
facilities required for the production of probes from cloned nucleic acid 
and the use of synthetic oligonucleotides should overcome this. 
Nevertheless, many problems in their use have still to be resolved. 
Probe length, for example, can be varied over a limited range, but what 
are the advantages and disadvantages of so doing ? The smaller the 
probe, the less mis- matching is permissible and therefore the more 
specific the individual probe. Thus, Sano et al. (1988) were able to 
distinguish hop stunt viroid of grapevine from hop stunt viroid of hop 
using a 15 -mer, despite only a single nucleotide difference between the 
types. On the other hand, small probe size might prevent hybridisation 
occurring at all in a situation where strain variations were common. 
In the current study, an oligonucleotide of 30 bases was selected in an 
attempt to balance these opposing factors and, by searching the 
GenBank database it appeared that the sequences chosen from HPV -1 a, 
HPV -G,5 and HPV -16 were different from any other PVs of known 
sequence. However, it was realised that some cross -reaction between 
HPV -6b and HPV -11 might occur since these types differed in only 4 
bases with a run of 19 perfectly matched consecutive nucleotides (see 
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Fig 9 ) and this was found to be the case (see Specimens 7 and 22, 
Table 35). 
The effectiveness of synthetic oligonucleotide probes does assume 
the accuracy of the sequence date lodged to date, and for HPV -16 at 
least, it has recently been shown that a single base was omitted from 
position 3906 in the original sequencing (Bubb et al., 1988) and indeed, 
it has been suggested that errors may be introduced from the bacterial 
strains used in cloning (Kasher and Roman, 1988). The advantages and 
disadvantage, = of short oligonucleotide probes are summarised in Table 
37. 
Selecting the best oligonucleotide sequences to give type sç cific 
HPV probes was difficult. Sequenced HPV types show a great degree 
of homology in the L 1 region, but much less so in the L2 region, and it 
might have been possible to select sequences from within L2. 
However, the E6 /E7 region, being important in transformation, was 
selected in the hope that strain differences between types of similar 
oncogenic involvement would be minimised in this region. 
Apart from the report by Jablonski et al. (1986) with alkaline 
phosphatase labelled oligoprobes, all publications to date reporting the 
detection of specific viral sequences used 32P labelling systems, either 
with polynucleotide kinase (Robertson et al., 1987; Sano et al., 1988) or 
terminal transferase (Lin et al., 1987). The latter enzyme was 
suggested in 1983 by Leary et al. to be a useful alternative to kinase 
labelling for biotinylated probes, but no results were included 
demonstrating its use. Terminal transferase has the advantage of being 
a one -step reaction and is less expensive in the amount of label 
required, but more than one biotinylated nucleotide may be added to the 
3' end (Roychoudhury et al., 1976). Provided this did not create a 
probe with ste hindrance nor result in many unlabelled molecules, 
such addition might be advantageous and increase the sensitivity of the 
probe. It was therefore selected for labelling of the oligonucleotides 
used in this project. Current synthesising methods now allow the 
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Table 37 Advantages and Disadvantages of Short Oligonucleotides 
in Hybridisation Studies (adapted from Coghlan et al., 1985) 
Advantages Disadvantages 
(NB Most relate to 
"newness" of method) 
1. They can be synthesised 
quickly. 
2.They are easier for an 
ordinary lab to have 
prepared and to label. 
3. They give better overall 
tissue labelling since 
unlimited amount of probe 
are available. 
4. They are consistent and have 
a higher specific activity. 
5. Pure synthetic probes give a 
a lower background. 
6. Absence of poly(T) tails 
eliminates one source of 
background. 
7. Discriminating sequences for 
similar genes can be made. 
8. Known sequences may be 
altered for different 
species using preferred 
codons. 
9. Shorter probes may be more 
accessible to cellular mRNA. 
10. Probes may be synthesised 
from amino-acid sequence 
when DNA sequence unknown. 
11. Bacterial sequences in cloned 
probes are not a problem. 
1. Fewer labels have been tried. 
2. The stability of probes has yet 
to be verified. 
3. Optimal conditions for short probes 
are not yet established. 
4. Sequencing errors in published 
sequences lead to "wild goose 
chases ". 
5. Cross -species hybridisation is 
more likely to be successful with 
longer probes. 
6. Some oligoprobes may fail because 
the region chosen is inaccessible. 
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addition of one biotin molecule to the 5' end of each oligonucleotide 
molecule during the synthetic process using an animo- linker. (Agrawal 
et al., 1986; Dr. Tom Brown, personal communication). Although 
HPV -6b and HPV -16 have been synthesised in this way, no results are 
available as to their effectiveness (Dr. Paul Kelly, Mercia Diagnostics 
Ltd., personal communication). Possibly one biotin in 30 nucleotides 
capable of binding to one copy of viral sequence may be less sensitive 
than required. Proportionately, this is similar to the level of 
substitution of thymidine by biotin -11 -dUTP in a nick translation 
reaction (Kozma and Adinolfi, 1987), but with the longer probe, several 
biotin molecules will be present in each molecule of probe hybridised to 
a segment of viral genome. Terminal transferase labelling may 
therefore be preferable to labelling during the synthetic process. 
Three ISH techniques were used in this study : biotinylated 
cloned probes of HPV -1 a, HPV-11 and HPV -16 detected with 
streptavidin, biotinylated alkaline phosphatase and NBT /BCIP substrate 
(Detection Method 1) and oligonucleotide probes of HPV -1 a, HPV -6b and 
HPV -16 detected with Detection Method 1 and with antibiotin, gold 
conjugated second antibody and silver enhancement (Detection Method 
2). All were successful on formalin fixed sections of skin warts, 
though it was notable that sections of a simple plantar wart mounted on 
untreated slides were less likely to be lost with the shorter processing 
and hybridisation schedule for oligoprobes. In the small sample of 
tissues examined, good agreement was obtained between hybridisation 
results using cloned and oligo probes for HPV (Table 35). However, an 
apparent increase in sensitivity was achieved using HPV -16 E6 
oligoprobe and Detection Method 2 (Table 36). It is appreciated that 
the same specimens were not tested by all three methods, but the 
saving in time by the use of oligoprobes, allowing completion of the 
process within one working day, coupled with increased sensitivity and a 
further saving in time during detection with the anti- biotin IGSS 
system, makes this a useful addition to ISH protocols. It would be 
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interesting to investigate normal, dysplastic and carcinomatous tissue 
from the uterine cervix using this method. 
New labelling and detection systems are however constantly 
being tried, and it is probable that greater sensitivity and efficiency can 
yet be obtained. Urdea et al., (1988) recently reported for example 
that enzyme- modified oligonucleotides could be made to give 
sensitivities comparable to that of 32P labelled probes. 
While the role of HPV in cervical carcinogentsis is still in 
question it is important to use the most sensitive, practical and 
applicable assay available to assess the biological significance of its 
detection. The high degree of spatial resolution achieved with ISH 
makes it particularly useful when infection is clustered in small foci 
with a high copy number per cell as is more likely in early lesions. 
The use of ISH may therefore help to identify patients potentially at 
risk of malignant progression in the presence of HPV types which may 
integrate more readily. Furthermore, using single- stranded RNA probes 
from plasmids containing a phage SP6 promoter not only are stronger 
signals obtained than for DNA in the same tissues, but the interplay of 
virus replication and gene expression, cellular differentiation and 
transformation can be investigated (Stoler and Broker, 1986; Crum et 
al., 1988 a and b). The new dimension in diagnosis provided by ISH 
with quick- acting, non -radioactively labelled probes detected sensitively 
is worth exploiting further, although it is appreciated that such probes 
may fail to detect low copy number. 
No attempt was made to assess the prevalence of HPV -DNA in 
a given population. Rather the aim of this part of the study was to 
perfect a rapid ISH technique which could be used in conjunction with 
immunocytochemical staining to give a better picture of the host 
response to HPV. This latter aspect did not progress as far as was 
envisaged because of technical difficulties. Whilst ISH worked well on 
paraffin sections, less success was achieved with frozen sections. On 
the other hand, many monoclonal antibodies work only on frozen 
- 162 - 
sections. This is particularly true for T cell markers. A recent 
report (Mason et al., 1988) suggests however that a new range of 
monoclonals suitable for phenotypic analysis of leucocytes in routine 
histological samples is becoming available. An alternative for LC is to 
use anti S -100 antiserum which detects some, but not all LC in 
formalin fixed tissue (Tay et al., 1987a) and this is being tried in 
conjunction with ISH using biotinylated probes (Dr. Kathryn McLaren, 
personal communication) on sections of HPV tumours from renal 
transplant patients. Of the many reports of HPV -ISH in the literature, 
while many mention the use of frozen sections in passing, few give 
details of results on them. In one series, however, frozen sections of 
mucosal papillomatous lesions were successfully detected using 
biotinylated cloned probes (Bouvard et al., 1986). Using their method, 
however, I was unable to retain the integrity of the sections, possibly 
due to the more severe denaturation stage of processing using boiling 
PBS. 
HPV -DNA typing of cervical lesions can now be achieved with 
five different types of technique. Viral DNA can be extracted from a 
biopsy sample and spotted onto nitrocellulose or nylon filters (dot blots) 
or separated after restriction end:,.:_ :: - =, digestioh by gel electrophoresis 
before blotting (Southern blots; Southern, 1975). This gives a more 
specific reaction than dot blotting, gives information on the state of the 
viral genome and is the most sensitive method when there is a low copy 
number of viral genomes per cell, as in cervical tumours. It is the 
"gold standard" of DNA hybridisation techniques against which other 
methods should be measured, but it is expensive, time -consuming and 
less suitable when only a few cells in a sample are infected. Without 
preliminary extraction, viral DNA can be detected and typed by ISH as 
described above on tissue sections or by FISH (filter -ISH) (Wagner et 
al., 1984; Schneider et al., 198S), when exfoliated cells are immobilised 
on a membrane prior to hybridisation. As with dot -blotting, FISH is 
less specific and great care must be taken to avoid cross -hybridisation 
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(Wickenden et al., 1987). 
A more recent DNA detection method involving amplification of 
target sequences through repeated cycles of denaturation and primer 
extension with DNA polymerase has been developed (Saiki et al., 1985). 
Polymerase chain reaction (PCR) was first applied to the search for 
HPV sequences by Shibata et al. (1988) in paraffin embedded tissue. 
Dewaxed tissue pellets were subjected to 40 cycles of amplification 
using oligomer primers and a 32P end -labelled probe. HPV -16 
sequences were successfully demonstrated in SiHa cells (1 -2 copies /cell) 
and HPV -18 sequences in HeLa cells (10 -50 copies /cell) and in several 
cervical and penile carcinomas. Dallas et al. (1989) report the use of 
PCR on pelleted cells from cervical scrapes using a probe directly 
labelled with alkaline phosphatase to give a very rapid detection 
method. Because the method is "exquisitely sensitive" great care must 
be taken to prevent non -specific positive results. Nevertheless, the 
use of PCR supports the suggestion that the prevalence of HPV 
infection is much greater than thought, with Young et al. (1989) finding 
HPV -11 or 16 in 7/10 women with no cytological abnormality and in all 
38 women with cytological abnormalities. Indeed, Tidy et al., (1989) 
very recently reported 84% of 140 normal cervical samples, 67% of 
dyskaryotic smears and 100% of cervical carcinomas to be carr 'ng HPV - 
16 sequences. This extremely high rate of infection in the general 
population begs the question of an aetiological role for HPV -16 in 
cervical neoplasia. The prevalence of multiple virus infections in 
normal and abnormal cervices using PCR (Bevan et al., 1989) supports 
the need for caution in interpretation. 
5. Mouse Model 
One of the major obstacles to HPV research remains the 
inability to produce sufficient amounts of infectious virus in the 
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laboratory. The system described by Kreider et al. (1986; 1987) in 
which human foreskin is infected with HPV -11 and grafted under the 
renal capsule gives experimental lesions similar to naturally occurring 
lesions and from which infectious virus can be recovered. Implanting 
under the renal capsule of a very small mouse is technically difficult 
and practice was gained using cervical biopsies, none of which remained 
as viable tissue. Attempts to reproduce the system using human 
foreskin and the small amount of mouse grown HPV -11 provided by Dr. 
Kreider met with limited success. Three of the four implants in the 
first experiment produced cysts, two of which were distinctly 
papillomatous and koilocytic and contained small numbers of HPV 
particles. None of the four mice implanted in the second experiment 
produced cysts and it seems likely that the human foreskin tissue used 
on this occasion was less viable or had more subcutaneous tissue 
preventing adsorption of the virus to basal cells. 
A success rate of 25% (2 out of 8 attempts) shows that although 
possible, the system is difficult. Furthermore, Kreider noted that in 
his hands, the cysts took 3 -5 months to develop. Given the short life 
expectancy of nude mice, the technical problems associated with this 
method are considerable. Recent work suggests that dexamethasone 
treatment of the mice might allow the development of experimental 
lesions from tissue implanted subcutaneously (Dr. J.W. Kreider, personal 
communication), a method technically much simpler than grafts under 
the renal capsule. It remains to be seen, however, whether the 
method can be adopted for larger scale production of infectious virus, 
or adapted for other HPV types. 
6. T~c Multifactorial Process of Tumour Development 
6.1 Initiating Events 
There seems little doubt that the development of malignant 
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tumours of the cervix and other genital tissues is a multifactorial 
process in which HPV may play some role. This role could either be 
as an "initiator" or a "promoter ", in a two -stage process, as first 
postulated by Berenblum (1941) for squamous cell carcinogenesis. 
In cottontail rabbits, infection with CRPV represents the initial 
event to which the adapted host responds and suppresses tumour 
progression, but in the non -adapted domestic rabbit, suppression is less 
active and the continued expression of some viral functions allows for 
the development and maintenance of a malignant phenotype. The role 
of initiator has also been proposed for BPV -4 in the development of 
bovine alimentary canal carcinomas (Smith and Campo, 198$) although 
no viral DNA is expressed or even detected in the tumours themselves. 
These two extremes may reflect different roles for different PVs in 
malignant progression. In human cervical carcinomas, while the DNA 
of HPV of restricted types is found in the majority of cases, tumours 
which lack viral DNA, despite sensitive detection systems, may truly 
have lost the HPV genome. Similarly, although viral expression of 
restricted parts of the genome is usually found, this is not always so, 
(Lehn et al., 1985; Pater and Pater, 1988). However, if progression to 
tumorigenicity takes place through a series of steps only one of which 
is virus dependent, the persistence of the viral DNA or its loss at later 
stages may be unimportant and have little effect on the cell phenotype 
(Crawford 1986). 
It has been suggested that in human genital carcinomas, the 
initiating role is played by another virus, herpes simplex virus (HSV) 
acting in a "hit and run" manner (zur Hausen, 1980; Galloway and 
McDougall, 1983). For several years, HSV itself was implicated in the 
development of cervical neoplasia (Rawls et al., 1973), but the evidence 
was mainly serological and inconclusive. Early studies had failed to 
detect HSV -2 nucleic acid in cervical tissue biopsies (zur Hausen et al., 
1974) and even when assays became more sensitive, HSV- specific RNA 
could only be detected in 35 -67% of tumours (McDougall et al., 1980; 
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Eglin et al., 1981; Maitland et al., 1981). Furthermore, no single 
sequence was always expressed in the HSV- positive specimens, and the 
proteins produced appeared to be so different that it seemed likely that 
they only gave some growth advantage rather than being necessary for 
the initiation or the maintenance of the transformed state (Galloway 
and McDougall, 1983). In addition, the higher incidence of HSV -2 
antibodies in cases and controls could be explained by covariance, with 
the same factors predisposing to HSV -2 infections as to cervical 
carcinoma development. On the other hand, the ability of HSV to 
induce chromosomal breaks (Hampar and Ellison, 1961) and to induce 
cellular DNA repair (Nishiyama and Rapp, 1981) may be far more 
important than the presence of HSV- specific nucleic acids or protein. 
Recurrent herpetic infections could then lead to an accumulation of 
possible initiating events and increase the risk of malignant conversion 
in cervical papilloma infections (zur Hausen, 1980; 1982). The 
simultaneous presence of HSV and HPV in 4/13 cases of CIN and 4/30 
cases of cervical cancer was recently shown (Di Luca et al., 1987), but 
a further 8 cases of CIN and 12 invasive tumours had detectable 
evidence only of HPV. Using PCR, Bevan et al., (1989) recently 
reported HSV or EBV with HPV in 19/36 abnormal smears, although HPV 
was present in all 36. 
6.2 Risk Factors 
In the promotion of the potentially tumorigenic cell, several risk 
factors have to be considered. Given the prevalence of HPV -16 in 
nwf 
various countries in which it has been studied and the incidenceAof 
cervical carcinoma, Pfister (1987b) calculated that the risk of HPV - 
16 infection in women was 10% and the risk of cervical cancer 1:300 of 
infected. For HPV-6/11, the risk was 1:2000 -3000 of those 
infected, which still exceeds the risk for other human tumour viruses 
such as human T -cell lymphotrophic virus, type 1 (HTLV -1), Epstein - 
Barr virus (EBV) and hepatitis B virus (HBV). While experimental data 
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supports an oncogenic potential for HPV, epidemiological evidence is 
still limited and is based on studies which do not satisfy basic 
epidemiological requirements of sample size, careful unbiased selection 
of cases and matching controls, and detection systems of comparable 
specificity and sensitivity (Munoz et al., 1988). Indeed, doubt is cast 
on the relevance of HPV in cervical cancer by the high prevalence of 
HPV -16/18 in normal cervical cells and tissues (Cox et al., 1986; 
Macnab et al., 1986; De Villiers et al., 1987; Meanwell et al., 1987; 
Reeves et al., 1987; Schneider et al., 1987; Murdoch et al., 1988). 
However, if other factors act synergistically, HPV infection would still 
represent an important stage in the development of cervical carcinoma. 
Heavy and prolonged smoking has been known for decades to be 
a major risk factor in the development of malignancies of the 
respiratory tract and implicated also in cervical cancer (Winkelstein, 
1977; Clarke et al., 1982) with Trevathan and colleagues (1983) 
concluding that the cumulative exposure was most important, with the 
risk being greatest in those who began smoking in their teenage years 
(La Vecchia et al., 1986). Certainly, carcinogenic nicotine products 
have been shown to accumulate in vaginal fluids (Sasson et al., 198.5). 
It has also been shown that smoking upsets vitamin A metabolism 
(Yamasaki et al., 1977), and since vitamin A in high doses can have 
beneficial effects on some warts (Blanchet -Bardon and Lutzner, 1985), 
its reduction may aid progression. Furthermore, smoking can lead to 
suppression of immune responses by exerting an anti -oestrogenic effect 
(Michnovicz et al., 1986) and by reducing LC in cervical epithelium 
(Barton et al., 1988). This could lead to the reactivation of viruses 
latent in cervical tissue (Grail and Norval, 1988). 
It is very difficult to separate correlated factors and various 
aspects of social behaviour have been considered with conflicting results 
as to their individual relevance. High sexual activity is generally 
considered to be a major risk factor, and in breaking this down to age 
at first intercourse, multiple sexual partners and pregnancy outside 
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marriage, Harris and colleagues (1980) noted that these risk factors 
were identical for cervical dysplasias of all grades and for invasive 
cervical carcinoma. While the number of sexual partners exerted its 
effects independently of age at first intercourse, the reverse was not 
found. This study therefore failed to support the suggestion that 
adolescence was the period when the cervix was most vulnerable to the 
effects of sexual behaviour. Recently, in a study of the development 
of CIN in Italian girls under 20, the major risk factors were shown to 
be the number of sexual partners and the existence of genital warts 
(Zaninetti et al., 1986). No association with smoking was found in this 
study, presumably due to the short duration of the smoking habit. 
The greatest single risk factor would appear to be the number 
of sexual partners a female or her single male partner has encountered 
(McCance, 1986). Skegg and colleagues (1982) showed that in societies 
where male promiscuity was high and female promiscuity low, the 
incidence of cervical cancer is high. This was recently confirmed in a 
group of poor Hispanic women : cervical cancer patients were more 
than five times as likely as controls to be married to husbands who had 
had more than 20 sexual partners (Zunzunegui et al., 1986). By 
considering different cultural and religious practices, an additive effect 
of age at first coitus and the level of penile hygiene was noted by 
Jayant (1987). 
The use of oral contraceptive pills (OCPs) has also been 
implicated as a risk factor in the progression of cervical dysplasias to 
cancer. In two out of three studies, the risk of dysplasia appeared to 
increase with increased duration of OCP use, but the confounding 
influences of sexual behavious patterns were not assessed (Prentice and 
Thomas, 1987). In three studies on the effect of OCP use on invasive 
cervical cancer, a risk was shown even when controlled for sexual 
variables, as in the study by Vessey et al. (1983) where nearly 10,000 
women attending family planning clinics in Britain were followed for 10 
years. Thirteen cases of cervical carcinoma developed in OCP users 
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with more than 6 years useage, while no cases in matched controls 
using intra uteric devices were found. However, in this study, the 
confounding variable of smoking was not assessed (Prentice and Thomas, 
1987). 
6.3 Progression 
In a gradually evolving hypothesis, zur Hausen has proposed that 
cancers develop as a result of failing intracellular control of persisting 
viral genomes in proliferating cells (zur Hausen, 1980; 1982; 1986). In 
HPV infection of cervical epithelium, a cellular interfering factor 
exists which, in the lower layers of the epidermis, suppresses early viral 
functions, but is itself switched off by differentiation allowing 
viral DNA replication to ensue. An earlier switch -off could result 
from modification of cellular genes as a result of smoking, or infections 
with initiating properties such as HSV, CMV or chlamydia and /or the 
accumulation of mutagenic metabolites from chronic inflammation, all of 
which would have more disastrous effects on the hormonally controlled 
cells of the cervical transformation zone than on external genitalia. 
This would explain the higher risk of cervical than of vulvar or penile 
cancers and also the older age of onset of the latter types. The 
presence of such a cellular factor regulating HPV expression has been 
suggested by the finding that, while HeLa cells containing integrated 
HPV -18 form tumours in nude mice, hybrids of HeLa and normal human 
fibroblasts or keratinocytes retain their HeLa characteristics in vitro but 
fail to produce tumours in nude mice (Schwarz et al., 1987; Rost. et al., 1988,. 
HPV -16/18 could further promote tumour development by their 
ability to integrate into the host genome, usually with integration 
occurring within E1 /E2 and transcription of E6 /E7 continuing. It was 
noted, however, that the message from the E6 region of HPV -18 
integrated genomes was altered by the insertion of cell nucelotides 
(Schneider -Gadicke and Schwarz, 1986) to cause a frame shift which 
could result in the expression of a protein distantly resembling 
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epidermal growth factor. Interestingly, HPV-6/11 lack the appropriate 
splice site and this might explain their lower tumorigenic potential. 
Nevertheless, integration of HPV -11 can occasionally occur (Byrne et 
al., 1987), transcription of HPV -16/18 does not always occur (Lehn 
et al., 1985; Pater and Pater, 1988) and progression of HPV -6/11 lesions 
can be as common as the progression seen in HPV -16/18 lesions 
(Syrjanen et al., 1988). The insertion site of an integrated viral 
genome may be more relevant with activation of nearby cellular 
oncogenes (Riou et al., 1985; Matlashewski et al., 1987) being the real 
trigger of oncongenic progression. It could even be that excision of an 
integrated viral DNA sequence with a neighbouring cellular control 
region are the events which finally precipitate conversion to a 
carcinogenic cell (Crawford, 1986). In this case, all evidence of virus 
infection would be lost. 
If transformation to malignancy is a series of steps only one of 
which is virus dependent, the persistence of the genome at later stages 
is unnecessary. Yet to play a significant role, the presence of HPV at 
some stage must always occur. Only by years of follow -up of large 
numbers of women on a regular basis could there be a chance of 
proving epidemiologically an aetiological role for HPV in cervical 
dysplasia. Such a study would be lengthy, expensive and dependent on 
adequate storage facilities for large number of sample (Munoz et al., 
1988), but these criteria are being currently met in a large London 
study involving the collection of 100,000 cervical scrapes with retrieval 
of those from patients developing CIN and matched controls who do not 
(Professor A.B. Malcolm, personal communication). The use of 
sensitive detection methods such as PCR on these samples (Tidy et al., 
1989) will yield valuable and hopefully conclusive results. 
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7. Concluding Comments 
Few studies of the involvement of HPV in cervical dysplasia 
take into account the host response to the infection. In the preceding 
section, various risk factors are considered, but allowances are not made 
for differing host responses to these factors. The level of nicotine 
metabolites required to exert an immunosuppressive effect will vary 
from individual to individual, the development of chronic inflammation 
in response to exposure to foreign antigens may be more pronounced in 
some than in others, the effect of OCP use will be dependent on the 
hormonal balance already existing in the individual and the response to 
HPV will be dependent on the state of the epidermis at the time of 
infection. It becomes difficult to predict the outcome of such complex 
encounters. 
The current study was initiated in an attempt to find markers of 
host response which would indicate the relevance of HPV infection in 
cervical dysplasia and was commenced at a time when HPV in normal 
tissues had not yet been detected. It became evident that finding the 
best HPV antigens to assess in vitro assays was in itself a major hurdle. 
Disrupted virions revealing group specific antigens will still detect the 
most commonly acquired HPV infections whatever their type and the 
inability to produce specific HPV types readily in cell culture is as big 
a problem as twenty years ago. Great promise for the production of 
natural HPV antigens lies in the work of McCance et al. (1988) with 
"raft cultures" on which differentiating keratinocytes can support HPV 
riPilc- nrIony or from the nude mouse work of Kreider et al. (1986; 1987) if 
the infection and implantation method can be adapted to HPV types 
other than HPV -11. The studies reported here showed that Kreider's 
work could be reproduced, although the efficiency of the technique was 
low and the complexity of operation high. Certainly, naturally 
produced antigens are likely to yield more constructive and meaningful 
results than the two systems currently available of fusion proteins and 
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synthetic peptides. Fusion proteins were tried here in LPA with some 
success, but the problems of removal of contaminating bacterial 
sequences and of alteration to the specified HPV proteins by bacterial 
passage are considerable, while the disadvantage of synthetic peptides 
must lie in their conformational arrangements. 
Even with the most suitable antigenic preparations, however, it 
is questionable whether examination of the systemic response, either 
humoral or cellular, to what is normally a locally contained infection, 
would now be considered the most valuable approach. Attempts to use 
in vitro assays of systemic responsiveness can be made more relevant, 
for example, by the use in LPA of APC from epithelium of the same 
type or area as that of the lesion. However, such studies can probably 
be compared to looking for "a needle in a haystack" and future work 
would do better to concentrate on local responses. 
Nevertheless, full examination of the local responses in a human 
system is difficult using functional assays, and information is currently 
being gathered from simpler and more adaptable cytochemical studies. 
In the last three years, increasing interest has been shown in 
lymphocyte markers within the area of HPV infection, but none have 
looked adequately at the HPV itself in the same lesion. Histological 
criteria such as the presence of koilocytes have been used to denote 
HPV infection, but a combination of HPV- typing by DNA hybridisation 
or of gene transcription by RNA hybridisation in combination with 
markers of immune responsiveness would be more relevant. 
The technical difficulties in obtaining sensitive ISH without 
radiolabelling of probes were evident in the current study and the time 
involved in the successful development of a new tool in ISH using 
biotinylated synthetic oligonucleotides, effectively curtailed studies 
iuvuivi,i6 multiple markers. Synthetic oligonucleotides themselves offer 
exciting opportunities for the rapid diagnosis of viral disease in 
situations where antigen detection is inappropriate, and I am already 
applying this approach to the search for respiratory viruses in 
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nasopharyngeal secretions from children. The investigation of multiple 
markers in cervical dysplasia is, however, an area well worth more 
comprehensive study and should involve the examination not only of 
clinically and histologicaly abnormal material, but of apparently normal 
tissues from the same patient and apparently normal tissues from 
clinically and histologically normal people. As more monoclonal 
antibodies suitable for use on paraffin sections become available, these 
techniques will be increasingly feasible on archival material to 
supplement the data obtained from controlled studies. 
In the search for models of PV cancinogenesis, animal models 
such as Mastorrlys minutus or the papillomatous lesions of hairless mice 
may prove to be of increasing value, and the CRPV model could be 
further exploited in the investigation of cellular actions and 
interactions. Furthermore, for HPV itself, the actions of cutaneous 
HPVs should not be forgotten, and it could be that immunocompromised 
people will increasingly provide living models in whom the host response 
can be investigated. Much has still to be done in analysing the part 
played by HPV -5 and HPV -8 in malignant and premalignant lesions in 
immunocompromised patients and relating it to the normal state of the 
skin in healthy individuals. 
At last more researchers are directing their attention to 
unravelling the complex and enigmatic interactions of the pathogenesis 
and host response to HPV. In the meantime, experimental molecular 
data on HPV have been accumulating very rapidly and controlled 
epidemiological data on the involvement of HPV in the progression of 
dysplasias will be available for analysis. The next ten years of HPV 
research should be exciting. 
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Humoral and Cellular Immunity to 
Papillomavirus in Patients 
With Cervical Dysplasia 
Heather A. Cubie and Mary Norval 
Department of Bacteriology, University of Edinburgh Medical School, 
Edinburgh EH8 9AG, United Kingdom 
Tbc cell -mediated and humoral immune responses to human papillomavirus (HPV) 
were tested in groups of patients with various degrees of cervical intraepithelial 
neoplasia (CIN) using a tympbocyte proliferation assay (LPA) as a measure of 
circulating sensitised T- e1Ls and an enzyme- linked immunosorbent assay ( ELISA) for 
antibodies. 
Twenty -three of 92 patients (25 %) gave stimulation indices (Si.) . greater than two 
to at least one of the several antigen preparations tested in the LPA. Of 282 patients, 
144 (50.1%) showed ELISA indices (El.) greater than one to HPV -1 and /or HPV -2 
antigens prepared by disruption of purified virions. 
No correlation was found between positive responses in either test and the presence 
in cervical biopsies of koilocytes (considered patbognomonic for HPV infections), or 
between positive responses and the degree of dysplasia observed. Rather, positive 
antibody and T-cell responses corresponded with a history of past or present skin warts. 
Although antibody was detected in 42/86 (48.8 %) women who thought they had never 
had warts, only 2/24 (83%) with no known history gave a positive Si. in IJA. 
IiCey words Manz papclloma *as, cell mediated imemait7, lymphocyte prniferatiioa assay, Immoral 
isassairri', -SA, cervical iatraegitherzal seoplamia 
INTRODUCTION 
The ballooned Dells with distorted nuclei and large halos found in cervical dysplasia 
and termed "koilocytes" [Koss and Durfee, 19561 were shown by Meisels et al [1977] to 
contain human papilloma virus (HPV) by electron microscopy and immunocytochemistiy. 
This was confirmed by Hills and Laverty in 1979, and since then, several types of HPV 
have been identified in such lesions; most commonly, types 6 and 11 in cervical 
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intraepithelial neoplasia (CIN) of grades I and II, and types 16 and 18 in CIN III and 
cervical carcinomas [Gissmann et al, 1984]. 
A role for HPV in the progression of dysplastic lesions to malignancy still needs 
clarification, although it seems likely that many cofactors are involved. Epidemiological 
evidence shows sexual promiscuity, early onset of sexual activity, and smoking to be major 
risk factors, but the immune status and responsiveness of the individual may also be 
important. 
It was recognised many years ago that renal transplant patients treated with 
immunosuppressive drugs often suffered from disseminated nortregressing warts [Spencer 
and Andersen, 1970] and that patients with deficiencies in cell -mediated immunity (CMI) 
secondary to Hodgkin's disease and chronic lymphatic leukaemia, were more prone to 
papilloma infections [Morison, 1975]. Furthermore, not only is the susceptibility to 
infection with different types of HPV related to the extent of CMI deficiency [Obalek et 
al, 1980], but the ability of papilloma viruses themselves to induce an impairment of 
nonspecific CMI is dependent on the viral type [Jablonski et al, 1982]. Using an in vitro 
assay of mitogen- induced lymphocyte transformation in patients with recalcitrant genital 
warts, Seski et al [1978] found that CMI was significantly reduced. However, a similar 
study of patients with CIN showed normal levels of responsiveness to three mitogeas, 
except for a reduced response to phytohaemagglutinin in patients with carcinoma -in -situ 
[Neill, 1984]. 
Several in vitro assays of specific CMI to HPV have been tried in patients with warts 
at various sites. Using a leucocyte migration inhibition test, Morison [1975] showed that 
few people were positive while they had skin warts, but many were positive just after 
resolution. Similarly, using lymphocyte proliferation assays (LPA), stimulation was 
greatest in those who had warts in the recent past [Ivanyi and Morison, 1976; Lee and 
Eisinger, 1976]. Weak or negative responses were obtained in those patients who had 
warts of long duration. 
Many studies of humoral immunity to HPV have been carried out on a variety of 
patients with skin and anogenital warts [Kienzler, 1985]. Early studies showed IgM 
antibodies present at the time of resolution, whereas IgG antibodies took many months to 
develop. The prevalence and titres were highest in regressing warts and lowest or 
nonexistent in warts of longest duration, greatest tumour burden, or lowest virion content 
Antibody can persist for many years and reinfection can occur despite its presence [Cubic, 
1972]. 
Pfister and Zur Hausen [1978] described a sensitive radioimmunoassay for specific 
HPV types and found HPV -1 antibodies in 50% of children, whereas HPV -4 antibodies 
were more prevalent in an older age group. They noted that 46% of patients with 
condylomata acuminata and 57% of patients with. genital cancers had antibodies to 
HPV -1. 
Raising antisera against purified papilloma virions reveals little antigenic cross - 
reactivity between different types, suggesting that the major capsid protein is type -specific 
[Orth and Favre, 1985]. However, antisera against alkali- disrupted or detergent - 
dissociate d pa tic1c show that common antigenic determinants exist within the virus 
[Jenson et al, 1980]. In 1983, Baird used detergent-disrupted bovine papillomaviruses 
(BPV) as antigen in an ELISA test to study the humoral response in patients with CN, 
invasive carcinoma of the cervix, and anogenital warts. All three groups of patients gave 
higher absorbencies than did control groups of children or adults. He also reported that 
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those with invasive carcinomas had higher mean titres than did the other two groups of 
patients. 
It was felt that the systemic immune response to cervical HPV infection in 
association with CIN required clarification. In this study we have used LPA and ELISA 
as indicators of cellular and humoral immunity, with purified or detergent-disrupted 
HPV -1, HPV -2, and BPV -1 as antigens. 
MATERIALS AND METHODS 
Patients 
Ten to 20 mis of venous blood were obtained from patients attending the Lothian 
Area Colposcopy Clinic and collected in preservative -free heparin. Patients were asked if 
they had warts at any site or had had warts or verrucas in the past. A histological report 
was obtained of cervical biopsies taken at the same time as the blood. 
Mononuclear cells were purified by centrifugation in lymphopaque (Nyegaard, 
Oslo) and plasma collected for use in both the LPA and ELISA tests. 
Preparation of Papilloma Virus Antigens 
Parings from plantar warts clinically identified as myrmecia (HPV -l) and mosaic 
(HPV -2) were collected separately into phosphate -buffered saline (PBS) containing 200 
units /ml penicillin and 200 µg /ml streptomycin. Pooled parings were thoroughly' minced 
and ground with sterile sand in a mortar and virus extracted by the method of Gissman 
and Zur Hausen [1976]. Two cycles of purification through caesium chloride of density 
133 were performed and the lower visible band containing full virion particles was 
collected and dialysed overnight against several changes of buffer. Analysis of viral DNA 
by restriction endonuclease digestion showed the two preparations to contain only type 1 or 
type 2 virions. The virus preparations were filter sterilised and stored in aliquots at -70°C. 
Purified bovine papilloma virus from a cheek fibropapilloma (BPV -1) was similarly 
prepared. 
The purified antigens were used directly in some assays In others they were treated 
by mixing 1:1 with 2% sodium dodecyl sulphate (SDS) and 2% mercaptoethanol (ME) in 
PBS, followed by ultrasonication for 1 minute. Occasionally in the LPA, an unpurified 
antigen was used that consisted of virions pelleted after grinding and sterilised by 
filtration. Further antigen preparations were prepared by extraction of pelleted virions 
with 0.1 M glycine buffer pH 9.0 [Booth et al, 1979]. 
Protein concentrations of all antigen preparations were measured by the Lowrey 
method and ranged from 0.2 to 1.0 mg /ml. 
Lymphocyte Proliferation Assay (LPA) 
Peripheral blood mononuclear cells were washed thoroughly three times with PBS 
containing 0.2% preservative -free heparin. The cells were resuspended in RPMI -1640 
(Northumbria Biologicals Ltd, Cramlington, Northumberland, UK) with 15% autoiogous 
plasma at a concentration of 106 cells /ml. Antigen was added at a concentration of 
0.04 -25 µg /ml where appropriate; 200 microlitre volumes were dispensed into the wells of 
flat -bottomed microtitrc plates (Falcon), five wells being set up for each antigen. The 
plates were incubated in a humidified atmosphere of 5% CO2 for 8 days. For the final 24 
hours, 0.75 µC; 3H- methyl thymidine (Amersham International, Little Chalfont, UK) was 
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added to each well. The cells were harvested using an flacon II harvester onto Titertek 
filter paper discs, which were counted in a toluene -based liquid scintillator for I minute. 
Lymphocyte proliferation was expressed as the stimulation index: 
mean counts /min in the presence of antigen 
S.I. - 
mean counts /min without antigen 
An S.I. of 2.0 or greater was considered positive. 
Enzyme -Linked Immunosorbent Assay (ELISA) 
The assay was a modification of the micromethod originally described by Voller and 
Bidwell [1976]. Briefly, SDS.ME disrupted virions were diluted in carbonate coating 
buffer, pH 9.6 to 1 -2 µg /ml; 100 µ1s were dispensed into alternate wells and PBS + 1% 
bovine scrum albumin (BSA) was added to the remaining wells as a background control. 
After overnight incubation at 4°C and washing four times with buffer (PBS + 0.05% 
Tween 20 + 0.1% BSA), 100 µl of PBS + 3% BSA was added for 1 hour at room 
temperature to block the remaining combining sites on the plastic [Forghani and Schmidt, 
1979]. Washed plates were dried and could be stored for up to 10 days at 4°C before use. 
Thereafter, plasma (1:50) and antihuman alkaline pbosphatase (1:500; Sigma Chemical 
Co., St. Louis, MO) diluted in PBS + 1% BSA were added for 2Y hours and 2 hours, 
respectively, both at 37°C. Substrate (paranitrophenyl phosphate, 1 mg /ml in freshly 
prepared diethanolamine buffer pH 9.8 without MgC12) was added for 20-30 minutes 
before stopping with 3M NaOH. The absorbance of each sample was measured 
spectrophotometrically. In each run a positive control (from a healthy staff member with a 
high titre to HPV -1 and HPV -2) and at least three negative controls were included. The 
negatives were selected from colposcopy patients with no known history of warts, no 
koilocytes, or warty atypic in histological sections and who repeatedly gave very low 
absorbancies on ELISA screening. 
The corrected absorbance was calculated for each sample by subtracting the 
absorbance of the background control well from that of the antigen-containing well. The 
ELISA Index (E.I.) was calculated by dividing the absorbancy of the test sample by the 
mean absorbance of at least three negative samples plus three standard deviations. 
RESULTS 
The lymphocyte proliferation assay is a useful in vitro guide to the existence of 
Tells already sensitised to a particular antigen in viva It was of interest to ascertain if 
proliferation occurred in response to papilloma virus antigens when lymphocytes from 
patients with CIN were used. Of the 92 such patients studied, 23 (25 %) gave a positive 
stimulation index (S.I. > 2.0) with at least one of the antigens chosen and at one or more 
concentrations of that antigen. As may be seen from Table I, positive responses were 
obtained in patients with all grades of CIN and there was no significant difference 
between the number in each group. Of the 23 positive responses, 14 were from patients 
with histological evidence of koilocytes and 9 from patients without koilocytes. The 
blastogenic response to the antigen was low as reflected in the stimulation indices obtained 
(Fig. 1). Figure 1 includes several different antigenic preparations used for each virus and, 
therefore, gives the number of patient tests performed rather than the number of patients 
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TABLE L Response of Peripheral Blood Lymphocytes to Papilla= Antigens i. Patients Wit Various 
Degrees of QTR as Shown b} LPA 
No. of patirnu with 
Grade of No. of No. with knilocytes or without koilocytes Total no. 
dysplasia patients (K+) or without (K -) giving S.I. > 20 with S.1. > 20 
No dysplasia 28 13 K+ (past) 3 K+ 5 (17.9%) 
at time of 15 K- (past) 2 K- 
assay 
CIN I 14 7 K+ 3 K+ 4 (28.5 %) 
7K- 1K- 
CIN II 22 14 K+ 6 K+ 9 (40.9%) 
8K- 3K- 
CINIII 28 11 K+ 2K+ 5(17.4 %) 
17K- 3K- 
Totals 92 45 K+ 14K+ (31.1 %) 23 (25 %) 
47 K- 9K- (19.1 %) 
themselves. Only the optimum concentration of a particular preparation for each patient is 
given. 
More positive results were obtained with the purified antigens (19/63; 30.2% of 
those tested) than with SDS /ME treatment (6/28; 21.4%) or using unpurified virions 
(3/16; 18.8 %). Fewest positive results were obtained with the glycine extract (2/26; 
7.7%). Nevertheless, several patients reacted only to one or other disrupted antigens and 
not to the purified preparations. 
Whereas no correlation with koilocytosis was found, the positive cases came almost 
exclusively from those with a history of skin warts (Table II). Out of 68 of those who knew 
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Fia. 1. Stimulation indices in LPA using BPV -1. HPV -1 and I- PV -2 antigens ta patients with CIN. 
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TABLE IL Influence of Skim Wart H'st«7 co the Urcode of LPA Against Pap-ioa Antigen i 
Patiets With CIIN 
Presence (K +) or atiene 
No. of No. with (K -) of kaüocytes in 
Skin wart history patienta S.I. > 2.0 positive reapottdrss 
Past or present warts 68 21 (30.9%) 13 K+ 8 K- 
No known history 24 2 (8.3%) 1K+ 1 K- 
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Ft; 2. ELLSA indice using HPV -1 and HPV -2 antigens in patients with CIN. 
they had or had had warts, 21 (30.9%) responded in the assay compared with only 2/24 
(8.3 %) with no acknowledged history. This difference is highly significant (X2 - 10.42, 
p - 0.005). 
Plasma from 73 of the above patients was tested for antibodies to HPV -1 and 
HPV -2. In addition, plasma from another 209 patients with a history of CIN was assayed. 
The specimens were screened at a dilution of 1/50, and 144 (51.1 %) were found to be 
screen -positive to at least one of the antigens. Of the 144, 72 (50%) had antibodies to 
HPV -1 only, 65 (45.1 %) to both HPV -1 and HPV -2, and 7 (5.8% of 139 tested) to HPV -2 
only. These results suggest that despite SDS /ME disruption of virions, type -specific 
epitopes were being predominantly recognised by the humoral immune system. 
The use of the ELISE Index allows quantitative comparison of results obtained at a 
single screening dilution to be made. With disrupted HPV -1 as antigen, E.I. values ranged 
from 1 to nearly 20, but with disrupted HPV -2 as antigen, the range was restricted to lea 
than 3 (Fig. 2). 
No correlation between the presence of HPV antibodies and koilocytosis or degree of 
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TABLE [V. [absence of Skis Wart History on Ambody Rtspome to HPV -1 and HPV-2 i Patients 
Wide CIN 
No. of 
No. with EL > 1.00 to 
Total no. HPV -1 HVP -2 Both 
Skin wart history Patients only only HPV 1 & 2 positives 
Past or ',molt 196 50 5 47 102 (52.0%) 
No known history 86 23 2 17 42 (482%) 
Totals 282 73 7 64 144 (51.1%) 
Presence (K +) or 









and without koilocytosis and in all grades of dysplasia is remarkably consistent. This 
finding mirrors the results obtained in the LPA. Table IV shows the distribution of 
antibody -positive patients between the two groups: those with a past or present history of 
skin warts and those with no known history of skin warts Whereas 102/144 (70.8%) of the 
positive ELISA results came from patients who knew they had had skin warts, the 
proportions within the two groups were similar. 
Apart from the greater sensitivity of the ELISA (51.1% positivity compared with 
25% by LPA), both assays gave essentially similar results. Nevertheless, there was little 
correlation between the ELISA and LPS results in the same patients. Of the 18 positive 
LPA specimens, 8 had no evidence of antibodies; of the 38 positive by ELISA, only 10 
reacted also in LPA. A further 27 of the 73 tested were negative in both tests. Thus, in 
patients with CIN, the response, both cellular and humoral, to antigens derived from 
HPV -I and HPV -2 reflects exposure to those types of papilloma virus and does not 
correlate with koilocytosis or grade of CIN. 
DISCUSSION 
In the LPA, 25% of the 92 patients gave a stimulation index greater than two against 
at least one papilloma antigen preparation. Lymphocytes from various patients responded 
differently to different preparations: thus, one patient had an S.I. of 12.7 using 
CsCI- purified BPV as antigen and 14.7 using SDS.ME -disrupted BPV, whereas another 
gave an S.I. of 1.26 with CsCI purified BPV and 10.7 with SDS.ME disrupted BPV. 
Perhaps it is surprising that any patient should react to purified virions of BPV, although 
Lancaster and Olson [1982] showed that 2/10 milk samples contained sufficient BPV 
particles to be detectable microscopically. SDS is toxic to lymphocytes, and in many 
patients the use of SDS.ME disrupted antigen led to cell death, but occasionally, as in the 
two patients described above, dilution of the antigenic preparation from 100- to 10,000 - 
fold eliminated this problem. 
LPAs for viral antigens usually require 5 or 6 days to obtain measurable responses 
by incorporation of 3H- thymidine. Lee and Eisinger [ 1976] used 6 days in their papilloma 
virus assay but reported that the blastogenic response was low at this time. An 8-day assay 
was found to yield more positive responses but led to larger standard errors (generally in 
the range of 10-25% between quintuplicate wells). The consistency of the response could 
not be significantly improved by feeding the cultures with additional medium at 5 days, 
nor by adding interlcukin -2 either on day 0 or day 4. It was felt that in many cases the 
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variation observed reflected a borderline response possibly due to a limited number of 
T -memory cells in peripheral blood. 
More patients with koilocytes gave a positive response in the LPA than did those 
without when all grades of dysplasia were taken together (Table I), but the difference is 
not significant. More patients with ON II gave S.I. greater than two than patients in other 
groups, but again the difference is not significant. On the other hand, 21/23 positive 
patients gave a history of skin warts, mainly on hands and fat. This association is very 
significant and suggests that, despite disruption of the papilloma particles to reveal 
internal epitopes, a type- specific memory response to HPV -1 and HPV -2 infections is 
being detected. 
The ELISA test is an increasingly used and sensitive assay adaptable for antigen or 
antibody detection. In this study it has been used to detect circulating IgG antibodies to 
SDS.ME disrupted HPV -1 and HPV -2 in patients with CIN. Just over 50% of patients 
were found to have detectable antibodies to at least one of these types. These results are 
comparable to those of Pfister and Zur Hausen [ 1978] already noted. 
Disruption of virions by SDS.ME is thought to reveal a group -specific antigen to 
which animal antisera with cross- reactivity can be prepared [Jenson et al, 1980]. In vivo 
the internal common antigens may not be exposed to the immune system. That the 
ELISA test described here detects type- specific antigens is shown by the fact that some 
patients reacted with HPV -2 and not HPV -1 (Table IV). The 64 patients who had 
antibodies to both HPV -1 and HPV -2 have probably had infections caused by both viral 
types, although it is also possible that some effect of cross- reactivity due to the use of 
disrupted particle is being seen. No cross -reactivity, however, was apparent with disrupted 
BPV: 55 patients gave negligible absorbancies (<0.13) with disrupted BPV used at similar 
concentrations to the HPV -1 and HPV -2 antigens in ELISA where absorbancies with 
HPV -1 ranged from 0.23 to 1.21 and with HPV -2 from 0.24 to 0.56. These variations in 
absorbancies (and thus in EI.) may reflect differences in exposure to antigen. In HPV -1 
lesions, there is greater antigen production and virion release than in HPV -2 lesions. The 
exposure to BPV will be much less. It is questionable, therefore, if the small differences in 
absorbancies noted by Baird [1983] in patients with CIN, genital warts, and cervical 
carcinoma are significant. 
The distribution of antibody to HPV -1 and HPV -2 (Table I.II) and its extent 
(measured by EL, Fig. 2) are fairly evenly matched across all grades of CIN, whether or 
not koilocytes are present. This suggests a response to an HPV other than that producing 
the cervical lesion, and indeed supports the concept of a type-specific reaction to a skin 
wart infection. 
Ivanyi and Morison [ 1976] noted no correlation between positive lymphocyte 
migration inhibition responses and the presence of antibody. Similarly in this study, there 
was little correlation between LPA and ELISA results, with 36/73 samples giving positive 
responses in only one test. In an investigation of CMI to BK virus, a member of the 
polyoma subgroup of papovaviruscs, Drummond et al [ 1985] noted no correlation between 
lymphoproliferation and antibody, also using LPA and ELISA. 
It is apparent from these results that further study of the cellular and humoral 
responses to papilloma virus in patients with cervical lesions requires the use of 
type- specific antigens. However, virus production in genital papillomas and CIN is too low 
to prepare sufficient amounts of viral antigen necessary to establish satisfactory serological 
tests [Gissman and Gross, 1985]. Nevertheless, evidence is accumulating that early 
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proteins, particularly those ended by the E6 and E7 open reading frames (ORFs) of the 
papilloma genone, can be produced both in a cervical carcinoma [Smotkin and Wettstein, 
1986] and in cultured cervical carcinoma cells [ Seedorf et al, 1987]. Fusion proteins, 
produced by the transcription of fragments of papillorna vVsus DNA containing the 
appropriate ORFs attached to an expression vector in Competent bacterial cells, have 
already been made to the E4 ORF of HPV -1 [Doorbar et al, 1986]. Fusion proteins to the 
early genes of the HPV types involved in genital lesions could be similarly produced and 
used in both the ELISA and LPA. Such work is already in progress (McCance, personal 
communication). 
Some of the early work on HPV antigens and antibodies suggested that antibodies 
were produced against wart virus infected cells [Matthews and Shirodaria, 1973]. This 
requires further investigation, and the extraction of such antigens from cervical biopsy 
material and their use in assays such as those described above could provide another 
approach for the study of the immune responses in patients with papilla= virus associated 
cervical lesions,. 
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Summary 
Using the published nucleotide sequence data for human papilloma virus (HPV) 
types 1, 6 and 16, sequences of 30 bases in length from the beginning of the E6 
open reading frame (ORF) were selected. Oligonucleotides were synthesised on 
an Oswel Gene Synthesiser and labelled at the 3' end with biotin using the enzyme 
terminal transferase. In situ hybridisation was carried out on paraffin sections of 
wart and cervical tissues mounted on silanated slides. A 2 h hybridisation step al- 
lowed the whole process to be completed within one working day. 
The technique successfully demonstrated the presence of HPV -1 in skin warts, 
and of HPV -6 and HPV -16 in genital warts and cervical lesions. This simple ap- 
proach has diagnostic potential for the detection and typing of papilloma viruses 
in biopsy material. 
Oligonucleotide; Human papilloma virus; In situ hybridization 
Introduction 
Nucleic acid hybridisation is becoming an increasingly used tool in virology (for 
review see Norval and Bingham, 1987), either by Southern blotting, dot -blots or 
in situ hybridisation. However, the full potential of hybridisation has yet to be re- 
alised for the diagnosis of viral diseases. Current methods often employ expensive 
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radiolabelled probes with limited half -lives and lengthy assay procedures. Brigati 
et al. (1983) first reported the use of biotin -labelled probes for the detection of 
different viruses in infected cells. Since then rapid in situ hybridisation techniques 
with biotinylated probes for herpes simplex virus (Forghani et al., 1985) and for 
cytomegalovirus (Ungar et al., 1986) have been developed. 
Most methods rely on probes prepared from cloned nucleic acid but few diag- 
nostic virology laboratories have the expertise, large scale bacterial culture sys- 
tems and containment facilities required for such production. Ten years ago Brahic 
and Haase (1978) suggested that DNAse digestion to reduce probe size to ap- 
proximately 50 nucleotides would increase diffusion and therefore the efficiency of 
reaction three -fold. Very recently, Lin et al. (1987) reported the use of a custom- 
ised 21- nucleotide sequence (21 -mer) probe, end -labelled with 32P, for the detec- 
tion of hepatitis B virus DNA in serum by dot -blot hybridisation and found that 
it gave an equally sensitive but quicker and simpler assay than that using 32P -la- 
belled by nick translation genomic probés. Similarly, Robertson et al. (1987) used 
a 50 -mer probe complementary to the measles virus nucleocapsid gene to identify 
persistent measles in lymphocytes from patients with autoimmune chronic active 
hepatitis. 
For human papilloma virus (HPV), DNA hybridisation is currently the only way 
to distinguish different virus types. Radiolabelled DNA probes have been gener- 
ally favoured in this situation because of their acknowledged greater sensitivity over 
non -radiolabelled probes (Burns et al., 1987). HPV DNA in cells obtained from 
cervical smears or scrapes has been successfully detected with 32P- labelled type - 
specific probes in dot -blot assays (Wagner et al., 1984; Wickenden et al., 1985). 
However, histology is a useful adjunct in diagnosing HPV infection in areas such 
as the cervix where epithelial dysplasia is commonly associated with viral infec- 
tion. In studies using in situ hybridisation to reveal the HPV types involved in 
cervical intra- epithelial neoplasia (CIN), radiolabelled probes have been used 
(Gupta et al., 1985; Syrjanen et al., 1986). Several attempts have been made to 
amplify the detection of bound biotinylated HPV probes, for example by intro- 
ducing additional biotin -avidin layers (Beckmann et al., 1985) or by silver en- 
hancement of horseradish peroxidase staining in a method capable of detecting as 
few as 10 copies of HPV DNA per cell (Burns et al., 1987). 
We have tried a similar approach to that described by Lin et al. (1987), using 
synthetically produced 30 -mers with sequences obtained from the published nu- 
cleotide sequence data for HPV types 1, 6 and 16. These were end -labelled with 
biotin and tested on paraffin sections of tissue by in situ hybridisation. 
Materials and Methods 
Biopsy material 
Sections of formalin -fixed paraffin- embedded tissue from skin wart lesions, gen- 
ital lesions and areas of cervical dysplasia were obtained from the Department of 
Pathology, University of Edinburgh. The sections were floated onto silanated slides 
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prepared according to the method described by Tourtellotte et al. (1987). Slides 
were used within 8 weeks of coating. A few slides were treated by dipping in 2% 
aminopropyltriethoxysilane (TespaTM; Sigma, Poole) in acetone as described by 
Burns et al. (1987). 
Synthetic oligonucleotides 
Published sequence data for HPV -la (Danos et al., 1982), HPV -6b (Schwartz 
et al., 1983) and HPV -16 (Seedorf et al., 1985) were studied and the E6 nucleotide 
sequences compared. Alignment of the sequences to allow comparison of the E6 
proteins was described by Giri and Danos (1986) and the 30 nucleotides which oc- 
cur immediately downstream of the ATG start codon of E6 were selected and are 
shown in Fig. 1. 
The entire GenBank database (12537 nucleotide sequence files) was searched 
for homologies to the chosen oligonucleotide sequences using the University of 
Wisconsin Genetics Computer Group software (Devereux et al., 1984). Variable 
levels of mismatching were permitted, mismatches of 9 or more bases being as- 
sumed to be insignificant. Only two comparable sequences were found. These were 
(i) HPV -11 differing from HPV -6 in 4 bases and (ii) a sequence from within the 
macrophage Fc -gamma R -beta 2 cDNA which had seven mismatches when com- 
pared with the sequence selected for HPV -16. 
The chosen 30-mer sequences were synthesised on an Oswel Gene Synthesiser 
in the Department of Chemistry, University of Edinburgh, using B- cyanoethyl 
phosphoramidite chemistry. The DNA was produced as 2 limo' contained in 1 ml 
of distilled water and had -OH 5' and 3' termini. It was purified by reverse phase 
HPLC and subsequently desalted by gel filtration. 
HPV -1a 
5' Base 107 





GAA AGT GCA AAT GCC TCC ACG TCT GCA 
134 
ACG 
HPV -11 (ATG) 
105 





ITT CAC GAC CCA GAG GAG CGA CCC AGA 
136 
AAG 
Fig. 1. Oligonucleotide sequences of 30 bases in length selected for HPV -la, HPV-6b and HPV -16, 
and including HPV -11 for comparison. 
242 
Labelling of oligonucleotides 
The oligonucleotides were labelled at the 3' end using the enzyme terminal 
transferase (Amersham, U.K.) and a biotinylated nucleotide, biotin -11 -dUTP (BRL 
Ltd., Paisley). The reagents were mixed in the proportions 3 µl of 30-mer in 12 µl 
distilled water, with 5 p.1 sodium cacodylate buffer and 10 p.l enzyme (Amersham 
3' end -labelling kit) and 25 p.1 biotin -11 -dUTP (BRL Ltd.). The reagents were 
carefully mixed, incubated at 37 °C for 2 h and the reaction stopped by loading di- 
rectly onto a pre -packed column containing Sephadex G -50 DNA grade (NickTM 
-column; Pharmacia Ltd., Milton Keynes) and eluted with TE buffer (50 mM Tris- 
HCI, pH 7.4, 5 mM EDTA, 150 mM NaCI) containing 0.1% SDS. Four drop frac- 
tions were collected and 2 µl of each were spotted onto nitrocellulose membranes, 
dried and vacuum baked for 30 min at 80°C. The labelled probe was detected with 
streptavidin, biotin -alkaline phosphatase and nitroblue /tetrazolium bromochlo- 
roindolyl phosphate (NBTBCIP) as substrate (BRL DNA detection system) ac- 
cording to the manufacturer's instructions. Strongly positive fractions were pooled 
and stored in aliquots at -70 °C. 
In situ hybridisation with oligonucleotide probes 
The paraffin sections were dewaxed in xylene twice for 10 min, washed in ab- 
solute alcohol twice for 10 min and rehydrated to water. Target DNA was un- 
masked by treatment with 002 M HC1 for 10 min followed by a 5 min wash in dis- 
tilled water and exposure to 0.2 mg/ml proteinase K (Sigma) in 50 mM Tris -HC1, 
pH 7.4, containing 5 mM EDTA for 15 min at room temperature followed by two 
5 min washes in Tris- buffered saline (5 mM Tris -HC1, pH 7.4, 150 mM NaC1) con- 
taining 0.2% glycine. The sections were dehydrated and air dried. 
The probe was added in the proportion 1:10 to the high stringency buffer de- 
scribed by Ungar et al., (1986). Sections were overlaid with 20-50 p.1 of this mix- 
ture and covered with a plastic coverslip cut from an autoclavable polypropylene 
bag, placed on a metal tray and floated on a water bath at 90 °C for 10 min. The 
tray was transferred briefly to a 37°C water bath and the slides placed in moist boxes 
at 42 °C for 2 h. 
After hybridisation the coverslips were removed by gentle agitation of the slides 
in 2 x SSC (300 mM NaC1, 30 mM sodium citrate, pH 7.0). Post -hybridisation 
washes were carried out by the method of Lewis et al. (1987), or more briefly by 
three 5 min washes in 2 x SSC. 
Hybridised DNA was detected using the streptavidin -biotinylated alkaline phos- 
phatase and NBTBCIP detection system described above, except that incubation 
periods with streptavidin and biotin -AP were increased to 10 min. After colour 
development, generally between 1 -2 h, the reaction was stopped with 20 mM Tris- 
HCI, pH 7.4, 5 mM EDTA and the slides mounted without counterstaining in 
glycerol -gelatin. 
In situ hybridisation with cloned HPV probes 
HPV la, 11 and 16 DNA inserted in pBr 322 were kindly provided by Dr. Har- 
old Zur Hausen, Heidelberg, F.R.G., amplified in Escherichia coli K101 and the 
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DNA extracted by alkaline lysis and chloroform treatment (Maniatis et al., 1982). 
The HPV -DNA still attached to plasmid was labelled with biotin -11 -dUTP by nick 
translation (BRL Nick Translation System; BRL Ltd.) and the labelled probe sep- 
arated by fractionation on a Sephadex G50 column. The plasmid alone was simi- 
larly treated and labelled. 
Paraffin sections were dewaxed and rehydrated and the target DNA unmasked 
by the method described by Lewis et al. (1987). This includes not only HCl and 
proteinase K treatment, but also brief exposures to Triton X -100 and acetic acid 
and post- fixation in 4% paraformaldehyde. Denaturation and hybridisation were 
carried out as for the oligonucleotide hybridisations, except that a hybridisation 
time of 16-18 h was employed. Post -hybridisation washes and DNA detection were 
as described above. 
Results 
The loss of sections from glass slides was prevented totally by coating with or- 
ganosilane according to the method described by Tourtellotte et al. (1987). It was 
TABLE 1 
In situ hybridisation results using genomic and synthetic oligonucleotide probes of HPV DNA types on 
selected tissue specimens 
Specimen 
No. 
Histological appearance HPV -DNA probe 
1 11 16 1E6 6E6 16E6 
1 Hyperkeratotic hand wart + ++ - - + ++ - - 
2 Simple plantar wart ++ - - ++ - - 
3 Keratotic wart on forearm - - - - - - 
4 Keratotic nodule on arm - - - +/- - - 
5 Vulvar warts K+ no dysplasia - ++ - - ( +) - 
6 Perianal warts K+ severe dysplasia ND ND ND - + - 
7 Anal wart same patient as No. 6, 
1 yr later ND ( +) - - ++ - 
8 Vulvar carcinoma ND ND - ND ( +) 
9 Vaginal warts, K +, no dysplasia, 
same patient as No. 8, 1 yr later ND - + - - + 
10 Cervical lesion, CIN II, same 
patient as No. 9 at same time ND - + - - + 
11 Anal wart, same patient as No. 8, 
3 yr later - - + - + + 
12 Cervical lesion, CIN II K+ ND - - - - - + 
13 Cervical lesion, CIN II K+ - - + - (4-) + 
14 Cervical lesion, CIN III K+ - - - - - - 
15 Cervical lesion, CIN II K+ - - + - - + 
K+ = koilocytes present; CIN II = moderate dysplasia; CIN III = severe dysplasia'carcinoma in situ. 
+ ++ = large numbers of nuclei containing HPV DNA; ++ = frequent patches of nuclei containing 
HPV DNA; + = infrequent patches of less well stained nuclei; (+) = HPV-containing nuclei only found 
with careful searching; +/- = clear nuclear staining found on one occasion but not on repeat testing. 
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necessary to stain the sections within 8 weeks, otherwise some detachment oc- 
curred. Silanation by dipping in 2% aminopropyl triethoxysilane in acetone was 
much quicker but an occasional section still detached during pre- treatment or hy- 
bridisation even on freshly coated slides. Sections of Specimen 2 (Table 1) were 
provided on uncoated slides and many of these were lost during processing. The 
concentration of proteinase K was found to be critical in maintaining the integrity 
of the sections and 0.2 mg /ml was optimal in our system. 
Material from four skin warts was examined (Table 1). Two of these contained 
HPV -1 DNA as shown by strong hybridisation with both the HPV -1 probe 32P- 
labelled by nick translation and the HPV -1E6 oligonucleotide probe (Fig. 2A,B). 
Neither genomic probes for HPV -11, HPV -16 and pBr 322 alone, nor oligonu- 
cleotide probes for HPV -6 and 16 (Fig. 2C) showed hybridisation. Consistent re- 
sults were obtained on repeated testing with hybridisation down to the parabasal 
layer being noted in Specimen 1 and in many scattered positive nuclei throughout 
the cross -cut tissue of Specimen 2 (Fig. 2D). On a single occasion, Specimen 4 
showed hybridisation with the HPV -1E6 oligoprobe in a restricted area but this 
was not observed on repeated retesting. 
Sections from five genital warts were examined (Specimens 5, 6, 7, 9 and 11; 
Table 1). Two specimens of anal warts from the same patient hybridised with the 
HPV -6E6 oligoprobe but the staining was more intense in Specimen 7 (Fig. 3A) 
than in Specimen 6, and was only just discernible with the HPV -11 genomic probe 
in the former specimen. Vulvar warts from one patient (Specimen 5) were strongly 
positive with the HPV -11 probe and weakly positive with the HPV -6E6 oligo- 
probe. 
Four specimens from a renal transplant patient known to have harboured HPV - 
16 in a malignant vulvar lesion (Rudlinger et al., 1986) were examined. Weak hy- 
bridisation was found in a restricted area of the vulvar carcinoma (Specimen 8) but 
only with the synthetic probe. One year later, vaginal warts and an area of mod- 
erate dysplasia of the cervix also contained HPV -16 DNA detectable with both 
probes (Specimens 9 and 10) and an anal wart two years later appeared to harbour 
both HPV -6 and HPV -16 (Specimen 11). 
Finally, four cervical lesions showing koilocytosis and dysplasia of moderate to 
severe degree were examined (Specimens 12 -15) and HPV -16 DNA was detected 
in 3. In two, HPV -16 DNA was detected with both the oligoprobe and the gen- 
omic probe. One of these also hybridised weakly with the HPV -6E6 oligoprobe 
suggesting a double infection (Specimen 13) (Fig. 3B). With both probes the po- 
sitive cells were found mainly in the lower layers of the epithelium. While these 
small cells could be confused with infiltrating lymphocytes, no signs of inflamma- 
tion were observed in this lesion. A further specimen hybridised only with the HPV - 
16E6 oligoprobe. 
Fie. 2. In situ hybridisation in skin warts: sections of hyperkeratotic hand wart (Specimen 1) hybri- 
. dised with: (A) biotin -labelled genomic HPV -1 DNA. (B) biotin -labelled HPV1 -E6 oligoprobe, (C) 
biotin -labelled HPV -16E6 oligoprobe and (D) section of simple plantar wart (Specimen 2) hybridised 
with HPV1 -E6 oligoprobe. 
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Fig. 3. (A)Section of an anal wart (Specimen 7) probed with HPV -6E6 oligoprobe. (B) Section of 
cervical lesion (Specimen 13) probed with HPV -16E6 oligoprobe. 
Discussion 
Paraffin embedded sections were used in this study because they are easy to ob- 
tain and retrospective analysis is possible. For a truly rapid typing service, cryostat 
sections would be preferable and work is under way to determine the optimal con- 
ditions for oligoprobes on frozen sections. Whether frozen or paraffin sections are 
used, in situ hybridisation enables the extent and site of infection to be seen. It 
has been suggested that non -invasive methods for obtaining cervical scrapes would 
be preferable to biopsy for typing of HPV (Wickenden et al., 1985; Webb et al., 
1987), but it is interesting to note that positive areas of HPV hybridisation in gen- 
ital lesions are often confined to the crevices (Chou et al., 1987) and might be 
missed by superficial scraping. A similar confinement of hybridisation to crevices 
in genital warts and to lower layers of epithelium in cervical lesions was noted in 
the current study. 
Selecting the best oligonucleotide sequences to give type specific probes was dif- 
ficult. Those human papillomaviruses whose complete DNA sequences have been 
determined show similar organisation with the conserved open reading frames being 
found in similar positions on a single strand of viral DNA. Sequence comparisons 
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also show a great degree of homology particularly in the Ll region which codes 
for the major structural antigen. It might have been possible to select a sequence 
from within L2 which is less conserved, to give type specific oligonucleotides, but 
it was decided that a sequence from within the E6 /E7 region which is important 
for transformation might give wider variation between strains with varying degrees 
of oncogenic involvement (Giri and Danos, 1986). 
Since HPV -6 and HPV -11 oligoprobes varied in only four bases it was thought 
likely that some cross -hybridisation between these types would occur. This was seen 
in Specimen 5 where a much stronger signal was obtained with the HPV -11 cloned 
probe than with the HPV -6E6 oligoprobe (Fig. 3) and conversely in Specimen 7 
where HPV -6E6 staining was much more intense. Such limited cross -hybridisation 
suggests that the oligonucleotide probes are selective for individual HPV types. Lin 
et al. (1987) chose their oligoprobe to hepatitis B virus to be universal and it might 
be possible to have one universal probe for all HPV types possibly selected from 
the conserved Ll sequence, followed by type specific probes where appropriate. 
Of great interest are the cases of CIN (Specimen 13) and of genital warts (Spec- 
imen 11) where positive signals, albeit weak, were detected with both HPV -6E6 
and HPV -16E6. There is increasing evidence that infection with more than one 
HPV type occurs. McCance et al. (1985) described 5 women with multifocal gen- 
ital intra- epithelial neoplasms in each of whom HPV -6 and 16 was found. Winkler 
et al. (1986) described HPV -6 and 16 in 65% of 43 patients with similar lesions, 
and recently Del Mistro et al. (1987) identified two types of HPV in 13 of 15 males 
with urethral condylomata acuminata. 
Good agreement was obtained between hybridisation results using cloned HPV 
probes and oligoprobes. The saving in time, with the 2 h hybridisation step allow- 
ing completion of the process within one working day, makes the technique of in 
situ hybridisation with biotin -labelled synthetic oligonucleotides an attractive 
proposition when considering a diagnostic service, not only for HPV but for other 
viruses of clinical significance. The probes, free from contaminating vector se- 
quences, can be produced in large quantities at reasonable cost and the use of to- 
tally defined sequences would allow better comparison of results obtained in dif- 
ferent laboratories. 
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